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Ab t ract 
u- 'y nucl in  aggregat ion IS the ke) pathogenic event In everal important 
neurologi al disorders inc luding Parkinson s Di ease, dement ia with Lev,)' bodies 
and mult ip le ,stem atrophy, giving ri e to a dist inct group of neurodegenerative 
di ease knm\,n a synuc lei nopathies. l though the molecular basis of u-s n 
to'Xic i ty ha not been preci el eluc idated. recent tudies indicate that u-syn 
toxi i ty i mediated b a nucleat ion-dependent aggregation process. To e lucidate 
the structural hasis of u-synuclein mediated toxic i ty, we developed various 
methods to prepare d i fferent a-synuclein species of a defined size and 
morphology di tribut ion, and v.:e inve t igated their toxic i ty in different human 
dopaminergic ce l l  l i nes. We observed that crude a-synuc lein ol igomers 
preparat ions, contai ning both monomeric and heterogeneous mixtures of u-
ynucJein o l igomers, were the most tox ic species. The toxic i ty of u- nuclein 
aggregates was directly l i nked to the presence of the monomeric a-synuclein. and 
strongly dependent on its abi l i ty in seeded nucleation-dependent aggregation 
convert ing i nto an1yloid fibri l s. Therefore any effort to identify compounds that 
could i nh ibit or e en reverse the aggregation process should assess the effect of 
the potentia l  inhibitors on the seeded aggregation of u-synuclein, among others. 
We screened th i rty Ch inese herbal medicinal compounds for their effect on u­
synucle in aggregation seeded polymerization and toxici ty by employing 
biophysicaL biochemical and ce l l -cul ture-based techniques. Among the screened 
compounds, only ginsenoside Rb I ,  salvianol ic  acid B, d ihydromyricetin and gal l ic  
ac id were shown to be strong inh ibi tors of u-syn fibri l lation, seeded aggregation 
and toxicity. Our results showed that gal l ic ac id, ginsenoside Rbi and salvianol ic  
ac id B inJ1ibit a-synuc le in fibri l lation by binding and stabi l izing the structure of 
vi 
the luble. non-toxic o l igomer. v.hich are devoi d  of p-sheet content. I n  contrast. 
dih) drom rieeti n \\a found to be able to bind to both ol igomeric and monomeric 
peel of u- ;nuclein .  I n  the case of gal l ic  ac id, th inhibit ion of u-synuclein 
fibri l lation is related to the compound' s hydroxyl moieties whose number and 
po it ion n the phenyl nng were proven to be signi ficant for the proce of 
inhibition. a i ndicated by the tructure act ivity relationship data obtained from 
fourteen tructural ly  simi lar benzoic acid derivat ives. Overal l .  the compounds 
identified herein rna repre ent the starting point for designing new molecules that 
could be ut i l ized as drug [or the treatment of Park inson's Disease and related 
di order . 
K eyword : u- ynuclein, Parkinson's Disea e, aggregat ion, seeded-nucleation 
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1 . 1  Pa l-ki n o n '  D i  ea e 
Park in. on ' s  di ea 'e ( PO)  i a neurodegenerati\ e di order caused by the 
gradual los of dl paminergic neurons ( b et a I . ,  2008) .  PO affect about 1 -2° ° 
of the current population ov er the age of 65,  \\ i th an average durat ion of 8 ) ears. 
\ I though the peak age of n et for PO i b t\-\een 5 5  to 6 �  y ear , the age of onset 
I"or the d isea c range from 20 to 80 years, the incidence of \\ hich ri es harpJ) 
aftcr the fi fth decade 0 1" l i fe. affect ing ] AO o and 3 Ao,0 of the population at 55 and 
7: ) ears of age. respect i\ e l)  ( . Wood, 1 997 ) .  Ca e of PO \\ i th an age of on et 
bet\\ ecn 2 1  and -+0 year ha\'e been cal led "young-onset Parkinson ' s Disease" 
and \\ hen it start ' before the age of 2 1  it i cal led j ll \ eni le  parkinsonism (Quinn, 
ri tchIe;. , & f\ lar den, 1 987 ) .  
PO atTect a region of  the brain known a the ubstant ia n igra, resul t ing in a 
dramatic 10 s of dopaminergic neurons and a concomitant p lummeting in  
dopami ne lev el in  the triatum. As a consequence, PO i s  manifested by a plethora 
of c l in ical symptoms, with the most prominent being impaired motor activity, 
muscle rigidi ty and a re ting tremor. europathological ly .  PO i characterized b) 
the pre ence of intrace l lu lar inclusions known a Lew) bodie ( LBs) and Lewy 
neuri t is  (LXs) , the main constituent of which are a-synuclein (a-syn )  fibri l s  (E l -
gnaf e t  a l . .  1 998 :  l -Agnaf. lakes, Curran, & Wal lace, 1 998:  lake , p i l lant in i ,  
& Goedert. 1 99-+: pi l lant in i  et aL 1 997 ) .  Mo t ca e of PO are idiopathic ( 85°'0) ,  
\\ hich are characterized by late-onset, non-inheritable movement disorder with 
neuronal loss in the brain ( revie\ ed by ( I rv ine, EI-Agnaf, hankar, & Walsh, 
1 
2008 ) .  Dopamine replacement by L-" -4-dihy dr '\y phenylalanine ( L-D P \) ha 
helped to in rca e d pamine in  the neurotransmi tter-depleted trlatum. I though 
thi i cffc t i \ e treatment in the earl y stage of PD. it \\ i 1 1  10 e it therapeutic 
qual it ic · \\ ith t ime. I o date there i no treatment that can arrest or rewrse the I 
r dopaminergic neurons. fhe etiology of PD i poorly  under tood. but 
eOl1\ crgent path I gical . biochemical. animal model and g net ic e\ idence 
ugge t that the Conllation of u- y n  protein depo i t  is  an important and. 
probably. eminal tep in  the de\ e lopment of PD and related di  orders. 
\ l though a- y n  belong the fami ly of nati\ e l)  unfolded protein , \\ hich 
demon trate l i tt le r n ordered structure. the protein has the intrinsic propen ity 
to fibri l late. gi\  ing ri e to insoluble fibri l  s imi lar to the one detected in  LB 
( onway, Harper, & Lan bury, 2000b; E I - gnat', Jake , Curran, Middleton. e t  a l . .  
1 998:  Gia on. rI'u, Trojano\\ ki. & Lee, 1 999b: Ha l1 imoto et a ! . .  1 998b). 
ddi tional ly,  fi v e mi en e mutation in the a-s n gene (SNCA ) .  namel y  53T 
( 1 .  H.  Polymeropoulo e t  a l . .  1 997) .  A30P (KrOger e t  a I . ,  1 998).  E46K (Zarranz 
et a l . .  2004) .  H50Q ( Appel - re wel l  et a l . .  20 1 3 ) and G5 1 D  ( K iely et a ! . ,  20 1 3 ), 
hav e been l i nked to inheri ted form of PD, while dupl ications and tripl ication of 
SCA l ead to auto omal dominant PD i n  a gene do age-dependent fashion 
( Ibanez et a l . .  2004: ingleton et a1 . .  2003b ) .  Moreover, transgenic animal and 
dro oph i la  model expres ing ei ther wi ld-type or mutant human a-Syn al 0 
develop fibri l lar inclusion and a Parkin onian phenotype (Cannon et a I . ,  20 1 3 : 
Feany & Bender. 2000 : Imai ,  Vendero\ a, Park, Cai. & chmidt, 20 1 ) :  Kahle et 
a1 . .  200 1 : M asl iah et a ! . .  2000) .  I t  i noteworthy that the fibri l lation of u- yn is 
impl icated in  the development of a eries of neurodegenerat ive di  ease . inc luding 
mult iple system atrophy ( M  A)  and dementia with Lewy bod ie ( OLB), which 
2 
are col lecti \ c l ;  referred t a alpha- ; nu lein pathie ( p i l lantini oedert. 
:WOO: Trojanov .• ki & l ee, 2003 ) .  Taken together, the e findings indicate a central 
role � r a- } n aggregati n in PO pathogene i a- ; n aggregation proceeds through 
sc\'cral key intermediate stages. \\ i th monomeric a- yn fir t assembl ing into 
l igomeric � rrn that gradual ly generate in oluble am) loid fibri ls .  Because a- ) n 
aggregat ion p ia; a rucial role in PO path genesi and related alpha­
S; nuclcinopathies, inten i \'c effort ha been put into ident ifying compound that 
could block or e\, en re\ er e the aggregat ion proce s.  O\, er the years, polyphenol , 
a 'et of more than 8000 c mpound that contain one or more phenol ic ring , ha\'e 
emerged a potent am) I id inhibitor , interfering \\ i th the ill vitro fibri l as embly 
of man} am) loidogeni proteins including a-s. n, �-amyl id ( �) ,  tau-protein and 
pri n ( re\, i wed b; ( Porae Abramowitz, & Gazit,  1006 ) .  
1 .2 y n u cle i n fa m i ly 
ynucleins are smal l ,  soluble protein  highly expres ed by neuronal cel l s  
(Jake . e t  aL 1 99�) . The ynucle in fami ly  ha  three dist inct member a-, � - and 
y- ) n ( reviewed by ( mer, I rvine, & EI - gnaL 1006). tructural ly ,  synuclein are 
characterized by the repeti t ive presence of the amino acid  mot if  KTKEGV 
throughout the fir  t 87  re idues, whi le their C-tenninal region is r ich in  ac idic 
amino acids .  Moreo er synucleins are natively unfo lded proteins meani ng that 
they have no structure under physiological conditions and their tructure is 
compo ed of random coi ls. Also, synucleins have high net charge and low 
hydropathy ( revie\ved by (Amer, et aL 2006 ). The s nuclein fami ly  genes are 
mainl} expres ed i n  the C but their distribution in  the brain i l ightly  aried. 
3 
J /o\\ e\t!r. the ') nucle in fami l y  i not 0 e'\.pre ed in  other ti ue uch a the 
heart. lung. keletal muscle. o\ arie . te te . col n and pleen. 
1 .2 . 1 tt-S) nuc J  In 
u-. ) 11 I S  a oluble protein \\ i th a equence of 1 40 aminO a id residues 
(Jake�. ct a! . .  1 994: L 'cda et al . .  1 993) .  SXC l i the g ne that 0.- _ n i encoded by 
and it i located on the long am1 of chrom orne 4 (4q2 1 -q23 )  ( . Chen et a l . .  
1 99 - : ia et aL 200 1 ) . orne homologous protein [or a-s n ha'\ e been ident i fied 
in  e lectric ray ( larotcall:\. ampane l l i ,  & chel ler, 1 988) ,  rat ( i .e. synllc lein- l )  
( \ laroteaux & chel leI'. 1 99 1 ). zebra finch ( i .e .  y ne lfin)  ( 1 .  M .  George, J in, 
Wood , . layton , 1 995)  and other species. 0.- ) n  was first di scovered in the 
neuromu cular junction of the electric ray. Antibodies against a-syn label led both 
'J nap e and nuclei lead to the name ynucle in ( Maroteaux, et a I . ,  1 988) .  rhree 
isofom1 of 0.- ) n protein  hm e been identi fied. 1 40 amino acids at ful l - length 
form \\ h i le  the other t\\ O are truncated at 3 ' end resul t ing in 1 26 and I I :? amino 
ac id protein  ( Be er et a l . .  2008: Campion et aI . ,  1 995) .  0.- yn can form 
amphipathic hel ices \\ hen it interact with phosphol ipid l ayers ( 1 .  L .  George et a l . .  
2009) .  and the a-hel ical structure wi l l  i nten i fy according to the binding to sma l l  
ynthetic .  acidic ,  unimolecular vesic les ( W .  ean Davidson, Ana Jona , David F. 
C layton.  & Ju l ia  M. George, 1 998) .  It was suggested that a-syn could be part of 
the fatty acid-binding protein fami ly  due to its b iochemical properties and 
structural moti f. hence a-syn could tran port fatty ac id between the aqueoll and 
membrane phosphol ip id compartments of neuronal cytoplasm ( haron et a I . ,  
200 1 ) . The abundance of 0. - 1'n i n  presynaptic tem1inal and early tages of 
de elopment indicate that Ct- yn plays an important role on the maintenance of 
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) napt ic \ e ic le pool '  and maintenance f pre ) naptl fun t i  n ( abin e t  a l . .  
_(02 ) .  
L1-Agnaf and co-\\ orkers have demon traled that a- ) n  can e lf-aggregate 
and form am) I id- l ike fi lament' simi lar to th se that have been i olated fr m 
I Bs. and that the mutant · a- ) n protein a ociated with fami l ial foml of PD 
aggregate ra ter than the \\ i ld-t) pe protein ( EI -Agnar. B dIe , Guthrie, Harriott, & 
I n i nc. 1 998) .  
Animal models.  genetic and biochemical tudi support the hypothesis 
that accumulation of a-'yn in  the brain ha a signi fi cant role in the pathogene is 
of a number of neurodegenerat ive d isea e l i ke PD. (L- yn has l i tt le or no ordered 
structure under ph) siologi al condition . and its econdary structure i a random 
coi l ( Weinreb, Lhen. Poon. onwa) , & Lansbur) , 1 996),  however, recent studie 
ha\'e indicated that (L- ) n occurs  as a hel ical l) folded tetramer ( Bartel , hoi. & 
, el koe. 20 1 1 ) . The region co"\ ered by the first 1 00 amino ac id  re idues of a-syn 
adopts an a-hel ical structure upon binding to pho phol ipid membranes (Chandra. 
hen. Rizo. lahn. & Ddhof. 2003 ) .  l ipid ve ic les ( Bus e l l  & El iezer. 2003b; W . 
. David on. . lona . D.  F. Clayton, & l. M. George. 1 998;  Perrin, Woods, 
la)ion. & George. 2000) and detergent micel les ( Bu el l & El iezer, 2003b) .  The 
con en u equence KTKEGY is con idered to play a key role in  the a-helical 
tructure assumed by a- yn (W .  . Davidson, e t  a ! . .  1 998;  Weinreb, e t  a l . .  1 996) . 
The C region of (L- yn i e 'ceptionally hydrophobic and amyloidogenic, thus 
promoting the confomlational change from random coi l to �-structure (E l -Agnaf 
& In i ne. 2000; eda, t a l . .  1 993 ) . In contra t, the acidic C-temlinal region 
remains unfolded and a oc iates with ve ic les or micel les (E l iezer, Kutluay, 
Bus e l l ,  & Browne, 200 1 b). Howe er, the -terminus is responsible for many 
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tran. icnt long-rangc interacti n \\ ith the -terminu and the ' regi n, thu 
conferring tabi l i ty to the U-S) n m lecule ( ung & l iezer. 2007: K. P. Wu. Kim, 
I eia, & Baum. 2008 ) A far a the phy iological function of u- ) n i concern d.  
i t  remain unclear. I I \\ cver. research indicate that u- yn ma) pia) a role in 
neural p ia t ic it} (J .  1 .  eorge, t aL 1 995 ) and in normal RE protein 
as embl ) , \\ hich i crit ical for neurotran mitter re lea e and ve icJe rec) c1 ing 
( Burn� ct aL 20 1 0) .  
1 .2 .2  p- y n uc lc in  
[he p-S) nuclein gene ( , SeB) i located on chromo orne 5q35 and code for 
1 34 amino acid protein named p- ynuclein ( p - y n ) .  u- and p- ) n  hare 78°'0 
homolog} and. B-s) n ha a conserved C-terminal domain containing three 
identical ly  p laced t) ro. ine re idu s. Both (t- and B- ) n have simi lar ubcel lu lar 
local ization and expression pattern in the brain.  However. p-S) n lacks 1 1  
hy drophobic ami no ac id re idue that corre pond to the 72-84 re idues of a-syn 
( Fig .  1 . 1 ) . In a recent tud:. p- yn \: as shown to ha e a neuroprotective role by 
i nhibi t ing a-s) n aggregat ion. Cel l s  over expre ing p-syn are more re istant to (t-
)'n accumulation ( H a  himoto et aL 1 998a) .  Moreo er, cel l that o\. erexpress p­
yn activate the erine threonine kina e AKT (a l  0 known as protein k ina e B) 
signal l i ng pathway and are more resi tant to u-syn neurotox ic i ty (Ha himoto et 
aL 2004) .  In tran genic mice, p-syn reduces (t-S n accumulation in the brain and 
improves survival rates, as wel l  as motor dysfunction (Ahmad, Attoub, ingh, 
Mart in .  & EI -AgnaL 2007). Double  transgenic mice expressing human SNeA and 
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F igur 1 . 1 :  equenc homology of ynucle in fami l ) . 
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,XCB ho\\ ed a reduced accumulation of a- yn in the brain (Ha  himoto, et 
aL 2004) .  dditional l ) , i t  ha been reported that p- yn exrubits a chaperone 
acti\ i t) more efficient ly than a- yn ( D. Lee. Paik ,  & Choi. 2004) .  However, 
unl ike a- yn, p- yn ha much les a tendency to aggregate and form amyloid 
fibri l . 
1 .2 .3 y- y n uclein 
The third member of the synuclein fami ly .  the y-syn gene (S rCG) i located 
on chromosome 1 0q23 and encodes a 1 27 amino acid protein ( reviewed by 
( Ahmad. et aL 2007) .  The y-syn gene was fir t referred to as BC G 1 (brea t 
cancer- pec ific gene 1 ). the levels of which increase dramat ical l y  i n  breast 
carcinoma ( J i  et a l . .  1 997). However, the name was l ater changed to S CG due to 
its h igh homology to synucle in proteins (La  edan et aI ., 1 998) ,  despite the fact 
that y-syn i s  overe 'pre sed i n  breast cancer tumours inkina et a l . .  2003 ).  
im il ar to a- and p-syn. the -term inus of y-syn i s  conserved but its C·terminus 
shows reduced homology to other members of the fanl i ly .  y-Syn colocal i zes with 
neurofilaments in the axons ( inkina, et aL 2003 ) ,  and alters neurofilament 
netv.ork i ntegrity by rendering neurofilament-H vulnerable  to calcium-dependent 
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protea e ( Buchman et a ! . .  1 998 ) .  Furtheml reo y- ') n i expre ed in the early 
stages of axonal outgro\'\'th and maintained throughout i t  l i fe. tIm indi  ating that 
y- yn ha a role  in the [; nnation of the nen ous ) tem ( Buchman. et a l . .  1 998) .  
nl ikc u- I n. y- yn has a weak tendenc) to [; nn amyloid fibri l ( ia  on. 
lurra) . Trojano\\l ki. & Lee. 200 1 ). 
1 .3 Gene  a ocia ted wi th  P D  
enetic tudie ha\ e l i nked sev eral gene to PD.  These genes can be 
categori7ed ba ed on thei r  mode of inheritance : aut somal dominant l i ke u- yn 
(. SC n and cucine-ri ch repeat k ina es 2 ( L RRK_ ) or aut omal rec sive l ike 
Parkin and 
PIX;:I . However. thi c ia, ification can be chal lenging due to the reduced 
penetrat ion in the dominant form and the putat ive role of single heteroz gous 
mutat ion in the re e ive foml ( see Table .  1 . 1 ) . 
The stud) of PD genetic can be a complex ta k given the interaction of 
se\ eral genes that are encoded by nuclear or mi tochondrial D A both. or 
epigenetic ( re\er ib l  , heritable change i n  gene expre ion without a change in  the 
D A equence). not to mention the influence of envi ronmental factor that alter 
the expression of relevant genes i n  relation to age-dependent effect . 
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rable 1 . 1 . 1 oci and gene a - c iated \\ ith PO adapted [r m E  chbach and Oanzer.20 1 " . 
,.- . . 
DesIgnation Gene Locus Protein function I nheritance LBs 
I '  \ R K  I \ \ (  f point -Iq2 1 among others: S) naptic \ esicle autosomal + 
mutation release amI homeostasis dominant ( ,\ D )  
P \ R K  2 I'adm 6q25-q27 ubiquitin l i gase autosomal -/( + )  
recessl\.: ( t\ R )  
�\ R I(3 unkno\\ n 2pl J  unJ...no\\ n .\D � 
I' \ R K  4 S \ C f  4q2 1  see abo\ e -\ D + 
g�nomic 
mult ipl ication 
I',\ RK 5 UCf/-U -Ipl -l 1 5  ublljultlJ1-h\ drolasl!ll igasc AD unJ...no\\ n 
P,\ R K  6 1'1\ 1\-/ I q35 -- 36 mitochondrial protein J... inasc A R  + 
I',\ R K  7 N-/ 1 )136 o,idati\  e stress response A R  UnJ...nO\\ll 
PAR K  !\ 1 RRI\.:: 1 2p l l .2-qI 3 . 1  protein J... inase A D  + 
P A R K  <) , "1'13 f ::  1)136 h sosomal (\PC 5 P-.\ I Pase A R  unJ...no\\ n 
I',\ RI\. 1 0  unkno\\ n Ip32 unJ...no\\ n not clear unkllo\\ n 
I' \ R K  I I  (,,(/ ) 1- :: 2q36-q37 unJ...no\\ n A D  unkno\\ n 
I',\ R K  1 2  unJ...no\\ II '\q2 1-q25 unJ...no\\ n '\ I inJ...ed unl-no\\ n 
I' \ R K  I J  IIlR L ?  0111/ 2p l 2 I l tr \2. Omi stres --regulated A D  + 
serine endoprotease 
I',\ R I\.  1 -1  I'lA::G6 2211 1 3 1 \ R  lInJ.. no\\ n 
P,\ R I\.  1 5  /' 8"'07 22q 1 1 _2-qt�r A R  unJ.../1()\\ n 
PARI\. 1 6  .WC.J5 t3 I q32 ( magncsium transport�r) not clear unl-no\\ n 
\ 1  C"-.�/ RAB7L I ( small  Gl P-bllldmg 
RA8 �L I  protein  pIa) ing an Important 
Sf C.J/A / role 
P I/::OD/ in  regulatlJ1g e,o- and 
endoc) totic path\\ <J)s) 
L C K I (nuclear protelJ1 
containing se\ eral consensu -
phosphor -
) latlOn slles for casein J... inase I I  
and c} c l in-dcpendent J... l J1ascs) 
P .\ R K  1 7 GIK'DGJ.:Q homosomc -I p GA K (C) cl in G-as ociated not clear unkno\\ n 
kinasc. a ccll cycle rcgulator) 
DGKQ (dlac) Igl) cerol J... inase. 
theta: lJl\ oh ed in the 
phosphaud) l inositol s ignal l ing 
s) tem) 
PARK 1 8  flU DRA 6p2 1 .3 class I I  l iLA-DR ant igcns that not clear unJ...no\\ n 
are e'presscd bi 
antigenprcsentlJ1g 
cell 
1 .3. 1 <l-Sy n uclein gene (SNCA ) 
To date PARK} ha been shown to play a significant role in  PO as 
demonstrated in  the genetic analysis of a l arge I ta l ian fami ly (Golbe, 1 990). The 
c l in ical symptoms are s imi lar to sporadic PO but have an early age of on et ( mean 
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agc ·r .6  ) car ). and l ight l)  m re rapid our e to\\ ard death (9 .2  ) ar ). The 
m)� ·cn c mutati n G t A tran i t ion at po i t ion 209 in exon 4 of SYCA wa 
identi fi�d a the disea t: locu resul ted in r placem nt of alan ine \\ ith threonine at 
posi tion 53 ( 53 J )  ( l i hael 1 1 . Poly mer poulo et aL 1 997) .  Kruger and co­
\\ orker ha\ e equenccd S\'C A gene in a German fami ly with fami l ial PD, and 
the) found a trong l i nk bct\\ cen for C ub t i tution at nuc leotide 88 in exon 3 of 
the S,YCA gene. Thi ub t i tllte replace alanine for prol i ne at amino acid 30 
(A30P) (Kruger et a! . ,  1 998) .  Pat ient with A30P mutation wi l l  have an onset of 
PO in their 50s. s l ightl) later than the mean age in the A53T patients. In 2004, a 
third missense mutati n in  S;VCA re pon ible fi r auto omal dominant PO and 
dement ia wa found in a pani h fami ly .  ingle ba e pai r  change at  posit ion 1 88 
from to A re ul t ing in the replacement of acidic polar glutamate residue \ i th 
the basic polar I) s ine re idue at posit ion 46 ( E46K) (Zarranz, et aI . ,  2004) .  
10reo\ er, 1I50Q ( ppel- re wel L  et a! . ,  20 1 3 ) and G5 1 D  (K iely, e t  a! . ,  20 1 3 ) 
mutation have been reported recently. Dupl ication (Chart ier-Harl in  et a! . ,  2004) 
and tripl ication of , SeA (trip l ication in  01 ing the 1 . 5 Mb region) ( ingleton et 
aL 2003a) have al 0 been reported, and i t  i bel ieved that the severity of PO 
depend on the do age f SNCA . 
1 .-t  Agg regat ion of a-Sy n u cle in  
The fact that aggregated a-syn is  the major component of inc lusions in  0.­
synucleinopathy brain uggests that a.-syn aggregat ion may be relevant to the 
pathogenesis of neurodegenerat ive d isorders uch a PO, DLB and M . The 
morphology of \ i ld type (wt) or mutant a.-syn fibri l s  generated in l'ilrO i s  imi lar 
to that detected in  L B  (Conway, Harper. & Lansbury, 1 998;  E l -Agnaf, Jakes, 
Curran. Middleton. et a ! . .  1 998;  G iasson. Uryu, Trojanowski .  & Lee, 1 999a; 
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Ha him to. et al . .  1 998b: rpel l  B '  Jak G d & C h . mman. 'e .  0 ert. . rO\\1 r. _000) .  
al 0 impl) ing  a ke) role  of u- ) n aggregat ion in  LB  pathology. 
The fibri l lation of u- ) n i a nucleation-dependent polymerization proce 
. J .  W od et aL 1 999). with an init ial  lag phase. an exponential pha e and an 
equi l ibrium pha e ( Fig.  1 .2 
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Figure 1 .� :  uc1eation-dependent polymerization model of amyloid aggregat ion 
( Adapted from ( Kumar & Walter. 2 0 1 1 ) . 
During the lag phase. the formation of nucle i  takes place, fol lowed by the 
exponent ia l  growth of the fibri ls .  which eventual ly reach a dynamic equi l ibrium 
state with protei n  in  solut ion ( Kaylor et a l . .  2005b; erpe l I .  et al . .  2000: U er kyo 
M Cooper. Bower. Li .  & Fink. 2002 ) .  a- n fibri l l ation proceed through 
o l igomerisation i .e .  the formation of mult iple non-fibri l lar o l igomer i ntem1ediates 
termed protofibri ls .  which ubsequent ly  convert i nto mature amyloid fibri l s  
( Conway. H arper. e t  a l . .  2000b: Kaylor. e t  a l . .  2005b) .  The secondary structure 
content of the protofibri l s  varies as a �-sheet structure appear in larger aggregates 
1 1  
(I� I -t\gnaL B dies. et a l . ,  1 99 ; ath. 'vleU\ i . Hendri.· .  arl . & Engelborgh . 
20 1 0 ) .  It \\ a '  h \\ n that spheroidal o l igomer a .'ume both an a-hel i  al and to a 
lesser degree. a �- heet conf nnation. the extent of \\ hich decrease and 
increase . re pect i\  e l) . as aggregati n proceed ( petri .  1a i t i .  Zagorski .  Carey, 
e' \nder on. 200 ). 
It \\ as sugge kd that fibri l de\ clop from ol igomer b) further 
aggrcgati 11 . The aggregat ion f monomeric a-s) n into fibri ls  run through 
d i lTerent tages, \\ here di fferent intem1cdiated forms protofibri ls and insoluble 
fibri ls .  or remains a ol igomer ( aughey & Lan bur) , 2003 : I Ioyer et al . ,  2002 ; 
\luni ·h\.. ina, Phelan, ver k) . & Fink, 2003 ) .  
Variou form of p r  tofibri l s  have becn ob  en:ed inc lud ing pherical 
( Colm a) et a I . ,  2000a; Di ng, Lee, Rochet, & Lan bur) , 2002; D.  P .  II ng, Han, 
F in\... & lh er k ) , 20 1 1 )  and pheroidal (Apetri . et a I . ,  2006), hort chain- l ike 
( onwa) . Lee. et al . ,  2000a), c i rcular uch as ring- l i ke, annular ( doughnut- l ike)  
and pore- l ike ( OI1\\ a , e t  a I . ,  1 998;  Ding. e t  a l . ,  2002 ; La huel e t  a I . ,  2002 ; 
Lo\\ e.  Pountne), Jensen, Gai, & Voelcker, 2004) ,  tubular ( La huel ,  et a I . ,  2002), 
granular ( Bhak, Lee, Hahn, & Paik ,  2009) and globular (Apetri, et aI . ,  2006) .  s 
far as the structure of a- n fibril s  i concerned, it i s  characterised by the pre ence 
of a central core composed of cross �-sheet tructure, in which �-strands extend 
perpendicular! to the fibri l axis ( M .  Chen, Margittai ,  Chen, & Langen, ... 007; 
Der- arki ssian. Jao, Chen, & Langen, _003 ; Heise et aI . ,  2005 ) .  Each �-strand 
compri es approx imate l ly the amino ac id residue 3 1 - 1 1 0  of a-syn monomer (Del 
1ar. Greenbaum. Mayne, Englander, & Wood . 2005;  Der- arki ian, et al . ,  
2003 ; Heise.  et aI . ,  2005 ; V i l ar et aI . ,  2008) .  
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' I he fibri l lat l n of u- ) n can be affected by vari u factor 1f1 "'ilro. The 
factor' m dulat ing fibri l l ation in ,'ivo may d i ffer from tho operat ing in \'ifro: ) et 
di<;sect ing the 111 " jlro aggregation of u- ' } n can lead t the ident ification of 
aggregati n inhibi t  r' and a better under tand ing of the underl) ing mechani m . 
1 . 5 I m pl ica t ion  of (1- yn  o l igomer a n d  fi br i l  
Even the I B ontai n mature fibri l of u-syn, there i e idence suggest ing 
that o l igomeric and protofibri l ar forms of u- n are the pathogenic pec ies in  PD 
(F 1 -AgnaC \Val h. c' Al l  op. 2003 : Winner et a I . ,  20 ] 1 ) . A number of 
mechanism bm e been sugge'teu as a potential consequences of a-s) n aggregates 
or o l igomers a endopla mic ret icu lum tre ( mith et a l . .  2005) .  oxidat i \e  stre s 
( E  teves. rduino. \\ crd lo\\ . Ol ivei ra. & Cardo o. 2009),  mod ified chaperon 
act i \  i t}  ( bandra. Gal lardo. Fernandez- bacon. chlLiter. & i.idhof. 2005 ). 
dy function of th ubiquit in proteasome ystem ( tefan i . Larsen. Rideout. ulzer. 
& Greene. 200 1 ;  Y. Tanaka et a ! . .  200 1 ), defects in the mi tochondria and Golgi 
apparatu (Go a i .  Lee. Lee. Pate l ,  & Lee. 2002; H u et a! . .  2000; ong. hults. 
i k. Rocken te in .  & 1a l iah. 2004) .  defecti\e axonal transport (A.  A. Cooper et 
a l . .  2006: Dalfo.  Barrachina. Rosa. Ambrosio. & Ferrer. 200- L Outeiro & 
L indqui t .  2003 ) .  \ e ic le permeab i l i  ation (Voi les & Lansbur) , 2002 : Vol le et 
a l . .  200 1 ) and Iy osomal defects (Cuervo. tefanis. Fredenburg. Lansbury, & 
ulzer. 2004 ; tefani . et a l . .  200 1 ) . I t  has be n uggested that a-syn pathology 
pread gradual l y  throughout the neuraxi as PD progress ( Braak et a l . .  2003 ).  s 
the underlying mechani m of di sease progre ion in  PD is st i l l  unknown. some 
recent studie sh wed that grafted heal thy neurons gradual ly  develop the ame 
13 
pathol g} a ·  the ho,t neuron ' in PO brain ( K  rdower. hu. Hau er. Ian \\ . & 
r reeman. 200 : J .  Y .  1 i ct a 1 . .  2008 ) \\ hich rai e ·  the pos ib i l I tv that u- '\'n i - -
re lea 'ed fr m neuron the extracel l ular "pace and i taken up b} ther cel l  . 
'J hi , is c nsistant with the fact that u- } n  can be detected in  cerebro pinal fluid 
and pia ma in  mea urable quanti t ie ( EI - gnaf et al . .  2006: 10 l lenhauer et a 1 . .  
2008) .  A I  '0  in  \'ilrO experiment ha\ ho\\ n that fibri l lar and o l igomeric form f 
u- 'J n can be taken up [rom extrac I I Ll lar space by neur n \ ia the endocytic 
proc\.: C l l . J .  Lee et al . . 2008) .  Other studies howed that recombi nant u-syn 
ol igomer' are a l  0 taken up by cultured neuron and ini t iate cel l death ( Danzer et 
a l . .  2007: Danzer. Kreb . W I ff. Birk. & l iengerer. 2009) .  The prion- I ike 
mechani m. ould repre ent a possible mechanism re ponsible for the ho t -to-
graft tran fer of PO pathology a ugge ted b De plats and col leagues ( Desplat 
ct a l . .  2009) when they demonstrated that u- yn can be direct l }  transmitted from 
neuronal cel l overexpre sing u- } n  to transplanted embryonic stem cel ls .  in 
t i  ue cul ture and tran genic animals .  The increa ing amount of data make the 
po ib i l ity that a spec ific  conformation of u-syn is tran mi tted from host ce l l s  that 
promote the aggregation of a-syn and trigger toxic ity in adjacent neuron . The 
i mpact of seedi ng on amyloid aggregation ha al 0 been establ i shed b a number 
of studie i ndicat ing that a-s n aggregat ion can be induced and accelerated by the 
addit ion of exogenous o l igomers and fibri l s  in cul tured cel l s  (Danzer. et a l . .  2007, 
Volpice l l i -Daley. et a I . ,  20 1 1 ,  onaka, et aI . ,  20 1 0) and in  mouse brain (Luk. et 
a l . .  20 1 2 ,  Masuda- uzukake. et a l . .  20 1 3 ), upport ing the hypothe i that the 
aggregation of  the native protein is d i rect l }  eeded b) exogenou aggregat 
O,eral l .  these studie support the notion that amyloid tox ic i ty is mediated b} a 
nucleation-dependent polymerization process. 
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1 .6 M u tat ion  a n d  t ru nca t ion  
1 .6 . 1 \- 1  u ta  t ion 
Fi \ e  missen e mutation in the a- I n  gene ( ). namel) A53T ( l i hael 
I I . P I) meropoulo . et a l . .  1 997).  A30P ( Kruger. et a ! . .  1 998).  E46K (Zarranz. et 
a l . .  2004). H50Q ( ppe l - re \\ e l J .  et a ! . .  20 1 3 ) and G5 1 D  ( Kie l ) . et a l . .  20 1 3 ) . 
hm I: been l i nkeu to c\ ere inheri ted form of PD. whi le dupl ication and 
tripl icat ion of A lead to autosomal dominant PD in a gene do age-dependent 
fa hion ( Ibanez. et a ! . .  2004; ingleton. et a ! . .  2003b) .  a- yn mutations. A30P . 
. \:'"  r E46K and HSOQ . have been reported to promote the aggregat ion of the 
protein ( h i .  rmstrong. Jone , E isenmesser, & Liu, 20 1 4; COIl\\ay. lIarper. et  
a ! . .  2000b; E l - gnat'. Jake , urran, & Wal lace, 1 998;  Gias on. et a t . .  1 999a; 
Greenbaum et a l . .  2005 ; Khalaf et a ! . ,  20 1 4 ; J .  L i ,  er  ky o  & Fink ,  200 1 ;  arhi 
et a t . .  1 999). Wherea 30P mutation acts b tab i l i zing a- )in into ol igomer 
( onway. Harper, & Lan bury. 2000a) . 53T and E46K increase the propensity 
of the protei n  to fibri l l ate (Com ay, et aI . ,  1 998;  Conway, Harper, et a ! . ,  2000b; 
Greenbaum. et aL 2005 ) .  It wa recently reported that whi le E46K accelerates the 
o l igomerization of u.- yn i t  can eed fibr i l  fom1ation more efficient l )  compared to 
\\1 and A30P o l igomer ( Ono. I keda, Takasaki .  & Yamada. 20 1 1 ) . Recently G5 1 D  
mutation was found to ignificantly attenuate a-syn aggregation in vilro and to 
decrease the abi l i ty of a- yn to bind to l ip id vesicles C-terminal to the site of 
mutat ion ( Fares et a l . ,  20 1 4) .  
1 .6 .2  C-te r m i n a l  tru ncat ion 
Partia l ly  truncated u.-syn has been detected in  LBs from DLB brains 
( Anderson et a! . ,  2006; Baba et aI . ,  1 998), gl ia l  cytoplasmic inclu ions (G I )  of 
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\ 1  \ ( ai , PO\\ CL Blumberg . ulYenoL & Jen-en, 1 999) and abn rmal neurite 
or AI/helmcr 's  Diseasc \\ ith ut I B ( lewi et al . .  20 1 0 ). ugge t ing that 
tt.:rminal truncat ions ma) play a r Ie in the aggregation f u-syn . number of in 
drro stud ic' ho\\ cd that -tcnninal l) truncated human 0.- yn, uch a 1 -87. I -
1 02.  1 - 1  1 0. 1 - 1 1 9  and 1 - 1 20 as emble at much fa ter rates compared to ful l  
length � nd mutant protein ( ro\\ ther. Jake . p i l lant in i .  & Goedert. 1 998;  Le\\ is. 
ct 3 1 . .  20 I 0 ;  ' .  \\ . Liu et a! . .  2005;  Murra) ct a ! . .  �003;  erpe l l .  e t  a l . .  2000). and 
ccrtain truncated fragments can al 0 eed the aggregati n of ful l  length u-syn b 
nucleat ing ful l - length u- ) n and th n forming hybrid protofibri l s. which develop 
into fibri l s  ( J .  Kim.  Harada. Koba) a h i .  K baya hi .  & ode. 20 1 0; . W. Liu. et 
aI . .  2005: \luITa) . et a! . .  _00"' ) .  An in d\"O stud) showed that the expression of 
truncated human U-S) n ( 1 - 1 20 )  on synuc le in nul l  background mouse. lead to the 
formation of pathological i nc lu  ion in the substantia nigra and olfactory bulb and 
to 3 rcdu t ion in striatal dopami ne level (Tofaris et a l . .  2006). 
l though the pathological input of C-teml inal l truncated a-syn ti l l  
unclear. i t  i has been ugge ted that the negative charges o f  the C-terminal 
domain of o.-syn exert counteracting influence on a-syn fibri l l at ion at the in i t ial 
tep of polymerization and eed ing ( Levitan et al . .  20 1 1 ;  McLean & Hyman. 
2002: Murray. et a ! . .  2003 ) .  
1 . 7 Post-tra ns lat iona l  mod ificat ions 
eyeral po t-translat ional modi fication have been described for a-syn ( Fig.  
1 . 3 ). i nc luding erine and t)- rosine phosphorylation. ubiquit ination. oxidation and 








Figur 1 . 3 :  a- } n  po t-translational modifications reported on the basis of 
their ident ification in  LB .  
1 .7. 1 Pho  phory la t ion  
a- yn accumulate i n  the LBs of DLB,  PD,  M A and L B  variant of 
Izheimer' Di ea e has been hown to be pho phorylated at 1 29 (p- 1 29 a-
yn) .  Furthem10re. a- yn pho phor lated at 87 (p-S87 a- yn) has been detected 
in the L B  of DLB.  while the I e  e l  of p- 87 a-s  n were shown to be increased i n  
the brain of AD.  D L B  and M pat ients, as wel l  as the brains of 
synucle inopathic m ice ( Paleologou et a1 . .  20 1 0) .  Taken together these findings 
advocate a pathological role  for phosphorylated a-syn. and much effort has been 
put i nto e luc idati ng the k ina e that regulate a-syn pho phorylation and the effect 
of phosphorylat ion on a-syn aggregation and toxic ity. 
A lthough, several k inases have been shown to phosphorylate a-syn in vitro, 
l it t le i s  known about the kinase that phosphorylate a-syn i n  the brain.  a- yn can 
be con t i tutively phosphorylated in vitro and in cultured cel ls  at S87 by casein 
k inase (CK) 1 ( Okoch i  et a I . ,  2000) and the dual spec ific ity tyrosine-regulated 
k inase 1 A ( D  rk 1 A) ( E .  1. Kim et aL 2006) .  Also, p-S87  a-syn colocal ize with 
CK 1 in LBs  of D L B  brains ( Paleologou, et a I . ,  20 1 0) .  As far as the 1 29 
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phosph )r) lation i c ncemed. e\ eral enz) me ' ha\ e been dem n trated to 
pho phory late U-Syn at thl po il ion : (a )  K 1  and K2 pho pho!) late u- ) n  at 
.' 1 29 both 111 " ilro and in cel l  ( . Lee et aL 2004: ko hi, et aL 2000: Zabr cki 
et aL 2008 ) .  P- 1 29 u- yn colocal ize v, ith K2 in the brain of PO tran genic 
mice ( Wakamat u et a I . ,  2007). v"hi le  K2 \\ a the major k ina  e isolated from rat 
brain homogenate that ph phorylated human u-s) n at 1 29 ( l  h i i  et a l . .  2007) .  
Also. up regulation of ' K2 b) Fe( U )  \\a h \\ n to enhance p- 1 29 a- yn le\ el 
in cel i - ( 1 .  Takaha h i  c t  a t . .  2007 ) .  wherea inhibition of CK2  in  II - Y5Y cel l s  
ani)  re  ulted in  " 00 0 reduction of p- 1 29 a- yn.  ugge t ing that C K2 i not the 
anI. enzyme that phosphory late a- yn. at lea t in cel l s  ( hau. Ching. chapira. & 
'ooper. 2009). (b)  G protein-coupled receptor kina es (GRKs). lIch as GRK L 
I RK2. GRK5 and GRK6 pho phor), l ate U-S) n i17 "itro and in cel l  (Arawaka et 
al . .  _006: Pronin. 101Ti . urguchov. & Benovic.  2000) .  (c )  Po lo- l ike kina e 
(PLK 1 - " )  have also been reported to pecifical l .  phosphorylate a- yn at 1 29 in 
"ilro and in cel l (lngl i  et al . .  2009: 1befo et a I . ,  20 1 0 : Wa'Xman & Giasson. 
20 1 1 ). and PLK2 wa hown to increa e in AD and DLB brains ( Mbefo, et a I . ,  
20 I 0 ) .  Furthem10re. u- yn can also be pho phory lated at Y 1 25 ( L .  hen e t  a I . ,  
2009: E l l i . chwartzberg. Grider, Fink. & ussbaurn, 200 1 :  akamura, 
Varna h ita. Takaha h i .  & akamura. 200 1 :  egro, Brunat i .  Don l I a-Deana, 
l a  s imino. & P inna, 2002; T. Takahashi et a l . .  2003 ) in vitro and in cultured cel l  
by c- rc, Fyn and yk k inase ( El l is. et aI . ,  200 1 :  akamura, et a J . .  200 1 ), at 
Y I 33 and Y 1 36 ( E l l i  . et a l . .  200 1 :  egro, et a l . .  2002) .  Y 1 25 phosphorylation of 
u- )'n wa detected i n  a PD Dro. 'ophila model ( L .  hen. e t  aI . ,  2009). 
Given the lack of kno\ ledge of the k ina e that phosphorylate a-syn in  the 
brain. the cost and the puri fication restriction of in vitro phosphorylation. many 
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·tudi� ha\ c employ ed pho ph f} lated mutant (1- ) n that ei ther mimiC 
pho 'ph rylation by introduc ing a negat i \  e charge. i .e. replacement of enne 1 11 
que -tion by aspart Ic or glutamic ac id, � O or E,  or render pho 'phOf} lation 
impo iblc by introducing an amino acid that cannot be pho ph Of) lated, i. c. 
alanine, � \ .  
mpari on  of the aggregat ion propensi t)  r \\t. 1 29 and 1 290 (1- ) n 
indicated that pho phof) lation at 1 29 ha no effect on the fibri l lation of u- ) n a 
a l l  protein. produced fibri l \\ ith the arne m rpholog) and abundance (L Chen 
, Feal1) , 2005), \\ h i le  another study comparing wt, 1 29 and 1 29 a-syn 
sho\\ ed that i t  \\as the mutant that mimic the lack of pho phor) lation 1 29A that 
promote' fibril lation, rather than the 1 29E mUlant, \\ hich had a fibri l lation 
propensit) im i lar to \\1 ( Pale logou, et a I . ,  20 1 0) .  n ill \'ilrO pho phorylation of 
phosphomutant U-S) l1 87A and 871 1 29A by CK I or K2 howed that 
pho phof)'latioll at 1 29 inhibi t  fibri l l at ion of a- ) n  ( Paleologou. et aI . ,  20 1 0; 
Waxman & Gia  on ,  2008)  in  a dose dependent manner ( Paleologou e t  a l . ,  2008) .  
Howe\ er, in  "ilm pho phory lation of wt  a-syn by  C K2 promoted the fibri l lation 
of a- ) n ( Fuj iwara et al . .  2002) .  87  pho phorylation, in \'itro aggregation studies 
demon trated an inhibi tory effect on fibri l lation of u-syn ( Paleologou, et a l . ,  20 1 0; 
\Va.·man & Gia  on ,  2008) .  
Expression of 1 29D a- yn in  H - Y5Y cel l induced higher levels of ce l l  
death than wt and 1 29A a-syn (Chau, et aI . ,  2009). expre sion of which ha been 
a ociated with decreased toxic i ty in  H- Y5Y ce l l  (Sugeno et  a I . ,  2008) .  I n  a 
drosophi l a  model ,  1 29A was shown to have a h igher aggregat ion propen it , but 
to be less toxic, \vhi le the phosphomimic 1 29D or GRK2-pho phorylated a-syn 
resulted in fewer inc lusions but accelerated the cel l loss ( L  Chen & Feany, 2005) .  
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In  tran geni mice, h wev er, 1 29D \Va a iated \vi th mcrea ed u- � n 
dcpo 'iti n but dec rea ed to'( ic i t) , unl ike 1 29A u- ) n, \\ hich promoted 
dopaminergic cel l  10 ( Gorbat) uk et aL. 2008) .  tudie on a rat m del ho\\ ed 
that 1 29 u-s n enhance u- yn toxicity and promote the formation, proteina e 
K-re i tant and B- heet-rich aggr gates ( leredo da i l\eira et aL. 2009 ) ,  \\ herea 
1 29D a- ) n  i not tox ic but l ead to the formation of fewer. larger aggregate 
( zeredo da i lveira, et a L. 2009). ub equent tudies on a tran genic rat model 
revealed that wt, 1 29<\ and 1 29D a- )n re ul ted in comparable degree of 
toxic ity and inc1u ion formati n, and it \Va proposed that the differences een in 
the re ult \\ i th rodent may be due to d ifferences in the experimental design. uch 
a' an incubation or do e of the a- ) n del i \  ering virus ( McFarland et a ! . .  2009) .  
ariation in the re u l ts may  al 0 I i  i n  the fact that 1 29D/E a-S) l1 do not 
reproduce a l l  structural and fibri l lat i  n aspects of native phosphor) lation; 
pho phor1'lated u- yn ha an extended conf011l1ation and doe not fibri l l ate, \\hi le  
1 29D mutations have a local ized effect and they possess a fibri l l ation property 
imi lar to \\t a-syn ( Paleologou. et a l . .  2008) .  
I ntere t ingly,  Y 1 25 ph sphorylation \ a sho\ n to reduce th soluble 
ol igomeric f01111 of u-s) n induced by expre sion of S 1 29D or the GRK2-
pho phorylated a- 1'n in Drosophila ( L. Chen, et aI . ,  2009) .  
There are also certain findings suggesting that u-syn aggregation an event 
occurs prior to phosphory lation. I ndeed, fibri l lar a-syn has been shown to be a 
good substrate for C K  1 ,  C K2 and PLKs in vitro (Mbefo, et a l . ,  20 1 0; Paleologou, 
et a ! . .  20 1 0; Waxman & Giasson, 2008), whi l e  in transgenic Drosophila, the 
appearance of p-S 1 29 a-syn fol lowed the deposition of un phosphorylated a-s) n 
(T.  Takahashi .  et aI . ,  2003 ). Addit ional ly, expression of P L Ks in cel l s  increa ed 
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the phosphorylation f s luble a-s) n. but it did n t promote it aggregation 
( \  axman & Giasson. 20 1 1 ) . 
hnaJ ty .  gi \ en that pho phor) lation IS  an Imp rtant post-tran lational 
modi ficati n that regulates pr tein function and ubcel ! ular local ization. a wel l  as 
a \\ ide range of cel l ular function , it can n t be excluded that a- yn 
ph pllory lation ma) have a non-pathogenic function. proteomic -ba ed tud 
identi fied ph sph r) l at ion-dependent a-syn interaction (McFarland, et a l . .  2009), 
\\ hi le there i increa ing evidence that pho ph ry lated a-syn ha a nuc lear 
local ization ( I befo, et a l . .  20 1 0: Wakamatsu, et a I . ,  2007). 
1 .7 .2 O x i d a t ion and ty ro ine  c ro l i n k i n g  
xidation i another po t tran lational modi fication that has been hown to 
affe t a- ) n aggregat ion. A lthough a l l  amino ac id can be potential !  oxidized, 
methionine is the mo t readi ly  oxidized amino ac id ( reviewed by ( Vogl, 1 995) .  a-
) n  conta in 4 1et re idues (at posit ion 1 .  5 ,  1 1 6 and 1 27),  and it was recently 
rep0l1ed that M t5 i more prone to oxidation compared to the other (W.  Zhou et 
aI . ,  20 1 0) .  n h7 vitro ox idation of which ( induced by hydrogen perox ide) has 
been hO\\I1 to inhib i t  th  aggregation of the protein at  normal pH (Uversky et  a I . ,  
2002) ,  and promote the fomlation of stable, non-toxic ol igomers (W.  Zhou, et a l . ,  
20 1 0) .  The degree of i nh ibit ion of  fibri l lation of oxidized a-syn was shown to  be 
proportional to the number of oxidized Met that the protei n  contains, i .e .  the more 
oxidized Met the lower the fibri l  f011l1ation, sugge t ing that the oxidation of 
individual 1et has a cumulative effect on a-syn fibri l lat ion ( Hoken on et a l . ,  
2004 ) .  I nterest ingly.  Met-oxidized a-syn could al 0 inh ib i t  the fibri l lation of non­
oxidized a-syn in a concentrat ion dependent fashion (U ersky, Yamin,  et a ! . ,  
2002) .  
2 1  
FurthemlOre. d irect xidali n of a- ) n by hydrogen p roxide in the pre en e 
of  C) tochrome c or hemin wa ho\\ n to induce aggregat ion of the protein  
pos<;ibly due to I )r cr �s- l i nking ( l-lashimot . Takeda. Hsu. Takenouchi . & 
lasl iah. 1 999: I tcanu & Pielak. �004: OU7a. la  011 he L & . n. ee. . 
I schirop ulo·. 2000) .  \\ hen e\.posed t hydrogen perox ide. cytochrome c forms 
ty roSy I radical . \\ hich in turn can be transferred to f) r residue on ther protein 
( Deterdi ng. Barr. lason. & omer. 1 998) .  uch a a-sIn. \\ hich contains Tyr 
residuc ' at po it ion 39.  1 25 .  1 32 and 1 35 .  
1 . 7.3 � i t ra t ion  
i trated a-s) n ha been detected in  brain t i s  ue  of patients \\ ith PO and 
other a- y l1uc leinopathie ( Dalf6. 1artinez. l untane. & Ferrer. 2006: Gias on et 
a l . .  2000) .  a- ) 11 can be nitrated at Tyr re idue through the action of 0, ygen and 
n i tric oxide. a \vel l  as their product . such a peroxynitrite . Wherea" it \Va 
in i tial ly  bel ie\' d that the exp sure of a- In to nitrating agent . uch a 
perox) n itrite. indue s aggregat ion of the protei n  ( Paxinou et a l . .  200 1 :  ouza. et 
a l . .  2000). i t  \Va later shown that in vitro Tyr ni tration of a-syn inhibits the 
fibri l logenesi of pr tein ( orri . Gia on. I schiropoulos. & Lee. 2003 : Yamin.  
yer k \ . & F ink .  2003 ) .  and it has been sugge ted that it is  the fonnation of 
co\ alent dityro ine cro l i nk rather than nitrat ion per se that promotes the 
fibri l logenesis of the protein  under oxidati v e condition (Norri . et al . .  2003 ; 
Yamin. et a1 . .  2003 ) .  
1 . 7.... U bi q u i t ina t ion  
biquit in ( b )  is a small protein, the role of which is c losely  related to the 
function of protea ome and the regulation of protein turnover in  cel l s .  b i 
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conjugated t the pr tel ll t be degraded by the pro tea orne \ Ia a three 'tep 
proce s, \\ hich require '  the acti n of ertain enz) m e  , that are col lect i \  e l )  kno\\ n 
as I I ,  I 2 and ['" l i gasc a- y n  can be ubiql l i t inated. and so far three prot ins. 
namely park in .  , iab- l ( se\ cn in absentia hom I glle- l )  and iah-2. hm e been 
identi fied to play the rolc f E3 enz) meso ' iah-2 llbiquit inate the unmodi fied 
t0l111 of a- ) n  ( L iani et a ! . .  200-+ ) .  \\- h i l e  iah- l ubiquit inates both the glyco ylated 
( Franck et a1 . .  2006) and the unmodi fied a- ; n  ( J .  T. Lee, Wheeler. L i .  & Chin. 
2008) .  \\'herea thl.: Iysi nes at posit ion 2 1 . 23 .  32 and 34 are l iable tor il7 rilro 
ubiquit inat i n. onl. I )  i ne 6. 1 0  and 1 2  are u ed for in \'i,'o ubiquit ination, which 
resemble the ubiquit i nation of fi laments ( onaka. h\at ubo. & Ha egawa. 2005 ) .  
T n  l B . a- ; Il ha  been sho\\ to  be  mon -, b i - and tri-ubiquit inated (Tofaris, 
RalZaq, Ghett i .  l i l l ey, & pi l lant in i ,  200"" ). \\ h i le  in cel l s. UCHL I ubiquit inate 
a-syn at l) -63 (Y. l iu. Fal lon. lashueL L iu. & Lan bury. 2002 ). l i nked 
ubiqui t inat ion of \\ h ich i u ual l )  not a sociated \\ i th proteosomal degradat ion. 
but promotes lB formation ( li m  et a l . .  2005 ; L im.  Oaw on. & Dawson. 2006) .  
im i larly. the iah- l mono- and d i-ubiqui t inat ion of a-syn does not target the 
protein  for degradation in Hela cel l s. but instead it promotes a-s n in olubi l ity 
and apoptotic  cell death in Hela and PC 1 2  cel l  (1 .  T.  Lee, et al . .  2008) .  
l ntere t ingly. the iah- l mediated ubiquit ination of a-syn wa shown to be 
abo l i  hed by the A30P. but not the A53T mutation, possib ly due to the i nh ibit ion 
of the ubiquit i nation of the Iysines near alanine 30 ( i .e. K2 1 ,  K23, K32 and K3-+) 
re ul t ing from the 30P- induced confolmational change in a-syn (1 . T. lee. et a l . ,  
2008 ) .  
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1 . 7. - G I) co ) la t ion  a n d  gl) ca t ion  ( n on-enZ) mat ic glyco y la t ion ) 
Glyco. ) lation i.., a p 5t-tran lational III d i ficati n dur ing \\ hich glycan . i .e 
o l igosaccharide or p I y accharide are enzy matical l )  attached to protein or 
other macromolecule,> .  G I ) co ') lation i a ite- peci fi c  modification and the major 
sites of gl) C )  l at ion in  protein are the n and rg C .V-glyco ) lati n). and er. 
I ) r and Thr ( O-gly os) lation) .  I though O-glyc ylated a-syn. a p22. ha been 
identi fied in normal human brain ( himura et a l . .  200 1 ), it i ti l l  unkno\\ n 
\\ hether glyco, y l al ion affect the aggregat ion of the protein .  evertheless. in LB 
from PO patients. (l- ) n co- Iocal i e \\ i th d anced Glycation Endproduct 
( r\G E  ). a heterogeneou group of molecule fOlmed through glycat ion (al  0 
kno\\ n as nOn-enL) matic glyco ) lation. which a the name impl ie i ,  unl ike 
gl ) co ) lation. non en?) matic and occur randomly) of protei ns \ ia the Mai l lard 
reaction ( i .e .  chemical reaction between amino ac ids and reducing ugar ) and 
chifr s  base fonnation ( i .e .  the formation of im ine products from the reaction 
bet\\ een amino acid and a reactive carbonyl group of reducing ugar5) 
( astel lani .  mith.  Richey. & Perry. 1 996) .  
In brain. glycation of prote ins i s  attributed to sugar l i ke gluco e. fructose. 
and reacti \ e dicarbon) I ,  uch a methylgl oxal (MGO).  glyoxal ( 0) and 3 -
deoxy g lucosone ( egre- alvayre, alvayre. Auge, Pamplona. & Por1ero-Otin. 
2009) .  Dicarbonyl molecular pecies have also been impl icated in  the production 
of AGE . \\ hich can modify prion proteins and A� (Wi l l iams. Weinberg, & 
mith.  20 1 1 ) . im i larl ) .  in " ilro glycation of a- yn by D-ribose ( ribo ylation) 
i nduced the format ion of molten globule . \ hich were toxic to H- YSY cel l s  (L .  
Chen. Wei ,  Wang. & He .  20 1 0) .  
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1 . 7.6 : L \ 1 0) la t ion  
l '\11 ylation i '  a rever ible po t-tran ' lat ional modi fication that covalent ly  
attaches smal l ubiquit in- l ike modi fier ( 'U�1 ) pol)  pept ide , \\ hich are imi lar to 
L Ib.  t I )- ine f prote in . 1 he proce - i imi lar to ubiquit ination. \\ ith the 
d i fference that U 1 )- lat i  n doe not mark protein for degradat ion) ( re\ ie\\ ed 
b)- ( Don al & ha er, 2007 ) .  It is wel l  documented that MO) lation i 
impl icated in  the path genesi of everal neurodegenerative diseases, inc luding 
pol )- glutamine di ea e ( eda et a I . ,  2002 ) ,  neuronal i ntranuclear inc lu ion 
d i  'ea e and 1 A ( Pountne)- et a I . ,  200"' ) ,  \\ h i le a number of protein involved in 
neurodegeneration c.g. am)- Ioid precur or protein { reviewed by ( arge & Park-
arge, 20 1 1 ). huntingt in  ( teffan et a l . .  200-+) ,  tau ( Don al & Fraser, 2006), DJ - l  
( 'h inbo et a l . .  2006) al 0 undergo U 1{0ylation. 
u- yn ha a lso been ho\\ n to be MO) lated i n  cel l s  co-expressing (J.- ) n 
and 10 protei n  ( MO 1 -3 )  ( Dorval & Fra er. 2006) and i t  \vas recentl 
reported that U 10 1 co-Iocal i e with u- yn in  L B  of PD and DLB brains ( Y .  
M .  K i m  e t  a1 . .  20 1 1 ) . 
1 .2 C ross- l i n ki ng and  Tis ue  Trangl u ta m inase 
Transglutaminase (TG) con t itute a fami ly  of Ca
2+-dependent enzymes that 
catal) e the intem10lecular and or. more rarely, the intramolecular cro s- l inking 
of i ntrace l l ular protein  by f0n11 ing i opept ide bonds between Iy ines and 
glutamines ( Folk & Chung, 1 985 :  Konno et a l . .  2005) .  Tissue transglutaminase or 
tran glutaminase 2, that po esse GTPa e,  A TPa e and transamidating activit ie 
( Achyuthan & Greenberg, 1 987) .  has been reported to pIa a role  in a number of 
di  eases, i nc luding neurodegenerat ive d iseases (A. J .  Cooper, Jeitner. & Blass, 
2002) .  A� (Jensen, 0rensen, Petersen. Gl iemann. & Rasmussen. 1 995)  and PP 
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pr tein . J. I I . Greg r) . m lrnova. Zoubine. & Fe tofT 1 994).  the . ,\ 
fragment f a-s) n ( Jen en, et aL 1 99 � )  and a- ) n ( Junn. Ronchett i .  Quezad 
Kim. & \l10urad ian. 200"' ) are al l ub trate of tTG In \'ilro and. r ill rim. 
1 .8 a- yn uc le in  a a ta rget for PD trea tment  
'om entional treatment of PO can only treat the ) mptom ; therefore, it can 
onl) be beneficial  i f  the di ea e i d iagno ed at an early tage. nfortunatel ) , w i th 
the progre ion of the di ease. the treatment can gradual ly  lose i ts cfTect i \  ene 
a it i bel i eved that treatment fai l  to prevent the ongoing cel l  death f 
dopaminergic neuron in d i  cussed above dopaminergic neuron death i s  
bel ieved to be du t the developm nt of LBs. \\ hich is  compo ed mai n l)  of  a-syn 
aggregate . u- yn change from random coi l to p- heet confornlation to form 
pre fi lbri l l ar o l igomer and then tran ient prototibri l s  before maturing into amyl id  
fibri l and fi nal l _  LB  ( Park, La iene. Chou. I Iorner. & Pun. 2007) .  'e\ eral 
trategie ha\ e now f cu ed on the prevention f (l- n aggregation and toxic i ty 
as a no e l  treatment trategy for PO CAmeL et a l . .  �006). As we learn more about 
the role of (l- } n  i n  PD, it becomes c lear that preventi ng the aggregati n r may 
be i lencing L. NCA can be a pos ible therapeutic trategy. 
1 .9 I n h ib i t ing  a-sy n uc le in  aggregation a n d  toxicity as a novel 
thera peut ic a p p roach for PD 
1 .9. 1 rn a  I I  pept ide 
EI -Agnaf and col leagues were the first to design pept ide inhibitor for a-syn 
aggregation and toxic ity C Hosia et a l . .  2004) .  A peptide l ibrar) wa s) nthesized 
from 0 erlapping 7-mer peptides spanning the whole (l- yn sequence. By means 
of a novel E L I  A, the sequence responsible for (l- yn e l f-aggr gation was 
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ident i fied ( n;sidues 69-1'2 r u- ·) n) .  Thi equence \\"as u ed a the ba i for the 
de 'ign f various peptIde inhibit r of u- ) n  aggregation and toxic ity (E I - gnaf et 
011 • :WO·n Prompting a focu'  on  de\ el p ing  peptid mimetic and ident i fying 
smal l  moleculc inhibi tors for u- )n aggr gat ion ( mer. et aL 2006). I Iosia et al 
rol lo\\ cd it up b) designing c\ eral hairpin peptides and inve tigating their effect 
on am) loid fi rmat i n inc luLl ing u-syn aggregat ion ( Ho ia. et aL 2004 ). group 
of hairpin peptides showed t induce non amyloidogenic a-syn aggregate (non­
tox ic)  sugge tcd an inhibitor) cffect ( I Iosia, et a l . .  2004). 
1 .9 .2  Dopa m i n e  and cat  cho lamine  
t\ lany tudies of L10pamine ( OA). 0 metabol ites. OA analogous and 
catecholamine in general have sho\\TI an effect on a-syn aggregat ion. I n  a recent 
tud} . Lee et al howed that OA can promote the production and secretion of u­
') n o l igomers ( H .  J .  Lee et al . .  20 1 1 ) . An increased formation of a-syn ol igomer 
\\ a found in  the \ e icles in the presence of DA. The ol igomers were ho\\ n to be 
D re i tanto non-fibri l lar et �- heet -rich.  imi lar findings were seen \\l ith 0 
metabol i tes. where ce l l  death i s  induced ( hal t ie l -Karyo et a I . ,  20 1 0) .  Ho\\"ever, it 
\\ a shown that catechol o-metheltran fera e inhi bi tor could prevent the toxic ity 
of a- )'n fibri l s  ( halt ie l-Karyo. et a1 . .  20 1 0) .  
1 .9.3 Heat  shock p rote in  
Heat shock proteins (H P)  are a c lass of functional ly  related proteins that 
act a molecular chaperones up-regulated by the cel l  under stress ( Oi Giovanni et 
a l . .  20 1 0) . Hsp70 confer thermotolerance and protects again t apopto is. 
endotoxins. reacti e oxygen species. radiations and ischemia (NolTis, et a l . .  2003) .  
I t  has been reported that I I sp70 is reduced in  PO brains (NolTis, e t  a1 . .  2003 ) .  Both 
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I Isp70 and I I  p40 can bind and inhibit u- yn aggregation in vitro ( Lata\\ i c et aL 
20 I 0 ). A recent . tud) sho\\ ed that I I  p I  04 can redu e the pho phor) lated foml of 
U-. yn and the nigrostriatal dopami nergic Joss in  a PD animal model ( rav,:aka. 
Mach i)a. ' Kato. 20 1 0 ) .  lore recent l ) . a compound termed J -072" (2-
fluor -6- [ (3 ) -tctrahy drofuran-3 -) lamino ] -4-( " .6.6-trimeth) 1-4 -oxo-4.5.6. 7-
tctrah) dro- I l l - indol- I -) I )bcnLamide) a JI p90 inhibitor. igni ficantl) increa ed 
striatal dopamine conknt in rat . uggesting a posit ive neuromoduJatory effect on 
triatal terminals (McFarland et aL 20 1 4) .  Taken together al l  the e finding 
regard ing H p inhibi tor · a J  0 repre ents an exci t ing new therapeutic strategy for 
PD. 
1 .9--' A n t i-Parkin  o n ia n  auents  and other  d rug 
One c ia  of drug that was identi fied to  ame l iorate u- n fibri l fonnation in  
PD \\. a ' irtu in  inhibitor ( I RT2 ) (Griinblatt e t  a ! . .  2004) .  I t  \va ho\\n that 
I RT2 inhibi tor re cue U-Syl1 mediated tox ic i ty in a drosophi l a  model of PD 
(AuJuck. Chan. TrojanO\v k i .  Lee. & Bonini .  2002) .  Li et a! . ,  demon trated the 
inhibitOr) effect of the ant ibiotic ri fampic in on u-syn fibri l lation that 
di aggregated u-syn amyloid fibri l  in a concentrat ion-dependent manner (J . L i ,  
Zhu. Rajamani .  ver k). & F ink. 2004) .  Furthermore. ri fampic in  was also shown 
to reduce a- ) n deposition in a transgenic mouse model of M A (Putcha et a I . ,  
20 1 0 ) .  Gangl io ide ( l ipids that contain saccharides) have shown to interact with 
the hel i cal stmcture of u- yn thus preventing i ts aggregation ( Putcha, et a1 . .  20 1 0) .  
im i lar molecules l i ke glyco phingol ipids have been shown t o  beha e as 
gangl iosides. \\.hich indicate the stmctural importance of ia l ic acid and 
carbohydrate moieties in the e molecules (AJcain & Vi l la lba. 2009 ) .  elegi l i ne i s  
another dmg which is ant i -Parkinsonian and was also repo11ed to  delay the 
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nuc leat ion lage o f  the \\ i1d t)- pe and mulant form of c.t-s� n l i gomer ( Braga et 
a l . .  20 1 1 ) . Interest ingl) . selegi l ine i '  a mon amino oxida e B ( 1  -B )  inhibit r. 
\\ hich in  rea 'e the dopamine le\ els .  The c mbine effect of elegi l ine b) 
inhibit ing L\ -B and delaying the nucleation of c.t- ) n  aggregation eem' to 
f;.l\ our the f rmation of non-t x ic aggregate of c.t-sy n ( J .  l i .  et a l . .  2004 ) .  
1 .9.5 H e rba l a n d  p l a n t  c"\ tract  
I l erbal and plant extracts have been u cd as remeu ies for thou ands of lear 
for a variety of d isea e inc luding n urodegenerat i \ c  di eases such as PD.  Recent 
\\ ork. has h igh l ighted a fe\\ herbal and plant extract as potential drug such as 
.\nemopaegma m i randum ( atuaba). Fructu P oraleae. Turmeric. Pueraria 
J "hom.oni i  and Bacopa 1onnieri . Ho\\ ever. onl) few of the e extract hm e been 
inwstigated for the i r  e lfect on (t- )'n aggregat ion and toxic ity. 
Re earch ho\\ ed that Baicalein (an herbal extract )  has the t\\O anti ­
o l igomeric and anti-amy loidogenic propertie that make i t  a potentia l  drug for P D  
(Frydman- arom. hal t ie l -Karyo. Mo he. & Gazit, 20 1 1 ) . Moreover, entacapone 
and toleapone \ ere also hown to prevent 0.- yn ol igomerization ( Di Gio\anni ,  et 
aI . ,  20 1 0) .  Poly -acromatic caffo ld (polyphenols, fla\'onoids and 
phthalocyanines) have al  0 ho\\ n anti -amyl idogenic  qual i ties. thi qual ity can 
be enhanced by an addit ion of metal s into the heterocycle centre (lL! et al . .  20 1 1 ) . 
tudies creened natural polyphenols  have shown that (-)-epigal locatechin-3-
gal l ate (EGCG) from green tea can also prevent o.-syn aggregation. I t  wa hown 
that EGCG could  bind n n-covalently to unfolded c.t-syn re ult ing in non-toxic 
D - table o l igomers. Thus. pre\ ent ing the formation of the toxic amyloid fibri l . 
117 vivo work has yet to determine and test its effectiveness in  PD animal models.  
but neve11heless EGCG hows great promi e a a potential drug for PD 
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U :hrnhoe ler. 2006: Dagmar E .  Ehmhoecer et al .. _'00 0 E h h t- t I - II  . . m oe er e a  . .
2008: Lamberto et a ! . .  20 ) ) ) . 
1 . 1 0  I m m u n othe r'a py fo r neu rodegenerat ive d i  ea e 
[mmunotherap) i s  con idered the be t di ea ' -modifying treatment for 
neurodegenerat i \  e d iseases. 0 has been the focu of man) immunotherapeutic 
stud ies. \\ h i l e  less attention ha been paid to PO and other neurodegenerative 
d i  'order . The rl!ason for thi di fference is that th ( �) protein 1 11 0 i an 
e:-;trace l lul nr molecule (G lenner & Wong. 1 984) that c irculates in  th blood and i s  
read ing recogni/ed b) antibodie . I n  contrast. depo i t s  of a- ) n  have been 
onsidered to be ex lu i \'el) intracel l u lar in nature ( p i l lantini. et a t . .  1 997) . 
l lo\\e\ er. the recent di co\ er) that tox ic o l igomeric ver ions of a-syn accumulate 
in the membrane and can be excreted to the extrace l lular environment ( De plat , 
et a t . .  2009: E I-Agnaf, et al . .  2006; ol lenhau r. et a l . .  2008) has pro\ ided a 
rational for the de\'el pment of immunotherap utic approach s for PD. dementia 
w ith Lew] bodie . frontotemporal dementia, and other neurodegenerat ive 
d i  order characterized b) the abnormal accumulation of these protein . Active 
i mmunization. pa s lve i mmunization. and T cel l -mediated cel lu lar 
immunotherapeutic approaches have been developed targeti ng A�. a- yn and tau. 
1 . 1 0. 1  (l- y n uc le in  a i m m u n othera peut ic  ta rget 
everal neurodegenerat i e di eases are characterized by the accumulation of 
111 1 folded protein  and d i tlerent approache u ing active or passi e immunization 
are being explored as potent ial  therapie . Recent ly.  immunotherapy has been 
evaluated as an approach to treat a-syn patho logy. Animals vacc inated \: i th 
recombinant a-syn which results in  a h igh-ti tre anti -a-syn antibody response on a-
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)'n .  ho\\ cd fe\\ er pathol gic aggregate I n  the triatum \ er u control animal 
that recei\ ed a m k \ accine .  l h i \\ that a pr te ti \ e  \ ac ination trateg) 
re u l t ·  in induction f regulatory 1 cel l and a t i \  ated micr gl ia .  Thi s  can induce 
immune tolerance agaIn t (1- ) n (R mero-Ramo . \ on uler helpin. & anchez-
uajardo. 20 1 4) .  \: hi le antibodie again t (1- yn pec i fical l y  target and aid in 
c learance of e,traccl lular (1-s) n b) micr gl ia,  thereb) prev enting their action on 
neighbouring cel l  ( Bae et a l . .  20 1 2) .  I t  wa reported that pa ive immunization 
with a-sy n anti bod) reduced neuronal and glial accumulati n of (1-syn and 
amel iorated neurodegeneration and behavioral defic i ts assoc iated \\ i th a- yn 
0\ erexpre ion ( Bae, et a l . .  20 1 2 ) . Targeting the C-tem1inal of a-s) n \\ ith spec ific 
antib  die . found to attenuate ynaptic and axonal pathology , reduced the 
accumulat ion of  -tem1 inal truncated a- ) n in  axon, and improved motor and 
memoI) deficit in mou e PO mod I (Game et al . .  20 1 4 ) .  When transgenic (1- ) n  
mice \\ ere treated \\ ith anti -human (1-s) n ant ibodie . an improv ement in  
behavioural defici ts  as  \\ e l l  as decreased accumulation of a-s) n aggregate . \ a 
observed and i n  add it ion the ant ibodies appear to enhance the phagoc) to i and 
autophagy of a- yn ( Masl iah et a I . ,  20 1 1 ) . I n  another tudy b) the same group 
(Ma l i ah et a l . .  2005). the active immunization of transgenic a-s) n mice with 
human a-syn lead to the production of relatively high-affinity ant ibodie and 
reduced the accumulation of aggregated human a-syn in  neuronal bodies and 
synapses. It was also proposed that immunization was found to degrade a-syn via 
the I so omal pathway ( Masl iah ,  et a I . ,  2005) .  I t  i s  possible that antibodie may 
recognize abnormal a-syn accumulation in the neuronal surface or even secreted 
form of the protein .  
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U 'ing intra e l l ular antibody fragment ( intrabodie ) an ther 
I lTImUn therapy appr ach that c uld potent ia l ly find application in the treatment 
of P O, that an re gni/e (1- yn and alter its folding. For that, human single-chain 
antibody fragments ( c r: \ ) bind to o l igomeric (1- ) n and block xtracel lular (1- yn 
to\.ic i t} in human neur bla toma cel l ( Emadi .  Barkhordarian. Wang. chulz. & 
' ierk. " 2007: madi .  Ka turirangan, Wang. chulz. & ierk , _009) .  In  a imi lar 
sllIdy . i ntrab die tran recled into a cel l  l ine that ov rexpres es \\ i ld-type (1- y n. 
stab i l i/ed detergent-soluble monomeric (1- \ n  and inhibited the format ion of � -
detergent-in oluble high-molecular-\\ eight (1-syn species (C .  Zhou, Emadi ,  ierk . 
c' l\.1es. cr. 2004). 
1 . 1 1 Aim of p roject 
There are numerous studies ugge t ing a eminal role for (J.- yn 
aggregat ion in  neurodegenerat ive d isea e .  I though the molecular basis of (1- yn 
to'\ ici ty ha not been preci e ly e lucidated, recent studies indicate that (1- yn 
toxic i ty is mediated by a nucleation-dependent poly merization process. creening 
mal l compounds that can block, slow do n or reverse a-syn aggregat ion and 
i nhibi t  the eeded nucleat ion-dependent polymerization process. therefore, 
provide an attractive approach for targeting the progre sion of the PO and related 
di  order . The a im of the project \vas to elucidate the mechanism and structural 
ba i of (1-syn mediated toxic i ty, and to creen smal l compounds that are capable  
of i nh ibit ing the aggregat ion and the mediated a-syn cytotoxicity. The idea behind 
screening compound extracted from Chine e medic inal herbs and plants (CMH). 
that have been u ed for the treatment of a wide range of disea e for over a 
m i l lennium including dementia and neurodegenerati e disorders. 
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I n the fi r t result chapter ( hapter " )  \ ariou aggregated a- yn preparation 
arc prepared . The effect or the e pecie on (1.- )- n mediated c)-10to\.ic it) and the 
add ition f the m nomcric \\1 or p- 1 29 a-s) n ef� ct on the mediated toxic i ty wa 
im c-;tigated b) cell \ iabi l i t)- as ay ( 1TT), Thiofla in  (Th- ) ,  congo red 
bund ing as a) ( R) and immun blotting a a) . I n  the econd re ult chapter 
( hapter -+ )  the effect or the phenol ic  compound, and i ts derivatives on (1.-S_ n 
fibri l formation and a-syn mediated tox ic i ty i in  est igated. The method u ed in 
this chapter inc lude E ll  , Th- as ay, TEM, MTT, CR and M R .  I n  the third 
and fOUl1h chapter of result ( hapter 5 and 6), M I l compounds were examined 
for their effect on (1.- ) n o l igomerization and aggregation and mediated cel l  
C )  toto\.ici t)  b) mean of Th- , TEM, MTT, immunoblott ing and MR.  
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2 ha pte r 2 :  Mate rial and Met hod 
2 . 1  u pp l i e r  
Detai l ·  of the suppl ier r r chemical and equipment are ummarized in 
D Bi science 'c 
1m i trogen 
Bi technology 
G i l  on 







orporation, 5 7 9 1  Van Al len Way 
A 92008, A 
A 
lInc International . L i fe Technologies Ltd . ,  
K .  
treet Midd leton, WI ,  
berbargoed,  Bargoed, K.  
Panreac . Ltd. Barcelona, palO .  
weden 
Bio-Rad Laboratories A lfred obel Drive 
Hercules, CA, A. 
Thermo Scient ific L i fe c ience Research Products, 
Rockford, I L, U A. 
Thermo cienti fic L i fe 
Rockford, I L, A 
Abcam, Cambridge, MA, A 
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2 .2  M a te ria l  and  eq u i pment  
Tahle 2 .2  . .  ummar) of \laterial and uppl iers. 
Materials l' quipment Compan) 
Di meth) I su l foxide ( OI\ lS0)  Sigma- Idrich 
Dulh"ecco' Y10d ified Fagle Medium Im itrogen 
'I i. llC Cul turc Flask. 7 i C 1\1 X75CM unc 
Ethan I Panreac 
l:thidi ul11 hrom ide Sigma-Aldrich 
Eth) h.:ned iaminctctraacctic ac id ( EDTA)  Sigma-Aldrich 
Fetal bO\ inc 'crul11 ( heat act i ,  ated ) I nvitrogen 
H) drogen chloride ( T IC I )  S igma-Aldrich 
I P rG Sigma 
1\ 1ethanol Panreac 
Mouse monoc lonal I gG antibody u- ynuc lein Santa Cruz 
( _ 1 I )  B iotechnologies 
. itrocel lu lo  e membrane fi l ter paper andwich.  
OA5�lm p re siz 
I nvi trogen 
OPT I -I\ lE  1 Medium Invi trogen 
Penici l in-Streptomycin solut ion ( 1 00 ml  
o lution! 1 0.000 units penic i l l in ,  1 0.000 units I nv i trogen 
treptomyci n )  
N itroce l lu lo e membrane Whattman 
Phosphate buffered a l ine ( PBS )  tablets Sigma-Aldrich 
Sodium Azide (NaN))  igma-Aldrich 
Sodium dodec, I u lphate ( SDS)  Sigma-Aldrich 
Tri S igma-Aldrich 
P-40 igma 
Triton X - l  00 S igma-Aldrich 
Be. Protein a say reagent ki t  Pierce 
Cel l  d i  ociation olution. non-enzymat ic Sigma-Aldrich 
Benzamidine sepaharose beads Amer ham 
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Thi navinc ' T  Sigma 
[ hi na\ in  S S igma 
SuperSignal r· L I SA femto 1a\imum 
, 
ensi t i \  I t) ubstrate 
rhemlo cientific 
1 i  rocentri fuge tube 1 . 5 ml Ro e Scientic 
Ti 'sue Culture Plate 96 Well Nunc 
Agaro e L1tra Pure F lectrophoe is Grade [ m  itrogen 
80\ ine Serum r\ lbumin S igma-Aldrich 
TEi\l E D  S igma 
mmonium per ul phate Bio-Rad 
Protein  M\\, marker I m itrogen 
Load ing butT r S igma-Aldrich 
Glutathion 'epharo e bends 4B lurry Amersham 
Thr mbin S igma 
Ti ue Culture FIn k 25 cm Nunc 
Ti 'sue Cul ture Fin k 75 em Nunc 
Sup rSignal We t Pieo Sub trate Themlo Scientific 
SuperS ignal West Femto Substrate Thenno Scient ific 
Parafonnnldehyde 19ma- Idrich 
Genet ic in  S igma-Aldrich 
FL- 1 40 rabbit polyclonal ant ibody Santa Cruz 
2 1 1 mou e monoclonal antibody anta Cruz  
HRP-eonj ugated goat ant i -rabbit DAKO 
Protease i nhibitor P ierce 
H RP-eonj ugated goat ant i -mouse DAKO 
Uranyl  a etate Agar 
u lfo- H S-LC-Biot i n  Pierce 
Zeba desalt ing columns P ierce 
Formvar coated 400 me h copper grid Agar 
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2.3 Ce l l  l i n e  
Table 2 . 3 .  L ist o f  Cel l  l i nes used i n  thi stud) 
e l l  l i ne Origin Cu!tme edia 
wt BE 2 )- H uman Dulbecco's MEM utrient Mix F- 1 2  ( 1 :  1 )  
M- 1 7  euroblastoma 
containing 1 0% fetal bovine serum and 1 %  
penic i l l in-streptomycin .  
BE(2)-M-
H uman Dulbecco' s  MEMlHigb Glucose containing 1 0% 
1 7-wt-o,-
euroblastoma 
fetal bovine serum. 1 % penic i l l i n-streptomycin 
syn and 250 )lg/mJ of G4 1 8  antib iot ic .  
Dulbecco' s  M EMINutrient Mix F- 1 2  ( 1 :  1 )  
wt- H Y- Human 
containing 1 5% fetal bovine serunl , 1 %  
5Y Neuroblastoma penic i l l i n-streptomycin, and supplemented with 
1 % non-essential MEM amino acid supplement 
and 2 mM freshly prepared glutamine . .  
Dulbecco' s  MEMINutrient Mix F- 1 2  (1 : 1 )  
S HSY-
Human 
containing 1 5% fetal bovine serunl, 1 %  
5 Y-wt-o,-
euroblastoma penic i l l in-streptomycin ,  and supplemented with 
syn 1 % non-essent ial MEM amino acid supplement 
and 2 mM fresh ly prepared glutamine . .  
2 .4 Com po u n d s  
Table 2 .4 .  L i st o f  compounds tested in  this study as inhibi tors o f  o,-syn 
aggregation and toxic i ty .  � 
Compound Name M .W 
CMC 1 Salvianol ic  acid  B 7 1 8  
CMC2 G insenoside Rg 1 800 
C MC3 G insenoside Rg3 785 
CMC4 Ginsenoside Rb I 1 1 09 
CMC5 Ammoni )l M  Glycyrrhizinate 840 
CMC6 Puerarin 4 1 6 .4 
CMC7 S inomenine 3 29.4 
CMC8 Paeoil florin 480.45 
CMC9 Gamma-schisandrin 400.46 
CMC 1 0  D ihydromyriceti n  320 
C MC l 1 M agnolol 266.32 
CMC 1 2  Honokiol 266.34 
C MC 1 3  Geniposide 388 . 37  
C MC 1 4  B i lobal ide 326.3 
CMC 1 5  Evodin 470.52 
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CMC 1 6  Tetrah) dropalmatine 
CMC 1 7  Protopine 
CMC 1 8  S ipeimine 
CMC 1 9  Synephrine 
CMC20 Peinine 
CMC2 1 Rhynchophyl l ine 
CMC22 I sorhynchophyl J ine 
CMC23 Berberine 
CMC24 Gal l ic acid 
CMC25 Praeruptorin 
CMC26 I cari in  
CMC27 Schisandrol B 
CMC28 (+ )-Tetrand rine 
CMC29 Neohesperidin 
PA l 3 A5-trihydroxybenzoic acid 
PA2 2A,6-trihydroxybenzoic acid 
PA3 2J-dihydroxybenzoic acid 
PA4 2A-dihydroxybenzoic acid 
PAS 2 .S -dihydroxybenzoic acid 
PA6 2.6-dihydroxybenzoic ac id 
PA7 3 ,4-dihydroxybenzoic acid 
PA8 3 ,5-dihydroxybenzoic ac id 
PA9 2-hydroxybenzoic acid 
PA l O  3 -Hydroxybenzoic acid 
PA l l 4-Hydroxybenzoic acid 
PA 1 2  Benzoic ac id 
PA 1 3  4-methoxybenzoic acid 
PA 1 4  3 ,4,5-tri methoxybenzoic acid 
PA 1 5  3 ,4.5-trifluorobenzoic acid 
2.5 Sol u t ions a n d  b u ffers 
2.5. 1 Phosphate Bu ffered Sa l ine  ( PBS),  p H  7.4 
355 .42 
353 .37  
-t29.6-+ 
1 67 .1 1 
429.64 
3 8-+ .47 
3 84.47 
336 . 1 
l 70. 1 2  
3 86.4 
677 .66 
4 1 6 .464 
622.76 
6 1 0 .56 
1 70. 1 2  
1 88 . 1 3  
1 54 . 1 2  
1 54 . 1 2  
1 54 . 1 2  
1 54 . 1 2  
1 54 . 1 2  
1 54 . 1 2  
1 3 8 . 1 2  
1 3 8 . 1 2  
1 3 8 . 1 2  
1 22 . 1 2  
2 1 2 .20 
1 52 . 1 5  
1 76.09 
One PBS tablet was di ssolved in 200 ml d. H20. The buffer was fi l tered 
through a 0 .2 �m fi l ter and stored at 4°C. 
2.5.2 Phos p h ate B u ffered Sa l ine  with  0.05% Tween-20 ( P BST) 
PBS with 0 .05% Tween-20. 
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2.5.3 Blocki n g  b u ff r fo r \H tern b lo t t ino  
5°'0 of dried skimmed mi lk  di . oh'ed in PB T. 
2.5..1 Stacking gel  b u ff r 
0 . - 1\1 'fri.- I !  ' L :  6g of l ri -ba e \\-ere di s h ed in  75ml d . H;!O and the pH 
\\ as adju  'ted to 6 .8 .  I he \ olume was then made Lip to 1 OOml \\l ith d .H;!O. 
2.5.5 30% ac,! lamide  
29 .2g acr) lamide and 0 .8g of bis-acr) lamide was d issolved In 1 00mi of 
2.5.6 20% o d i u m  d od ecy l u l fa te ( D ) 
20g laur) I odium dodecyl sulphate \va d i  olved in 1 OOml  d . H20. 
2.5 .7  1 0 % a m m o n i u m  per u ] fate ( A P  ) 
0. 1 g P \Va di solved i n  1 m l  of d .H20. 
2.5.8 T ra n  fer b u ffer 
3g  of Tri s-base and 1 4 .4g G lycine were d issolved i n  800ml d . H;!O to \: hich 
200ml of methanol wa added. 
2.5.9 Eth lened i a m i n  Tetra Acetic acid ( E DTA)  
93 .05g EDT d isodium sal t  was d issol ed in  400 m l  d .H20 and pH was 
adj u ted to 7 then the sol ution wa made up to a final volume of 500 m! .  
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2.:-. 1 0  \- I TT (3-(-t -- d i m eth)  I th iazol-2-y l )-2,S-d iph n. I tet razo l i u m  brom ide) 
so lut ion 
60 g f Ml r \\ a '  d i s  )h ed in 1 0ml  oj PB • .  
2.5. 1 1 L) olut ion  fo r M TT a ay 
20° 0 ( \  \ )  D '  d i  01\ ed in  v. ann water containing 50°'0 ( \'  v)  
dimeth) lfI m1amide. 1 he pl l \\a then adj u ted to -t .7  using a olution of 80°'0 
acetic a id and 2 .  - °'0 I 1 I I 1 .  
2 .5. 1 1 o l u m n  " a  h i ng b u ffe r 
SOm 1 Tri - I I  L 1 50m 1 a I ,  1 0mM EDT . 1 %  Triton .I - 1 00, the pH 
adj u ted to 8 .0  
2.5 . 1 2  T h ioflayin-T o lu t ion  
_O�l 1 Th-T in  PB 
2.5. 1 3  T h ioflayi n - o l u t i o n  
20�M Th-T in  PB 
2.S. 1 -t  D -PAG E a m ple  load i n g  b u ffer 
250 m 1 Tri Hel  pH6.8 .  1 0% D , 30% Glycero l ,  5% �-mercapitalethanol .  
0 .02°,0 bromophen I blue 
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3 h a pte r 3 :  l p h a - ynuclein ne u rotoxicity i mediated 
by ongoing eeded polyme rization p roce 
inhibited by (1 - yn 1 2 9 p ho p ho rylation. 
3 . 1 I n t rod u ct ion  
and i 
Parki nson ' Disea c ( PO)  i a progre ive neurodegenerative di order. the 
c l in ical feature, of \\ hich include brady kinesia. rigidi ty, resting tremor and 
postural instabi l i ty (Dunnett & Bjorklund. 1 999). These motor Sy mptoms are 
l i nked to the degeneration of the dopaminergic neuron in an area of the brain 
knc \\ n as sub'tunlia nigra. \\ hich appear to be e lectively affected in PD ( Dauer 
c' Prledb r k i .  2003 ; Fearnley & Lees. 1 99 1 ) . imi larly to e\ ral other 
neurodegenerat ive di ea 'es. including Izheimer's disease (AD) and Prion 
di 'ea e . PD i referred to a a proteinopathy indicating that the di  ease i 
a, sociated \\ i th  the accumulation and deposit ion of a mi  folded protein ( hit i  & 
Dob on. 2006; Fom1an. TrojanO\ k i .  & Lee. 2004; Ross & Poi rier. 2004) .  
I ndeed. the neuropathological hal lmarks of PD are neuronal inc lu  ions either in 
neuronal perikarya or in  cel l proce ses. knO\\ n a Lewy bodies ( LBs) and Lew) 
neurite ( L  s ) .  respecti e ly ( Dickson. 20 1 2) .  the main component of \\ hich is  
fibri l lar a-s)nuclein (a-syn)  ( Ami et a l . .  1 999; V .  M .  Lee & Trojanowski ,  2006: 
p i l lant in i .  et a l . .  1 997).  
a- yn i s  a mai l ,  heat-re i stant. acidic protein compo ed of 1 40 amino ac id 
residue ( Jakes. et a l . .  1 994). expressed predominantly  in  certain regions of the 
brain.  such a neocortex. hippocampus. o l factory bulb. triatum. thalamu . and 
cerebe l lum ( Iwai et a l . .  1 995) .  a-Syn can be detected tn great abundance at 
pre ynaptic nerve terminal ( Iwai . et a I . ,  1 995:  Kahle et a l . .  2000; Murphy, 
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Rueter. Tr jan w k i ,  & Lee. 2000) and i found in both o luble and membrane­
a s  c iatcd fract ion or the brain ( l \\ ai , et al . .  1 99 - ). I n  term of ·tructure. 
mon mcric a- ) n i soluble, p 5 e ing an cxtended tructure of random c i l  
( L1 ieler. e t  a l . .  200 1 b) .  I lo\\ e\ cr. th is  protein is  characterized b\  the intrin ic 
pr pen it) t aggregate, forming fibri l s  both in vitro ( onwa) , Harper, et  a I . ,  
2000b: L 1-AgnaC Jake , UlTan, & Wal lace, 1 998:  l Ia himoto, et a l . .  1 998b) and 
in \'i\"(} ( pi l lant in i ,  et a l . .  1 997) .  
Al though the precise mechani m of a-syn aggregat ion in  the brain remains 
to be elucidated, in vitro studie have shown that a- yn fibri l lation i a nucl ation­
dependent proce ( . 1 .  Wo d, et al . .  1 999), \\ hich proceeds through a nuc leation 
( I ag-pha e), an elongati 11 ( grO\vth-phase) and a tead) - tate pha e ( onway, Lee, 
et a l . .  2000a: . 1 . Wood. et aI . ,  1 999) .  In agreement \\ i th this nuc leated a embl 
model of fibri J lati n, it has been shown that the add ition of exogenou , preformed 
nuclei ,  refelTed to as ' seeds' re u l ts in the reduction of the lag pha e and the 
immediate aggregat ion of a- ) n (Conway, Lee. et a l . .  2000a: . J. Wood. et a1 . .  
1 999) i n  a do  e dependent manner ( . 1 .  Wood, e t  aI . ,  1 999). imi lar results have 
also been reported for � -amyloid (A�) .  which is impl icated in the pathogenesis of 
D. More peci tical ly  it ha been shown that the ab ence of the pre-aggregated 
eed i ncreases the lag t ime needed for the formation of AP fibri l s ( JalTett & 
Lan bury. 1 993 ) .  \\ h i le  seeding of monomeric P aggregation with fibri l lar AP 
i nduce neuronal cel l  death ( Wogul is et aI . ,  2005 ) .  Furthermore, i t  has been 
reported that the tox ic i ty of Ap42. is not l inked to pecific prefibri l lar 
aggregate(s) .  but to the abi l i ty of these spec ies to grow and form fibri l \\ hich can 
be achieved by the pre ence of AP42 monomer ( Jan et a t . .  20 1 1 ) . The impact of 
seeding on amyloid aggregat ion has also been establi shed by a number of studies 
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indi  at ing that a- ·yn aggregati n can be induced and a celerated b} the addition 
of  exogenous o l ig mer and fibri l both in cul tured cell ( Danzer. et a I . ,  2007: 
onaka. Watanabe, 1 \\ at ubo. & Ha egawa, 20 1 0; Ipi e l l i -Dale) et a! . .  20 1 1 )  
and in mou e brain ( Luk et aL 20 1 2 ; a uda- u711kake et aL 20 1 3 ) .  llpport ing 
the h) pothcsi that the aggregation of the native protein is direct l)  eeded by 
exogcn us aggregate \ eral ] .  these studies llPpOrt the n tion that am) loid 
toxic i ty. i mediated b a nucleation-dependent pol) merization proce s. 
0\ er the year numerou factor ha e emerged as potent modulators of a­
S) n aggregation in vitro and/or in vivo, witb u- n pho phorylation at 1 29 being 
the most controver ia l .  Given that the a- yn depo i ted in the LBs of many. u-
s) nuclei nopatb ie pho phor) lated at 1 29 and that th is  finding i al 0 
recapitulated in  man) animal models  (re\ iewed by (Paleologou & E I - gnaL 
20 1 2) ,  i t  can be argued that thi s  p t-tran lat ional modification of u-s) n has a 
patbological role .  However, de pi te the s) tematic effort put i nto elucidat ing the 
impact of pho phorylat ion on a-syn aggregat ion and t xic ity, it remain unclear 
\\ hether a-syn phosphorylation promotes or inh ibits the aggregat ion and tox icity 
of the protein ,  a the re ults of these tudies are rather contradictory and 
i nconc lu ive. I ndeed, whi le there are man studies indicat ing that pho phorylation 
at 1 29 (ei ther by employing certain k ina es and/or the phosphorylation mimics 
1 29D/E and the non-phosphorylatable  mutant 1 29A) promote u-syn 
aggregat ion and inc lu ion fomlation (Arawaka, et a I . ,  2006; Fuj iwara, et aI . ,  2002; 
Gorbat uk, et aL 2008; Kragh et a ! . .  2009; M. Takahashi, et a I . ,  2007; B. Wu et 
aL 2 0 1 1 :  Zabrocki. et aL 2008) .  There are equal ly  as many studies showing that 
phosphorylation at 1 29 i nh ib i ts a-syn accumulat ion (Oueslati, chneider, 
Aebischer, & Lashuel ,  20 1 3 )  and aggregation ( Paleologou, et a I . ,  2008;  Waxman 
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& ( J las on. 200 ). v. ith the pho ph 1) lation-bl eking 1 29 \ a- )e n  aetual l )  being 
more pr ne t aggregat ion and inclu i n formation ( zeredo da ih  eira. et a l . .  
2009: I .  h�n, et aI . ,  2009: on�al\'e & Outeiro, 20 1 3 :  Paleologou, et a l . .  _008: 
'aneenon et a l . .  20 1 2: Tenreiro et a l . .  20 1 4 ) .  There are also report indicat ing that 
phosphorylation either ha no effect on inc lu  i n formati n ( L .  Chen. et a l . .  2009: 
chrellr� et a I . ,  20 1 4) r that aggregation of a- J n is ind pendent of 
phosphorylation ( Ba o et a l . .  20 1 3 ; Waxman & Gia on, 20 1 1 ) . far a the p-
1 29 u- yn-related tox ici t  is concerned, the result  of the ariou tudie are 
equa l l y  contradictory and inconclusive. Wherea tudies on yeast. o l igodendrial 
cel l  and a dro 'ophi la model of PO have show that u-syn phosphorylated at 1 29 
(p- 1 29 a-s) n )  by \'ariou k inases (casein kina e 1 ( K l ), C K L  Polo- l ike kinases 
(PLK ). G-protein-coupled k inases ( G RKs) )  correlates "vith a- yn toxicity ( L .  
hen. et a J . ,  2009; Kragh. e t  a I . ,  2009; Zabrocki .  et aI . , 2008) ,  studies employing 
the pho�ph01l1utant 1 29D and 1 29 are pm1icularly contradictory. I n  studies, 
L 90 u- ) n appears to be toxic (Chau, et aI . ,  2009) ,  whi Ie there are al 0 reports 
support ing that the pho phomimic S 1 29D u-s n plays a rather protective role  
( orbatyuk. et a l . .  2008;  Kuwahara, Tonegm a, I to, Mitani, & lwatsubo, 20 1 2; B .  
Wu ,  e t  a l . .  20 1 1 )  o r  ha no  effect on the toxic i t  of the protein (Azeredo da 
i lveira, et a l . .  2009: F ischer et a I . ,  2009) .  imi l arly, blocking of a-syn 
phosphor, lat ion at 1 29 by employing the mutant S 1 29A u-syn ha been shown 
to be toxic by some studies (Azeredo da i l veira, et a I . ,  2009; Gorbatyuk, et a I . ,  
2008: Kuwahara, et  aL 20 1 2 ; ancenon, et a I . ,  20 1 2 ; Tenreiro, et a l . .  20 1 4) and 
protecti ve ( L .  Chen, et a I . ,  2009; Kragh, et aI . ,  2009) or without any effect ( hau. 
et a l . .  2009: F ischer, et a l . .  2009; M .  Tanaka et a I . ,  2004 ) by others. 
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I he dl crepanc le ob er. ed b} the aforementioned tudie mal be explained 
b) the fact that the kina e� phosph rylming (1- ) n in the brain remain unknown. 
and by the findings that phosphomimics d not recapitulate a l l  a pect of 
pho�ph H) lation ( Pale I gou. et a l . .  2008)  and that (1- } n  pho phorylation at 1 29 
mal occur after the a cumulation and depo it ion of fibri l l ar (i- n. gi en that 
fibri l lar (1- ) n  ha been hO\\ 11 to be a good sub trate for many kina e ( befo. et 
a l . .  20 1 0 ;  Paleologou. et a I . ,  20 1 0 : Waxman & Gia on, 2008. 20 1 1 ) . However, 
there is an immediate need to im estigate further the correlation between the 
aggregation and tox ic i ty or (L- ) n and the pho phorylation at 1 29, e pecial ly i n  
the l ight o f  the rect:nt finding upporting the idea that (L- yn mediated toxici ty i 
caused the nucleati n-depend I1t pol) merizat iol1 proce s .  
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.2 pe ri m e n ta l  proced u re 
3.2 . 1 E :\ p res ion a n d  pu rificat ion  of reco m b i n a n t  h u m a n (1- } n . 
r\ ,'T-a- )- n fu ion c n truct in the p -4 f1 \ ector ( k indl) pro\ ided by 
Dr. I I yang huk Rhim of the athol ic n i \ er i t) Cal l ge of 1edic ine, eouL 
Korea) \\ a inserted into 8L2 1  E coli bacteria b) heat hock .  The transfl rmed 
bacteria were gro\\ n in an L8 medium supplemented \\ ith 0. 1 mg/ml ampic i l l i n  at 
3 7° in an orbital shaker to an 0600 of 0 .5 .  Expres ion was then induced by 
add ing 0.5  III 1 I PTG ( igma- Idrich Chemie mbI L Germany), and the cul ture 
\\ as incubated for 2 hours at " 7°e.  The cel l \\ere har\' ted by a 1 5  minute 
entri fugat ion at 9000 x g, and the result ing pel lct \\ a resu pended in a Iy i s  
bu lTer ( 50 m 1 Tri - I lCL pI I 7 . 4 ,  1 - 0  mM a L 2 m 1 EOTA, 1 % PAO, 0. 1 0'0 
D rT) and haken for 1 0  min at room temperature. To improve the effic iency of 
cel l I )  i , the re u pended pel l  t was ubjected to 6 freeze-tha\\ cycle in  l iquid 
ni trogen and a 3 7°C w ater bath.  The lysate wa then centri fuged at 27,000 x g for 
1 5  min . and the resul t ing upernatant wa retained for pur ification by affinity 
chromatography using epharo e bead conj ugated to glutathione, which has a 
h igh affi nity for the G T tag. The cel l  I) ate wa mixed with glutathione 
epharo e bead and incubated for 1 hour at room temperature, fol lowed by 
centri fugat ion at 500 x g at 4°C for 8 mins. The beads were then washed twice 
with wash buffer ( 5 0  mM Tri -HC! ' 1 5
0 mM aCI .  1 0  mM EOTA, I % Triton X-
1 00, pH 8 .0), twice wi th 50 mM Tris-HCI .  pH 8 .0, and once with 1 X PB . The 
\\ a h d bead were re uspended in 5 ml of I X PB , and the G T tag wa c lea ed 
w ith  human pIa ma thrombin ( 1  unit/f..d) ,  ( igma-Aldrich, SA). The thrombin­
catalyzed c leavage reaction was incubated 0 ernight at room temperature with 
continuous mix ing fol lowed by a 5 minute incubation at 3 7°e. The reaction 
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mixture wa then centri fuged for 8 mm at -00 x g at 4°C. and b nzamidine 
epharo e bead ( mer ham. \\.eden) were u ed to ' fish ouf thrombin. Pure a-
) n  \\ a col lected b) c ntri fugat ion at 500 x g for min at 4°C . The a- )'n 
concentrat ion wa e timated u ing a BC a ay ( Pierce Biotechnology. Rockford. 
I L ) .  
3.2.2 (l- yn p u rificat ion  and c h a racte rizat ion .  
rude a- )n protein after G T tag c leavage wa purified u ing rever ed 
pha e H PLC.  The column u ed were an anal }1ical Phenomenex Jupiter C4 (250 3 
4.6 mm)  and a preparat ive Phenomenex J upiter C4 (250 3 1 0  mm). a- yn was 
load d i nto the column and eluted with a l inear gradient ( 3 0-80%) of acetonitri le 
( 700 0 acetonitr i l  . 0. 1 0'0 tr ifluoroacetic acid. )  ver u water (0 . 1 % trifluoracetic 
acid )  for 38 min  a t  a flov rate of 0.5 mllminute. ( cheme 3 . 1 ) . The homogeneit 
of a- ) n protein v,:as a certained b using analytical HPLC and D -page 
cheme 3 . 1  A-C) .  
A B C 
·98 
·64 ·98 





cheme 3 . 1 .  H P LC analysis and characterization of crude a-syn. A. HPLC 
analysis was done using phenomenex Jupiter C4 (250 3 4.6 mm) column. with a 
gradient of 3 0%-80% solvent B i n  solvent A at 0.5 mllminute over 3 8  mins. B .  
Coomassie b lue staining of 1 5% SD -PAGE for H PLC purified recombinant a-
yn. C.  I mrnunoblott ing for HPLC purified a-syn detected by mAb 2 1 1 .  
47 
3.2 .3 Aggregat ion  of u-"') n ill vitro. 
The purit) of the (J.- ; n  employ d in thi a a) \\ a >95°'0 a e timated b) 
, 0  gel The u- ) n  ample placed in  1 . 5 ml teri le polyprop; lene tube . topped 
\\- ith drops of mi neral o i l  to prev ent ample e\ aporat ion. and sealed \\- ith parafi lm 
\\- ere incubated at  3 7  ror e\ eral day \\ ith continu u shaking at  800 rpm in a 
I hcrmomixer ( EppendorO. The sample were col lected at certain point , \\ h i le the 
aggregat ion of u- ) n \Va mon i tored by the ThioIla\ in a ay. The samples were 
tared at -80° unt i l  requi red [or fut1her analy ses. 
3.2 ""  ced ed pol. m criza t ion a ay. 
The aggregat ion or  monomeric wt or p- 1 29 u-syn \\ ith or without eeding 
wa performed as de cri bed el e\vhere (O i  Gi vanni ,  et  a I . ,  20 l O) .  The v"i or p-
1 29 eed \\'ere prepared b) fragmenting the mature (j,- yn fibri l s  by sonication 
re ult ing in  short fibri l  , Monomeric a-syn at a concentration of 1 00 �IM was 
eeded with d i fferent concentrat ions of seed and i ncubated at 3 7°C \\-ith 
continuous shaki ng. The fibri l l i zat ion v as monitored by the Th- binding assay a 
described above. 
3.2.5 T h ioflav i n - (Th- ) a ay. 
u- yn fibri l format ion wa monitored by Th- binding as ay. Th- IS  a 
fluorescent dye that interacts with fibri l s  containing a �-sheet structure. For thi 
a say, a total of 1 0 �l of the ample was d i luted in 40 �t l of  Th- in PB (20 �M 
final concentrat ion) and the mixture was dispen ed in a 3 84-wel l ,  untreated black 
plate unc. Denmark) .  The fluorescence was mea ured b a microplate reader 
(V ictor X3 2030, Perkin  E lmer) with the excitation and emis ion wavelengths set 
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at 4 -0 and - 1 0  nm, re pect i \ el) . To a l l  \\ for ba kground fluon: cen e. the 
Il uore cence intensit) or a blank PB ample \\ a ubtracted fr m all reading . 
3.2 .6 Pnparat ion  of (1- ) n crude eed o l igomer and fibr i l . 
I 00 �M of m nomeric a- yn was aggregated a described above ( ee 
\ggregation of a- ) n in )'ilro) either for 2 or 7 da) . leading to the a-s) n 
ample referred t herein a, ' crude ol igomer ' and ' crude fibri l s ' . re pectively. 
For the preparation of crude eeds. the crude fibri l were fragmented by 
ul trasonication \\ h i le  kept n ice u ing a onic ruptor 250, equipped with a fine tip 
( - second pul e . output 0 1' 40 \\ att for 5 mins) .  
3.2.7 Prepara t i o n  of ( 1 - y n  p u re fibr i l  and p u re eeds. 
1 00 �M of monomeric a-syn was aggregated a de cribed above for 7 days. 
To prepare pure fibri l . the crude a-syn fibril ample was spun at 1 0,000 . g for 1 0  
m in  at 4°e in  a refrigerated microfuge ( Eppendorf). The supernatant \\ as then 
di carded. and the pel let was washed twice with Ul tra-pure water, before 
re u pending in 1 x PB . For the preparation of pure seeds. the pure fibri l s  were 
fragmented by u l tra onication while kept on ice using a sonic ruptor 250. 
equipped with a fine t ip ( 5  second pulses. output of 40 watts for 5 m ins) .  For the 
e t imation of a- yn concentration of the fibri l s  and seeds. the samples v,ere 
denatured b) 6M Guanidine-Hel  and BeA assay which were used according to 
manufacturer ' s  instructions. 
3.2.8 Tran mi s ion  e lec t ro n  m ic ro copy ( T E M ). 
E lectron i mages were produced from aged a-syn ei ther alone or in the 
pre ence of variou percentages of p-S 1 29 a-syn. The sample ( 5  �L)  were 
depo i ted on Formvar-coated 400-mesh copper grids (Agar cienti fic. U K ), fixed 
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briefly  \\. ith 0 -°'0 gl utaraldehy de ( - , .. d ) , negat i \'ely tained \\ ith 2° ° uran) I a etate 
( Igma-Aldrich, L 'A ) and examined in a Phi l ips 1 - 1  0 TE�1 electron 
micro cope. 
3.2.9 l m m u n o b l o t t i n g. 
, amples of (J.- ) n (20  ng) incubated alone or \\ ith variou percentage of p_ 
. ' 1 _'9 . d . \  ' \\ ere mlxe \\ It 1 1 X ample butTer (250 mM Tri -He! .  pH 6.8 ,  30% 
gl)  ct:ro l .  0.02° ° bromophenol b lue)  and eparated in  1 mm 1 5% D -PAGE gel . 
The separated proteins , ere transfened to 0.45 Ilm nitrocel lulo e membrane 
( \\ hatman mbh- ermany ) at 90 for 80 min . The membrane \V re boi led for 
5 min in PB and then blocked for 1 hour with 5% non-fat mi lk  prepared in PB -
1 wcen-20 (0 .05° 0; PB T) .  The membrane v" ere incubated overnight at 4°C with 
the pri mary mouse monoc lonal anti-a- yn ( 2 1 1 )  antibody, which recognize 
human (J.- ) n ( 1 2 1 - 1 25 )  ( anta Cruz Biotechnology, A), at a d i lution of 
1 :  I 000. The membrane \\ ere then washed everal t imes with PBST, fol lowed by 
incubation \\ i th an H RP-conj ugated goat ant i-m use antibody ( Dako Ltd . ,  Ely,  
UK) at a d i lution of 1 : 70,000 for 60 mins at  room temperature with gentle 
agitat ion. The membranes were then extensively washed for 25 mi llS,  and 
immunoreactive band \'.:ere vi ual i zed with the uper S ignal West Femto 
hemi luminescent ub trate Ki t  ( Pierce, Rockford, USA) according to the 
manufacturer ' s  instructions. The amount of monomeric a-syn in the amples f a-
syn aged alone or with various percentages of p- 1 29 a-syn was evaluated by 
densi tometric analysis using ImageJ software and by comparing the monomeric 
bands of a l l  samples with the band generated by a fre h a-syn sample containing 
onl} monomeric species. 
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3.2. 1 0  is ' ue u l t u re of \\ t B E( 2 )-� 1 - 1 7  h u m a n  neurobla toma cel l  . 
\\ t B1.(2)- 1 - 1 7  human neuroblastoma ce l l ' were routinel) cultured In 
Dulbecco' MEM utrient 1 rx r - 1 2  ( I :  I )  ( I I ) c lone) containing 1 0°'0 fetal bo\ ine 
serum ( H y c l  ne ) and 1 %  pcnici l l in- treptomycin ( PI : 1 00 'm l penic i l l in, 1 00 
mg/ml strcptol11) c in- ' igma).  The cel l s  0\ erexpre ing wt a- ) n  were cultured in  
Dulbecco 's  E 1 ( I I ) lone) containing 1 0% fetal b vine serum ( IJyclone) and 
1 %  penici l l i n-streptomy c in .  To maintain the el l  overexpressing a- I n, 250 
�lg/ml or  4 1 8  antibiotic \va added to  the cultur ing media for p ia  mid election. 
1 he cel l '  \\ ere maintained at 3 7°C i n  a humidi fied incubator with 5°'0 02/95% 
<Hr. 
3.2. 1 1 Ti u e  c u l t u re of B E( 2 ) -M- 1 7  
oyere � p re i n g  w t-u.- y n .  
h u m a n  neurobla  t o m a  cel ls  
BE(2)- 1- 1 7  human neuroblastoma cel l o\ erexpre s l I1g \\1-a-syn \\ere 
routinely cultured in Dulbecco ' M E  I1H igh Glucose ( Hyclone) containing 1 0% 
fetal bo\ i ne erum ( H yc lone), 1 % penic i l l in- treptomyci n  ( PI : 1 00 U/ml 
penic i l l in ,  1 00 mg/ml treptol11ycin-S igma) and 250 Ilg/ml of G4 1 8  ant ibiotic was 
added to the culturing media.  The cel l s  were maintained at 37°C i n  a humidifLed 
i ncubator \\ ith 5° 0 C0219 -010 air . 
3.2. 1 2  Ti ue c u l t u re of H Y-SY h u m a n  dopam inergic n e u robla  toma cell  . 
H Y-5Y human dopaminergic neuroblastoma wt or overexpre ing wt-a­
s) n ce l ls  were routinely cul tured in  Dulbecco 's M E  1 utrient 1 i x  F- 1 2  ( 1 : 1 )  
( H } c1one) containing 1 5% fetal bovine serum ( H yclone), 1 �'o penic i l l in­
streptomyci n  (P : 1 00 U/ml penic i l l in ,  1 00 mg/ml streptomycin- igma), and 
upplemented with 1 °'0 non-es ential MEM amino ac id supplement ( Gibco) and 2 
5 1  
., 
mM Ire h I )  prepared gl utamine.  The cel l were maintained at 37  In a 
humidi fied incubat r \\ i th -0 ° 
3.2 . 1 3  !\l ea u re m c n t  of cel l  \ ia b i l it) . 
I he � 1T r assay \\ a emplo) ed � r the a e ment of the cytotoxic effect of 
the di fferent a-s) n spec ie . ce l l  uspended in a culturing med ium \\ re plated at a 
density of 1 5 .000 cel ls  ( 1 00 II I '\ve l l )  in a 96-\\ el l  plate. fter 24 hour . the 
medium \\ a rcpla ed \\ ith 1 00 III of MEM-R ( I Iyclone) serum-free med ium 
contain ing the d i fferent olution [ a- yn pecIc d i luted in  erum-[ree m dia to 
obtain the de ired c ncentration . The cel l \\ ere then al lo\ved to gr \\' for 24 or 
48 hours. total of _0 II I of MTT (3 -(4. 5-dimethylthiazol -2-y 1 )-2 .5-
diphen) I tetrazol ium br mide) ( igma-Aldrich. ) (6  mg/ml )  in PB \\ a 
di spensed into each wel l .  and the plate \ a incubated at 3 7°C for 4 .5 hour . The 
HT-containing medium \\'a careful ly  removed, and replaced with 1 00 �L 1/v, el l  of 
I ) si bul  r ( 1 5% D , 50°'0 . -dimethyl formamide, pH 4 . 7) .  The Iy i buffer 
wa i ncubated at 3 7°C ovemight. The absorbance alues at 590 nm were 
mea ured i n  a m icroplate reader ( Perkin Elmer). For the experiment a e ing the 
toxic effect of eeded poly merization, the cel l were prepared a mentioned 
abO\ e .  The ce l l  were then incubated at 3 7°C in 5% CO2 for 1 hour and 
monomeric a-syn wa then added to the cel l treated \\ ith a d ifferent species, then 
the cel l s  were i ncubated again for another 48 hour . 
3.2 . 1 -'  III vitro pho phory l a t io n  of (l- n .  
10nomeric a-syn (wt) was phosphor lated by PLK2 ( Invitrogen) at a 
concentration of 1 .44 mg/ml ( 1 00 11M) .  The phosphor lation reaction wa carried 
out in the presence of 1 .09 mM A TP ( igma), 1 X reaction solut ion (20 mM 
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I l I�PJ  . 1 0  mM vIg 1_. 2 m\'1 DDT. pH 7 ... l ) . and 1 Ilg of PLK2 at 30 n f r 24 
hour ' \\ i thout hak ing. Ihe reaction volume \" a 1 00 �t ! .  
3. 1 . 1 .  W t  a-s) n gene S N " m a l l  i n terferi n g  R N A ( i R A )  i l enc ino. 
The pre-de igned � iR .\  sequence 5 ' - A G C tt- 3 '  
target l l1g human wt  Ct - )- n. a wel l a non-targeting crambled iR  \"ere 
purcha ed from mbi n ( L ife technologie ) .  BE(2)-M- 1 7  human neuroblastoma 
cdls  gro\\ n in  1E 1 serum-free media \"ere plated either in  6-\\.e l l  r 96-\vel l  
platc a t  a den  ' i t;  of 3x 1 O� r 4.000cel l 1\\ ell resp ctively. The next da . the 
cel l s  in the 6-\\ e l l  plate \\ ere tran fected \" ith a 200 pmol s iR wel l  for 
immunoblott ing. \\ h i le the e l l  i n  the 96-\\ e l l  plates were tran fected with 8 pmol 
iR A, \\ c l l  for u -e III 11 r as a, . The si R A was tran rected using a 
transrcction reagent ( .  untn Cruz B iotechn I g) . U A ) .  After 6 hours of 
incubat ion. 1 ml of a nonnal growth medium containing 2 times the amount of 
bo\ ine erum \Va added \\ i thout removing the tran fI ction mixture. The cel l s  
then i ncubated for 72 hours before applying the appropriate protoco ls  (WB,  
1 TT) .  F r the iTT a ay the cel l s  were treated with pure fibri l , pure seed or 
monomer . 
3. 1 .2 .  Aggregat ion  of p- 1 29 a-sy n in vitro. 
Recombinant Ct- ; n  \'v as m ixed \\- ith di fferent percentages of in vitro 
prepared p- 1 29 Ct- yn ( 1 00. 50. 20 and 5%) in  1 . 5 m l  steri le  polypropylene tubes. 
topped \vi th drops of m ineral o i l  to prevent sample evaporation, and incubated at 
-, 7° for everal da) s \'v ith cont inuous haking at 800 rpm in  a Thermomixer 
( Eppendorf). amples \\- ere then col lected at certain point and a thioflav in­
as ay \\as perfonned. 
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3.3 Re u l t  
3.3. 1 M o rpho logica l a n d  t ructura l  req u i rement fo r (1- .)- n-med ia ted 
n e u ro n a l  cel l death  
, c\'cral l i nes of c\ idencc upport the idea that tox ic AP contain a mixture 
of high molecular \\ eight aggregat \\ ith di fferent i7e and tructures (Jan. 
I lart le) . . La hue ! .  20 1 0 :  Lashuel et a I . ,  �003 : Wal h et aL 1 999) .  To in  e tigate 
\\ hether thi al 0 appl ie  to a- yn-mediated tox icit  . we ought to detel1l1 ine the 
tru tural feature of the mo t toxic pecies of a-syn. For thi purpo e we a e ed 
the tox ic effect of d i fferent pecies of a- ) n on neuroblastoma BE(2)- 1- 1 7  and 
I I  Y - 5 Y  \"\1 cel l . The a-s) n pec ie emplo) ed for the e studie ranged from 
mon meric to ol igomeric/intemlediate and fibri l lar forms.  The ol igomeric and 
fibri l lar pec ies. which are referred to herein a ' crude ol igomers' and 'crude 
fibri l s' . re pect ively. were prepared by aggregati ng 1 00 �IM of monomeric a-s)n 
with continuou mixing for 2 and 7 days. re pecti \'e l ) . The ample 
referred to as . crude seeds' ,"\ ere in tum prepared by ubj cting the crude fi bri I to 
brief onication as described abo e. The structure and the P- he t content of these 
samples were evaluated by TEM and Th- a ay. respectively ( F ig. 3 . 1  . B ) .  To 
a e the effect of the prepared spec ies on the viabi l ity of neuronal cel l an MTT 
a say wa carried out employing \\1 H Y-5Y and BE(2)-M- 1 7  - human 
neuroblastoma cel l , The total amount of a-syn expressed in these cel l s  was 
estimated by immunoblott ing as shown in ( Fig. 3 . 1  C). For the MTT a say. the 
cel l s  were treated with solutions of a-syn monomers and the various a- yn specie 
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Figure 3 . 1 .  hara terization of the a- yn pecies and evaluation of the a-syn 
expr ion in the variou neurobla tom a cel l  . A. The fibril content of the variou 
a- yn pecie . namely crude ol igomers, crude eeds, crude fibri l s  and monomers 
( 5  � 1 )  wa eval uated by Th- fluorescence. The a ay \ a performed in  
trip l icate. and the mean ± tandard deviations are hown. B .  E lectron micro copy 
image of negat i \  e ly stained ample of a- yn species ( 1  00 �M). Scale bar 500 
nm. C. The Iy ate (20 ng) of both the wt and the a-syn stably transfected 
neurobla toma cel l  BE(2)-M - 1 7 and H Y-5Y were separated b 
ele trophore i i n  a 1 5% D -PAGE gel and tran ferred to nitroce l lulose 
membrane, which was probed with anti -a- yn (2 1 1 )  and anti p-actin ant ibodies. 
s hown in Fig .  3 . 1 .  A and B. treatment of BE(2)-M- 1 7  -wt a-syn cel l 
(i. e. the cel l s  expres i ng only endogenous a-syn) with monomer had no effect on 
cel l  v iab i l i ty. whi le  the treatment with the rest of the a-syn species (crude 
o l igomers. seeds. fibri l s )  had a mi ld  impact on both cel l  l i nes. This mi ld  effect on 
the ce l l  iab i l i ty was comparable  for a l l  these three a-syn species. but was more 
prominent in the cel l s  treated with the h ighest concentration of a-syn species (20 
�M)  and for a longer period (48 hours) ( Fig. 3 .2  B) .  Comparable results were 
obtained when H Y-5Y expressing only endogenous a-syn was used ( Fig.  3 .2  C .  
D) .  
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Figure 3 .2 .  The effect of the arious a-syn species on the viabi l i ty of B£(2)-M- 1 7  
and HSY-5Y \\<1 neuroblastoma cel ls .  The iabi l i t  of BE(2)-M- 1 7  human 
neuroblastoma cel l s  was estimated by the MTT a say. The results are expressed as 
the percentage of the control average (i. e. , untreated cel ls) .  The cel l s  were treated 
with d ifferent concentration of a-syn specie either 24 or 48 hours prior to MTT 
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addit i  n (a\ erag of 3 \\ e l l  :::: tandard de\ iat ion ). . BE(2) -;"'1 - 1 7  -\\1 c I I  
incubat d for 2 4  hour . B .  BE(2)-M- 1 7  - \\1 cel l incubated for 4 8  hour . C .  
I I  Y- - \\1 cel l  incubat d for � 4  hour . D. H Y-5Y \\1 cel l  i ncubated for 4 
h ur . tati t ical anal)  i wa perform d u ing one way anova. fol lowed b) 
Tuke) ' mult ip l  compari on te t u ing the GraphPad Pri  m 5 oft\\ are. ( * * * .  p< 
0.00 1 : * * .  p< 0.0 1 .  * .  p< 0.05 ). 
The r ult  obtained from th \\1 cel l u ed in  the above exp riment . 
prompted u to u e the am cel l  o\ erexpre ing \\1-a- yn to di t ingui h any 
d ifference. Howe er. in the ca e of the BE( 2 )-M- 1 7  c 11 overexpre ing wt a-
) n ( i. e. expre ing a- )'n in xce s ) .  a- yn monomer had no effect on cel l  
\ iabi l it) . Tr atment \\ i th a- )'n ol igomers. e pecial l y  in h igher concentration (20 
Il 1 )  reduced ce l l  viabi l ity b) approximately 50% and 65% after 24 hour and 48 
hour f incubati n .  r pectively ( Fig.  3 . 3 A. B) .  At 20 IlM. a-syn crude eed and 
fibri l had a comparable effect on ce l l  viab i l i t  . reduc ing i t  by approximately  20% 
and 30°'0 after 24 hour and 48 hours of i ncubation, re pectively ( Fig.  3 .3 . B) .  
0\ eral ! .  the i mpact of a- yn crude o l igomer . seeds and fibri l s  on the iabi l it of 
the BE(2)-M- 1 7  cel l overexpressing v.1 a-syn sho\'ved a dose-dependent relation 
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Figure 3 . ' .  The effect o f  the \, ariou a- ) n  pecie on the viab i l ity of BE(2 )-�1- 1 7  
and H Y-5Y n urobla  t rna cel l o\ erexpre ing a.- ) n . The Yiab i l it) of H Y-
5 human n ur b la  t rna cel l  was e t imated b\ the iTT a ay. The re ult are 
e pr d a the p rcentage of the control average (i e. , untreated cel l  ). The cel l 
\\- ere treated \'\- ith di fferent concentration of a- yn pecie either 2.+ or 48 hour 
prior t MTT addition (averag of 3 wel l  ± tandard deviation) .  . BE( 2 )- 1 - 1 7  
o\, er xpre ing \\-1-a.- ) n cel l i ncubated for 24 hour . B .  BE(2)-M- 1 7  
\ er xpre ing \\1-a- ) n  e l l  incubated for 48 hour . H Y-5Y c I I  oyer 
c\.pre ing \\1 a- ) n incubated for 24 hour . D. H Y -5Y cel l  over expre ing \\1 
a.- ) n incubated for 48 hour . tati tical analy i wa performed u ing one \'\ a) 
ano\, a, fol lowed by Tuke) I multiple compari on te t u ing the GraphPad Pri m 5 
oft\\ ar . ( * * * , p< O.OO l ;  * * . p< O.O l . * , p< O.05) .  
Taken togeth r .  the above result i ndicate that the different form of 
aggregated a- yn pecie and e pecia l ly the crude ol igomers, can be more toxic in 
the pre en e of exce amount of monomeric a- yn. 
To further confirm the e findings. thi experiment was can-ied out u i ng 
another H Y-5Y cel l over expre ing wt a.-syn. In ( Figure 3 .3 C and D) it i s  
hO\\TI that treatment of H Y -5Y cel l ( overexpres i ng  wt  a.- yn )  with the 
\'arious u- yn pecie had an effect analogou to the one produced by the 
treatment of BE(2) -M- 1 7  cel l with the arne a-syn pecles. 
3.3.2 A d d ition of a- yn monomer to p re-treated , ith prefo rm ed 
aggregate cel l  enhance the a-syn-med iated toxicity 
Gi  en that a.- yn crude o l igomers had a stronger effect on cel l iab i l i ty 
compared to crude eeds and fibri l s  and taki ng into account that the crude 
ol igomeric a-syn samples contain both monomers and protofibri l s  ( Fig.  3 .4 B),  we 
as umed that the toxic effect of the ol igomeric a-syn may be l inked to its abi l i ty to 
seed the aggregation of monomeric a-s n. To i nve t igate this h pothesi , we 
prepared a-syn species 0 that they contained the minimum number of monomers, 
namely pure seed and fi bri l s  ( Fig.  3 .4), and we evaluated their effect on the 
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viabi l i t) of n urobla toma cel l . For thi purpo e. both BE(2 )-�1 - 1 7  and H Y_ 
5Y \\1 ce l l  were treated v-. ith thr  e differ nt concentration (2 .  5 and 1 0  11M )  of 
pure eed and fibri l for 48h . .  
A 
B 
pllJ"e \\1-0-SYll fibn'h pUTt WI"" S}"tl seeds 
Figure 3 '-+ .  Characterization of a- yn pure fibri l s  and pure seeds. A .  The fibri l 
content of pure fibri l , pure eeds, and monomeric a-syn ( 5  11M )  wa e aluated by 
Th- fluore cence. The a ay was perfom1ed in  trip l icate. and the mean ± 
tandard deviation are hO\\TI. B .  E lectron m icroscopy images of negatively 
tained an1ple of a-syn species ( 1 00 11M) .  cale bar 500 nm .  
To a se the effect of these a-syn specIes In the presence of a- yn 
monomers. monomenc a-syn wa added to the cel l  hour later at a final 
concentration of 1 0JlM .  Whi le both pure seeds and fibri l s  had an effect on the 
v iab i l it, of the ce l ls  ( both B (2 )-M- 1 7  and H Y-5Y)  at a l l  concentrations ( Fig.  
3 . 5) ,  with eeds being more toxic  than fibri l s, the addition of monomeric a- yn 
rendered this effect e en more pronounced 
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F igure '" . 5 .  The effect of u- yn eeding on the iabi l ity of neurobla toma cel ls .  
The " iabi l ity of . BE(2)-M- 1 7  -wt cel l , B .  H Y-5Y - human neuroblastoma 
\\1 cel l was e t imated by the MTT as ay. The resul t  are expre ed as the 
percentage of the control average ( i. e . ,  untreated cel ls) .  The cel l s  were treated 
with d ifferent concentration of u-s n pure fi bri l or pure eeds and one hour after 
treatment monomeric u-syn to a final concentrat ion of 1 0  11M was added. The 
cel l v;ere then i ncubated for 48 hour prior to MTT addit ion. ( average of 3 "ve i ls  
I tandard deviat ion) .  tat i st ical anal i wa performed using one way anova, 
fol lowed by Tuke ·1 mUlt ip le compari son test using the GraphPad Pri m 5 
oftware. ( * * * _ p< 0 .00 1 :  * * , p< 0 .0 1 .  * . p< 0 .05) .  
As the effect was i ndependent of the concentrat ion of the pure seed and 
fi bri l s_ we attempted to evaluate the toxic i ty of the cel l s  varying both the 
concentration of seed and fibri l s  ( at a lower concentration scale. i .e. 0.000 1 - 1 0  
11M )  i n  the pre ence of a constant concentration of u- yn monomer and vice 
versa. The resul ts of this series of e 'periments are i l lustrated in  Fig. 3 .6. As 
6 1  
ho\\ n i n  Fig.  " .6 and . pure eed and fibri l decrea e cell \ iabil it) in a 
ncentrati n-dependent fa hi on. but the) exert a more toxic effect m th 
pr ence of monomeric (l- ) n (final concentration of 1 0 �M). with eed b mg 
once again more toxic than fibri l . I ndeed. even at a concentration a 10\\ a 0. 1 
n\1 .  pur eed produced a trong toxic effect reducing cel l v iabi l it) b) 
appr ximate l)  .. wo'o . 
T i ll' e t igate the effect of varying concentration of monomeric (l- yn ( 1 -
20 � 1)  on cel l  \ iabi l i t) . the cel l were first treated with a constant concentration 
(2  � 1 )  of either pur fibri l  or pure eed . hO\\11 in  Fig.  3 .6 B and D. the 
addit ion of monomer appear to be a prerequi ite for cel l toxic i ty when cel l  are 
pre-tr ated \\ith pure fibri l  and eed (Fig .  3 .6 B) a (l- yn monomers alone had 
no effe t on cel l viabi l i t  . 
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F igure 3 .6 .  The effect of a- yn eeding on the iabi l it of neurobla toma cel ls .  
The viabi l i ty of B E (2)-M- 1 7  and H Y -5Y human neuroblastoma wt cel l was 
e t imated by the MTT a ay. The re ult  are expres ed a the percentage of the 
control average ( i. e. ,  untreated cel ls ) .  A. The BE(2 )-M- 1 7  -wt cel l s  were treated 
with d ifferent concentration of a- n pure fibri l s  or pure eed (0 .000 1 - 1 0  )lM )  
and one hour after treatment, monomeric a-s n t o  a final concentration o f  1 0  )lM 
of was added. B .  The BE(2)-M- 1 7  -wt cel l s  were treated with 2 )lM ( final 
concentration) of a- yn pure fibri l  or pure eeds and one hour after treatment. 
monomeric a- yn wa added to a final concentration ranging between 1 -20 )lM .  
C .  The H Y -5Y -wt cel l s  were treated with different concentration of  a-syn pure 
fibri l or pure eeds (0 .000 1 - 1 0  )lM )  and one hour after treatment, monomeric a­
syn \va added to a final concentration of 1 0  )lM .  D. The BE(2 )-M- 1 7  wt cel l s  
\\'ere treated with 2 )lM final concentration of a-syn pure fibri l s  or  pure seeds and 
one hour after treatment , monomeric a-syn was added to a final concentration 
ranging between 1 -20 )lM .  The cel l s  were then incubated for 48 hours prior to 
MTT addit ion.  ( average of 3 wel l s  ± standard deviation) .  
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3 . .  3 The effect of p u re ed a n d  fibr i l  on the cel l  v iab i l ity of BE(2)-:\ 1 - 1 7  
c I I  " h o e en dogenou (l- y n  h a  been knocked do" n 
To im e t igate furth r the role  of monomerlc (l- yn in  inducing the 
nu leati n polymerlzat ion proce of (l- )- n. \\' a e ed the effect of pure eed 
and fibri l  on the \ iabi l it) of BE( 2 )-M- 1 7  -\.vt cel l \\ ho endogenous (l- yn \Va 
kn ked do\.\ n by i RN i lencing. The i lencing \va evaluat d by 
immun blott ing and th expre ion level of (l- yn \Va quantified bJ the image 
proce ing program I mage] ( Fig .  3 . 7  . B ) .  The i RNA transfect d BE(2 )-M- 1 7  
\\1 e l l  were treated with pure fibri l and pure seeds at four d ifferent 
concentrat ion ( 1 .  5 .  1 0  and 20 11 1 ). ",,'hi le monomeric (l- yn was emplo 'ed a a 
ontrol at the same concentrat ion . ccording to the MTT results ( Fig.  3 . 7  C-E). 
the cel l whose endogenous (l- n was knocked down ere less susceptible to the 
toxic effect of pur fibri l  ( Fig.  3 . 7  C) and eed ( Fig.  3 . 7  D) .  However. the 
treatm nt of the cel l  wi th monomeric (l- yn at any given concentration had a 
comparable impact on the v iab i l i ty of both the i RNA-transfected and the control 
cel l  ( Fig .  3 . 7  E) .  The e re u l t  confinn further the role  of monomeric (l-syn in  the 
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Figure " . 7 .  The effect of pure eeds and fibri l  on the cel l viabi l ity of BE( 2 )-M- 1 7  
cel l . \, hose endogenou a- yn has been knocked down. Pre-de igned i RNA 
equence targeting human wt a- yn wa u ed to i lence the expre sion of a-syn. 
and non-targeting crambled iRNA wa u ed a negative controL 
I mmunoblott ing for cel l  l ysate to detect total a-syn using the mou e monoclonal 
anti-a- yn ( 2 1 1 )  anti bod I and anti �-actin for loading contro l ,  lane 1 : 
recombinant a- yn. l ane 2 :  non- transfected cel l I ate. lane 3 :  scambled s iRNA 
tran fected cel l l yste. lane 4 :  R- 1 2  peptide transfected cel l lysate. l ane 5 :  i RNA 
tran fected cel l l ysate . B. Quant ification of a-syn expression Ie e ls by 
den i tometric analysis using the Image] oftware. C-E. The viabi l i ty of BE(2)-M-
1 7  human neuroblastoma \\1 cells was estimated by the MTT assay. The results 
are expre sed a the percentage of the control average ( i. e  . •  untreated cel ls) .  C. 
The B E( 2)-M- 1 7  wt cel l s  were treated with d ifferent concentrations of \\1-a-syn 
pure fibri l s  D. wt-a-syn puree eeds .  E. Monomeric a-syn. The cel ls  were then 
i ncubated for 48 hours prior to MTT addition. (a erage of 3 wel l s  ± tandard 
deviat ion) .  tat ist ical  analysis wa performed using one way anova. fol lowed b 
Tukey's mult iple comparison test using the GraphPad Prism 5 software. ( * .  p< 
0.05) .  
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3.3.4 d d i t ion of p- 1 29 (l- } n  monomer to p re-treated wi th  p reformed 
aggregat e  ce l l  doe not p romote the (1.- yn-mediated toxicity. 
The finding that the majority of (l - yn pre ent in  LBs i pho phol) lated at 
1 29. \\ h i le  the arne m dification appear only in 40/0 of the protein in  the 
n rmal brain ( nder on. et a l . .  2006: Fuj iwara. et al . .  2002: H i rai. Fuj ita. 
Iwat ubo. & Ha ega\\ a, 2004) indicate that the pho phorylation of (1- yn at 1 29 
p ia] a major role in PD.  De pite the huge effort put in to eluc idating the rol of p-
1 29 (1- yn in th pathogene i of PD, it remam unknown whether 
pho ph l) lation take place before or after (1- yn i depo i ted in  the brain, whi le  it 
t i l l  debatabl whether (1- yn pho phory lation at 1 29 promotes or i nh ibit the 
aggregation and toxic i ty of the protein .  To better understand the impact of 
pho phor ' lation on (1-syn aggregation and toxicity, we ought to uma el  the role  
of (1- 1'n pho phorylation at 1 _9 i n  the seeded polymerization and toxicit  . 
Our finding prompted u to i n  estigate wh ther adding monomeric p- 1 29 
(1- )'n to the ce l ls  pre-treated with either pure fibri l s  or pure seeds would have an 
effect on their toxic i ty .  For thi purpose, in )'ilro phosphorylated monomeric and 
aggregated recombinant (1- yn (characterized by immunoblotting and Th­
binding Fig.  3 .8 A and B )  were u ed to a e s the abi l ity of ariou p- 1 29 (1-syn 
pecies to seed the aggregation process. The phosphorylation of (1-syn was 
a sessed by immunoblott ing employing a p-S 1 29 (1-syn-specific antibody ( Fig.  3 . 8  
C ) .  Both \\t and p - 1 29 (1-syn pure seeds were characterized b y  EM and Th-S 
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Figure 3 . 8 .  Characteri ation of in 1'ilro prepared p- 1 29 a-syn . 
Characterization of monomeric and aggregated a- 'n by i mmunoblott ing. B. Th­
fluore cence reading of the monomeric and aggregated a-syn samples. C .  
l mmunobloting for the  ample of a-syn incubated with PLK2 at  d ifferent time 
point . Pho phory lation at 1 29 \Va detected b an p-S 1 29 a-syn-speci fic 
anti bod}. Total a-syn wa detected by anti-a-syn ( 2 1 1 )  antibody. D. E t imation of 
the fibri l content in the p- 1 29 seed , wt  eeds and aged a-syn by Th­
fluorescnce. The as a \Va performed in trip l icate and, the means ± standard 
deviation are hOWTI. E. E lectron microscopy image of negatively tained 
an1ple of p- 1 29 seeds, wt seeds and aged a-syn ( 1 00 11M ) .  Scale bar 500 run. 
Prior to an toxic i ty experiment incorporati ng various species of a- yn, the 
effect of monomeric p- 1 29 a- yn alone compared with wt a-syn was a essed i n  
both BE(2)-M- 1 7  and H Y-5Y wt cel ls .  Monomeric p- 1 29 a-syn employed at 
a range of concentrations (0 .3 1 -20 11M)  was not toxic to neither BE(2)-M- 1 7  cel l s  
( Fig .  3 .9 ) or to H Y -5Y cel l s  ( Fig .  3 .9  B) .  
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For the xp rim nt a e ing the ffect of monomeric p- 1 29 a- ) n on 
the \ iabi l i t) f the cel l pr -tr ated \\- ith pure eed or fibril . BE(2)-M - 1 7 and 
H Y-- Y-\\1 c 1 J  v .. 'ere treated v .. i th d iffi rent concentrat ion of i ther pure fibri l 
or pure d ( 1 0. 5 and 2 11M )  and after one hour incubation. monomeric p- 1 29 
u- ) n \\ a added to the cel l  at a final concentration of 1 0  11M .  urpri ingly. a 
ho\\ n in  fig.  "'1 .9 and D. in  contra t to the \\1 monom ric a-s) n (F ig .  3 . 5 ). the 
p- 1 29 monomer had no effect on c II viabi l i ty \\ hen pre-treated with any 
oncentrat ion f pure fi bri l or pure eed . I ndeed. the toxic ity levels ob e[\'ed 
after treatment with the monomeric p- 1 29 a- yn fol lo\'ving treatment \\ i th pure 
eed or fibri l  were comparable (and tati tical ly  non- ign ificant )  to the ones 
en in cel l treated only with pure eed or fibri l . 
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F igure 3 .9 .  The effect of p- 1 29 a-syn seeding on the iab i l ity of neurobla toma 
cel l  . The effect of monomeric \vt and p- 1 29 a-s n on the viabi l i ty of A. BE(2)­
M- 1 7  -wt cel l . B .  H Y-5Y - human neuroblastoma wt cel l s  was est imated by 
th iTT a ay. The re u l t  are expres ed as the percentage of the control average 
( i. e  . .  untreated ce l l  ). C. The BE(2) -M- 1 7  and D. H Y-5Y cel l s  were treated 
with d ifferent concentration of a- yn pure fibri l s  or pure eeds and one hour after 
treatment. monomeric p- 1 29 a-syn \ as added to a final concentrat ion of 1 0  IlM .  
The cel l v,,'ere then incubated for 48 hour prior to MTT addit ion. (average of 3 
\\ e l l s  ± tandard deviat ion) .  tati t ical analysis was perfom1ed using one \\Oay 
anoya. fol lowed by Tukey' mult ip le comparison te t using the GraphPad Pri m 5 
software. 
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.3 .5 ing  t h e  a b i l ity of p- 1 29 to e d t h e  aggregat ion of (1- yn 
To a e the abi l i t )  of p- 1 19 a- ) n  to eed the aggregation of the pr t in .  
1 00 JlM of monomeric a- } n \\a incubated alone or in  the pre ence of 1 Jl 
( final c ncentrat ion) \,,1 r p- 1 _9 a- yn eed for 5 h ur . Con idering that (1- }n 
aggregation i a nuel ation-d pendent proce , the addit ion of exogenou 
preD mled nuel i .  namely th eed . i xpected to reduce the nucleation pha e of 
th pr e . re ult ing in  an immediate aggregation of the protein (Wood . et a l . .  
1 999: Conwa}. e t  a l . .1000b). I ndeed. a i l lu  trated in Fig .  3 . 1 1 .  the  addit ion of w1 
and p- 1 19 a- yn eed accelerated the aggregation of monomeric a- yn as 
compared to the ontrol .  which howed comparable Th- fluorescence reading 
throughout the 5-hour incubation proces . I t  i noteworthy, that the \\It a-syn eeds 
had a greater i mpact on the aggregation of monomeric a-syn compared to the p-
1 19 a- )'n one ( Fig .  3 . 1 0) ,  but i nce th is effect wa not statistical ! s ignificant 
the experiment wa r peated employing a 10\\'er concentration of seeds (0 . 1 JlM )  
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c:3 wt-a-syn+ p- S 1 29 seeds 
EJ wt-a-syn+ wt seeds 
F igure 3 . 1 0. As es ing the abi l ity of p 1 29 a-s n to seed the 
polymerization/aggregation of a-syn. Samples of monomeric a- yn ( 1 00 JlM )  
were incubated for 5 hour a t  37°C with continuous shaking i n  the pre ence or 
absence of 2 JlM of wt or p 1 29 a-syn seeds.  F ibri l formation was mea ured by 
Th- fl uorescence. The a say was performed in  tripl icate. and the means ± 
standard deviation are shown. 
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he r u l t  of thi ene of experiment are hO\\TI in  Fig . .., . 1 1 and B . 
. 1 1  . e\ en aft r 48 hour of incubation. the eeding effect of 2 
�\t1 \\1 v, a tati t ical l )  ignificant \\ hi le 2 �M p- 1 29 u- yn eed v.;ere not 
ignifi ant . Ho\\ e\ er. at 0. 1 11M. the impact of p- 1 29 u- yn seeding as compared 
to \\1 e d ing \\ a pr min nt. hown in Fig.  3 . 1 1 B .  at 0. 1 11 . \\1 u- ) n  eed 
accelerated the aggr gati n of u- yn. with th trend b coming apparent after 8- 1 2  
hour of incubation and increa ing in  a t ime-dependent manner thereafter. I n  
c ntra t .  a t  0 . 1 11M .  p - 1 29 u - yn  eed not only d id  not accelerate the 
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F igure 3 . 1 1 .  The abi l i ty of p- ] 29 a-s n to seed the on 
polymerization/aggregation of a-syn. . Monomeric a-syn ( 1  00 �M) wa 
i ncubated alone or with _ �M or B. 0. 1 �M (final concentration) of p- 1 29 or v.1 
eeds for 48 hour . C .  amples of  p- 1 29 monomeric a-syn ( 1  00 �M)  \ as 
i ncubated alone or v,;ith 2 �M or D. 0. 1 �M ( final concentration) of p- 1 29 or v.1 
seed for 48 hour . The fibri l lation wa evaluated by Th- fluorescence. The a ay 
wa performed in  trip l icate. and the mean ± standard deviat ions are shown. 
tat i t ical  analy is  was performed u ing one way an ova, fol lowed by Tukey's 
mult ip le compari on te t using the GraphPad Prism S oftware. ( * * ,  p< O .OL * .  
p< 0.05) .  
To further i nvest igate th is  rather unexpected finding, we assessed the 
abi l i ty of wt or p- 1 29 a-s n eeds to seed p- 1 29 a-syn monomers instead of wt. 
The monomeric p- 1 29 a-syn wa incubated in the pre ence or absence of wt or 
p- ] 29 a-s n eed at two d ifferent final  concentrations (2 and 0. 1 �M) for 48 
hours. As shovm in Fig.  3 . 1 1 C and 0, regardless of the type or the concentration 
of the eeds. p- 1 29 a-syn fai led to aggregate e en after 48 hours of incubation. 
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indi ating that pho ph 1) lation at 1 29 ha an inhibit  1) effect on the aggregation 
f the pr tein.  
3.3.6 A e ing the effect of p- 1 29 (l - yn on the  auurega t ion of (l- yn 
To further explor th impact of pho phor} lation at 1 29 on the aggregation 
of the protein .  and on idering that only 5° 0 of a- n i pho phorylated at 1 29 
und r ph) iological condition ( H irai , et ai . ,  2004 ). we in  estigated the effect of 
\ ariou amount of p- 1 29 a- yn on the aggregation of a-syn. For thi purpo e. 
pure monomeric p- 1 29 a- yn v,;a mix  d with d ifferent concentrat ion non­
pho phor) J ated a- yn to obtain the de ired percentages of p- 1 29 a- yn 
monomer (0- 1 00 °'0 p- 1 29 ) .  The e ampJes were incubated for up to 20 days, 
and the aggregation wa a se ed at d ifferent t ime points by Th- assay. As 
hown i n  Fig.  3 . 1 2 . the non-phosphorylated a- yn gradual ly aggregated reaching 
approximately 35 .000 Th- count after 20 day of incubation. The ample 
contain ing - 0 ° p- 1 29 a-syn exhibited a im i lar tendenc to aggregate to the non­
pho phoryJated sample. with the only d ifference in the aggregation pattern of the 
t\\ O ample being the sl ight ly slower rate of aggregation observed for the 5% p-
1 29 ample during the incubation period of between 3 - 1 2 days ( Fig.  3 . 1 2 ) .  
HO\\'e\'er. the  an1ple containing 20% p- 1 29 a-s  n howed a marked inabi l i t  to 
aggregate. given that the reduction in Th- fl uorescence readi ngs was more than 
50°'0. I n  the case of the san1ples containing 50% and 1 00% p- 1 29 a-syn. the 
fibri l lation was almo t completely inh ibited. with the Th- fluorescence readings 
reaching approximately 2.000 counts after 20 da s of i ncubation. Interestingl , 
the non-phosphorylated sample reached this aggregation level after only 2 day of 
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incubati n ( Fig .  3 . 1 2 ) .  The e re ul t  further confirm that pho phOly lat ion at 1 29 
exert an inhibi tory effect on 0.- ) n aggregation. 
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F igure 3 . 1 2 . The effect of p- 1 29 on 0.- yn aggregation. Monomeric 0.- yn ( l Oa 
J.l 1 )  \" a i ncubated in  the pre ence of variou percentage (0. 5 . 20 .50 and 1 000/0) 
of p- 1 29 monomeric a-syn for 20 days at 37°e with continuou shaking. The 
fibri l lation wa evaluated by Th-S fl ucre cence.The assay \ as performed in  
trip l icate. and the mean ± tandard deviations are shoVJIl. 
Col lectively. the above re u l ts advocate a protecti e role for p- 1 29 a-syn. 
ince it has been hown (i) not to be toxic to cel l s  ( Fig.  3 . 9  A and B) . ( i i )  not to 
promote the seedi ng-mediated toxic i ty ( Fig .  3 .9 C and D), ( i i i )  not to aggregate 
( Fig .  3 . 1 1 C and D).  ( i  ) to i nhib i t  the seeded polymerisation of wt a-syn 
monomer (F ig. 3 . 1 1 A. B )  and ( ) to inhibi t  the aggregation of monomeric a- yn 
in a concentrat ion-dependent manner ( Fig. 3 . 1 2) 
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3 . 4  Oi c u  I n 
I denti fying the to'..: J pecles f u- ) n  together \\ ith the mechani m of their 
fOnlwtion play s a central ro le in e luc idating the U-S) n-induced toxic i ty as ociated 
\\ ith PD and related di order . e\ eral l ine f e\ idence indicate that the u-s) n 
'iPCCICS dri \ ing neur degenerat ion are the earl ) aggregate . referred t a oluble 
o l igomers. rather than mature amy loid fibri l (E l - gnaf. et a l . .  200'"1 ; Winner. t 
a l . .  20 1 1 ) . In  rdcr t ident if pec i tic tox ic a-syn pec ies. which contribute to the 
to'..: i c i ty of the protein.  we prepared various a-sy n pec ie ( referred to a crude 
o l igomcrs. crude ccds and rude fibri l ) fol lowing a \vel l -characterized in " ilro 
aggregat ion protocol \' af) ing the incubat ion t ime from 2-7 day . The morphology 
and d i stribution of the aggregate pre ent in the \, arious preparations of a- yn 
\\ ere characteriz d by M ( Fi g. 3 . 1 ) .  The tox ic effect of the e a- yn preparation 
\\ a c\ a luated in t'>'" o d ifferent neuroblastoma cel l l ines. BE(2)- 1 - 1 7  and I I  JI-
5Y .  ei ther expressing only endogenous a-s) n or overexpre sing wt a-syn . The 
to'..: ic i t) of the variou a- ) n spec ies \Va fir t a essed in the cel l l i ne expres ing 
onl) endogenous a- yn.  A hown in Fig .  3 .2 .  the majority of the a-syn pecies 
employ ed in  thi experim nt d id not have a significant impact on the viab i l ity of 
the cel l . \vi th the crude o l igomers being l i ght ly toxic .  Howe er, when the arne 
(l- ) n pecies were u ed for the treatment of the cel l l i nes overexpressing \\1 a-
yn. i t  became apparent that crude o l igomeric preparat ion of a-syn. which is a 
heterogeneous m i xture of monomeric and o l igomeric a-syn ( Fig .  3 . 1 )  was more 
toxic  compared to c rude eeds and fibri l ( F ig .  3 . 3 ). Considering that the latter 
two preparations conta in Ie s or no monomeric or protofibri l lar a- ) n. and ince 
they were more toxic in the cel l s  overexpres ing wt a- yn. we h pothesized that 
the 100ver leve ls  of neurotoxicity observed for crude seeds and crude fibri l s  ma 
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reOcct their inabi l i ty t gr \\ . 1 0  supp rt thi tinding, a pre\ iou tudy ha h \\TI 
that the tox ici t) or  A�42 i not l i nked to peci Jic prefibri l lar aggregate( ), but to 
thei r  abd it) to gro\\ in the pre ence of B42 monomer (Jan, et a I . ,  20 1 1  � 
Wogul i  , et a l . .  2005 ). To further in \'estigate the impact of monomeric u- yn on 
the aggregation- induced t i i t} of the protein, we as essed the effect of u- yn 
monomer-free preparation', namely pure fibri l and pure eed ( Fi g. 3 .4 ) ,  on the 
viab i l i ty  oC the \\ t 8 [(2 )  M- 1 7  and H Y-5 Y cel l  e. pres ing only endogenou 
u- OJ n in  the presen e or ab 'ence of ex genou Iy added monomeric u-syn ( 1 0  ).lM 
linal concentrat ion) .  s i l l ustrated in  F ig . ... . 5 ,  the addi tion of monomeric u- yn to 
the cel l pre-treated \\ ith pure eed and fibri l increased the le\'els of t x ic i ty 
\\ hen compar d to the cel l s  treated only \\ ith th pure eed and fibri ls .  It i worth 
mention ing that, in the pre ence of a- yn monomers. pure seed and fibri ls  
i nduced a good le\ el of tox ic ity. even at concentration as 10\ a 1 00 nM ( Fig .  
3 .6 A and ) .  
The ignificance of a-syn monomer tox icit  as ociated wi th  the 
polymeri ation/aggregation process was further confi rmed \ ith a senes of 
experiment . during vv hich the B E(2 )-M- 1 7  cel ls .  whose endogenous a-syn was 
knocked down. wer treated with pure fibri l and pure seeds. Compared to the wt 
cel l , a ignificant level of protection against the eed and fibri l growth- induced 
toxic i ty was achieved when the expression of endogenous a- yl1 was s i lenced 
( Fig. 3 . 7) .  
A the a im of the present study was to unravel the structural prerequi i tes of 
the seeding proce s and i t  relation to toxic i ty, we ought to unravel the role  of p-
1 29 a-syn monomer in eeding the a- n polymeri ation/aggregation and to 
compare the mode of seeding act ion of wt and p- 1 29 a-syn. A sho�n in Fig .  
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.9 .  add ition f p- 1 29 (1- ) n  mon mer to the cel l  pre-treated \\ ith pure eed or 
pure fibri l s  has n effect on cel l  \ iabi l i t) . B)  c mparing the e finding \\ i th the 
corre p nding data I' r the \\1 (1- ) n  mon mers ( Fig .  3 . 5 ) .  \\ hich " ere sho\\ n to 
prom te the toxici ty  of pure eed and fibri l when added to the ce l l . it b come 
apparent that p- J 29 (1- yn monomers behave d ifferently from the \\ t (1- ) n  
monomer , ugge t ing a potential role of p- 1 29 (1- ) n  in inh ibit ing the seeded 
p J) merizati n proce . It i sti l l  debatable whether (1- yn pho phor) lation at 
J 29 promote or inhibits the aggregat ion and toxic i ty of the protein. as far as the 
p- J _9 a- ) n-related to. ic i t) i concemed . the results of the various studie ar 
equal l )  contradictor) and incon l u  i \ e .  Wherea tudie on yea t. o l igodendrial 
cel l  and a Dro oph i la  model of PD have hO\\,11 that (1- )'n phosphor) lated at 
1 29 (p- 1 29 (1- )\1) b) ariou kinase [ca ein kinase 1 (CK 1 ). CK l .  Polo- l ike 
k ina e (PLK ).  G-protei n-coupled kinase (GRKs) ]  correlates with (1-syn tox icity 
( L .  hen & Feany. 200 - ;  L .  Chen. e t  a I . ,  2009; Kragh. e t  a t . .  2009: ZabrockL et 
01 1 . .  2008). studie  employing the phosphomutants 1 29D and 1 29A are 
part icularl contradictory. In  orne studie , 1 _9D a-syn appear to be to. ic  
(Chau, et al . .  2009; L .  Chen & Feany, 2005 ) .  whi le  there are a l  report 
upporting that the pho phomimic 1 29D (1-S n play a rather protect ive role 
( Gorbatyuk. et a l . .  2008; Kuwahara, et 011 . .  20 1 2 ; B .  Wu, et a1 . ,  20 1 1 )  or ha no 
effect on the toxic i t  of the protei n  (Azeredo da i l  e i ra, et a l . .  2009 ; Fischer, et 
a J . .  2009). 
The findings above prompted us to further investigate the impl ications of p-
1 29 a-s) n in the seedi ng of the aggregation process and accord ing to the data 
obtained ( F ig. 3 . 1 0  and F ig  3 . 1 2 ), monomeric p- 1 29 a-syn fai led to seed the 
aggregation of wt a-syn at the concentrations used and for the given incubation 
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t ime \lore \'er, pr I nged incubati n of \',:t a- ) n \\ ith vari u percentage of p­
'> 1 29 u- "} n al o re ulted in a trong inhibitol) effe t, \\ hich \\ as dependent on the 
percentage of p- 1 29 a-s) n pre nt in the ample (Fig .  3 . 1 2 ) .  The e finding are 
in  accoruance \\ i th pre\ ious tudie indicat ing that ph sphorylation at 1 29 ha a 
rather inhibi tor) effect on the aggregation f a- )-n ( Paleologou. et a\ . .  2008:  
Wa:\.man la · n, 200 ) .  
u r  data sugge t that ph  phorylation f u- ) n a t  1 29 rna play a 
protl:cti \'e r Ie against the tox ic effect of u- yn by inhibit ing the eeding 
polymerization proce which was shown to underl ie the u- yn-induced toxic i ty .  
,\ deeper under tanding of the role  of p- 1 29 a-syn on cel lu lar re ponse 
to nuc leation dependent pol) merization may pro ide a promis ing novel approach 
� r treat ing PD and other as ociated disorders. 
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4 h a pte r 4 :  t ruct u re activity relation hip of p henolic 
acid in hi bito r of al p ha- yn uclein fi b ril fo rmation and 
to. icity 
4 . 1 I n t rod uct ion  
(1.-.  Y n aggregation proceed through everal key intermediate tage , with 
monomeric (1- ) n fir't a embl ing into ol igomeric forms that gradual l  generate 
I I1so luble amyloid fibri ls .  Becau e fJ.- y n  aggregation plays a crucial role in PD 
pathogene is and related synucleinopathie , int n ive effort has been put into 
ident i t) ing compounds that could block or even reverse the aggregat ion proce . 
O\ er the year , pol)  phenol , a  et of more than 8000 compounds that contain one 
or more phenol ic rings, hm e emerged as potent am loid inhibitors. interfering 
\\ i th th i l l  vitro fibri l a embly of many amyloidogenic proteins including fJ.- n, 
�-al1l)'loid ( �) .  tau-protein and prions ( reviewed by Porat, et a i . ,  2006) .  
Gal l i c  c id  (G  ) i a phenol ic  acid .  Pheno l ic ac ids consti tute a group of 
compound , which are derived from benzoic acid and cinnamic acid, giving r i  e to 
hydrox benzoic acid and hydroci nnamicacids, respectively. GA ( 3 ,4,5-
trihydroxybenzoic acid)  is  a benzoic acid derivati e that can be found in  almost 
a l l  p lants. \',; ith the highe t GA content detected in gal lnuts, witch hazeL 
pomegranate, berrie such a blackberries and raspberries, sumac, tea leave and 
oak bark. GA can also be i olated from the root of Radix Paeoniae (white­
flowered peony), \vhich i commonly  used to treat va cular and l iver di ea es in 
traditional Chine e medicine (1. H. Ho & Hong, 20 1 1 ) . I t  has been reported that 
G po sesses anti-oxidant (Y .  J .  Kim, 2007), ant i - inflammatory ( Kroes, an den 
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Berg, uarle ' van l ' fforo, \ an Oijk .  & Labadie, 1 992) and anti-viral ( Krel . 
Kaplan, I reeman, un, & 'arin .  1 990) propertie . and a \\ e l l -d cumented ant i ­
cancer t:ffe t ( I I . I I . I Io et  a l . .  20 1 : K .  . L iu  e t  a I . ,  _O I l :  . , . Yang et a I . ,  
2000) .  Recent l; , ,\ ha<.; been reported to act a a p tent ant i -oxidant and free 
rad ical U\ enger in a rat PO model ( ameri , arkaki, farbood. & ian un, 
20 I I ) . Additional h ,  G wa sho\\ n to eHi iently inhibit  a-syn and �-am; loid 
( f\� )  aggregat ion and tox icity in vitro ( Ba tianetto. Yao, Papadop ulo , & 
Quiri n, 2006; Oi Giovanni,  ct a l . .  20 1 0) .  
1 he  a im of the pre ent chapter wa  t sy tematical ly asse the abi l i ty of 
J,\ to (a) inhibit a-syn o l igomerization and fibri l l ation. (b) bl  ck a- • n-induced 
to'\ic i ty and ( c )  oi aggregate preformed a-syn fibri l . To gain in ight of the 
mechani III of action of G against a- yn aggregati n and to ' icily and to 
e tab l i h a tructure-act i\ it; relation hip, we as e ed the anti -fibri l logen ic effect 
of de\ en d i tTerent hydroxybenzoic acid derivat i\e  \\ ith chemical structures 
imi lar to G . The elect ion of pheno l ic  ac id \ as based on the number of the 
hydrox) I Illoietie attached to the phenyl ring. To further invest igate the role of 
hydroxyl  groups in  the inhibi tory acti i ty of phen lic acids, we al 0 included and 
a e ed the effect of three different benzoic ac id deri atives that have fluorides 
and methoxy group in tead of hydroxyl moieties. 
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4.2  E peri m e n ta l  pr  ced u re 
... . 2 . 1 F>' p ression  a n d  pu rificat ion of reco m b i n a n t  h u m a n  a- y n  
As des ribed in the c\.perimental pro edure 3 .2 . 1 
... . 2 .2  a-s) n p u rificat ion and characterizat ion 
As de cnbed in the c",perimental procedure .... . 2 .2  
... . 2.3 Aggrega t ion  of a- ) n ill vitro 
Sto k solution of the omp und tested ( 1 0  mM) \vere prepared in OM O. 
,'o lution. of lower concentration \\ ere prepared by d i lut ing the tock solutions to 
final con entrat ion of 25 - 1 00).1 1. The amount of DM 0 in the final amples was 
1 %. amples of 25  ).1M (unless otherwi e stated) a- yn in  PB were aged ei ther 
alone or with pheno l i c  ac id at variou molar ratios ( phenol ic  acids to protein  
molar rat io of 4 :  L 2 :  1 and I :  1 ) . The ample were placed in 1 . 5ml  steri le 
polyprop) lene tube . sealed \\ ith parafi l m  and incubated at  37°C for 5 day \\ ith 
cont inuou shaking at 800 rpm in  a thermomixer ( Eppendorf). ample were 
col l ec ted at regular i nterval . The thioflavin- (Th- ) fluorescence \ a measured 
immediate l } . \\ h i le  the re t of the ample were stored at -80°C unti l required for 
further anal)'  i s  . 
... . 2 A  T h ioflav i n - ( T h - ) fluore cence a say 
A described in the experimental procedure 3 .2 . 5  
...  2 . 5  T ra n  m i  ion  E lectro n  M ic roscopy ( T E M )  
Electron m icroscopy images were produced from a-syn aged in the presence 
or absence of GA. The sample ( 5  ).1L )  were depo i ted on fOl1lwar-coated 400 
me h copper grids. fixed briefly with 0 .5% glutaraldehyde ( 5  Il l ). negat ively 
8 1  
·tai ned w i th 2% uran) I acetate ( I gma- ldrich ) and examined in a Phi l ip  \ [ - 1 0  
TI:I 1 e lectron micros p 
.t.2.6 I m m u noblot t ing  
' ample 20 ng) of u- ) n incubated alone or \\ ith were mixed \\ i th a 
ading 'ample burfer ( 250 m 1 Tri - I I I ,  pI l 6 .8 .  "' 00 0 gil' erol ,  0.020/0 
bromophenol blue) \\ i thout D r boi l ing and then eparated n 1 mm 1 50'0 
, D  ' -P  gel . 1 he eparated protein \\ ere transferred to  nitrocel lu lose 
membrane' l0 .45 I-lm.  Whatman Gmbh-Gen11an; ) at 90 V for 80 min . The 
membrane \\ ere boi led for � min in PB and then blocked for 1 hour with 5% 
n n-fat mi lk prepared i n  PB -T\\een-20 (0 .050 0 PB T).  The membrane were 
incubated ov ernight at 4° \\l i th the primar; antibody. name ly the mouse 
monoclonal anti-u- _ n ( 2 1  1 )  that recogn izes human a- yn ( 1 2 1 - 1 25 )  ( anta Cruz 
Biotechnology, ) ,  at a d i lut ion of 1 :  1 000. The membranes \\ere then wa hed 
·e ...  eral t ime with P B  T, fol lo\\ ed by incubat ion with H RP-conj ugated goat ant i ­
mou e ant ibody ( Dako Ltd . ,  Ely, K) at a d i lution of 1 : 70,000 for 60 mins at 
r om temperature and \ i th gentl agitation. The membranes were then 
exten ively wa hed for 25 mins .  The immunoreactive bands were visual ized with 
a uper ignal We t Femto Chemi luminescent ubstrate K i t  ( Pierce, Rockford, 
) according to the manufacturer' s in tructions . 
.t.2 .7  I m m u noa ay fo r m ea s u ri n g  o l igomeric (t- y n  
A 3 84-we l l  EL I  A plate ( unc Maxisorb, unc, Denmark) was coated with 
I-lg ml of non-biotinylated mouse monoc lonal anti -u-syn antibod [m b, 2 1 1 -
recognizes amino acid re idues 1 2 1 - 1 25 of human a-syn ( anta Cruz 
Biotechnology, Cal i fornia, U A) ]d i luted in 200 mM aHC03, p II 9.6 (50 
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II I  \\ el l )  and in ubated vemight at 4°C. The plate wa then \\ a hed 4 t Ime \\ ith 
PB. r and bl eked \\ i th 1 00 III \\ e l l  of bl ck ing buffer (5° 0 gelat in fr m cold 
water fi sh kin, 0.05% ' J ween 20 in I PB p l l 7.4) for 2 hour at ' 7 fter 
beJ11g wa hed 4 t ime \\ ith PB T. 50 III of the ample were di pen eu in each 
welL  and each ample \\ a te ted in dupl icate. The plate were then incubated at 
' 7  f r an ther ' hours. A fter \Va hing 4 t ime \\ith PB T, 50 II I of biotin) lated 
2 1 1 ant ib  d) d i luted in block ing buffer to a concentration of 0.4 Ilg/ml wa added 
and incubated at 37°  f r 2 hour . The wel l  were washed 4 t ime with PBST and 
incubated \\ i th 50 �t l/\\e l l  of e. tra\'idin-peroxida e ( igma-Aldrich, GmbH-
erman) ) d i l uted 1 : 7,500 in  blocking buffi r and incubated for 1 hour at " 7° . 
The \\ e l l  \\ ere then \Va hed 4 t imes \\ ith PB  T before adding , lIper ignal 
EL I  A Femto 1ax imum en iti i ty ub trate ( Pierce Biotechnology, Rockford, 
) ( -0 ilL \\ e l l ) .The chemi lum inescence in  re lat ive l ight unit \\ as measured 
immediately u ing a micr plate reader ( Perkin E lmer). 
-t.2.8 C u l t u re of B E( 2 )-M- 1 7  h u m a n  neu robla torna cel l  
described in  the experimental procedure 3 .2 . l 0 
-t.2.9 Mea u re m e n t  o f  cell  v i a b i l i ty 
s de cribed in  the experimental procedure 3 .2 . 1 3  
-t. 2. 1 0  Congo red b i n d in g  a say 
Congo red (20IlM)  \ a d is  o lved in  PB  (pH  7 .4 )  and fi ltered through a 
0.45 11m fi l ter. ample of a-syn (5 11M) ,  aged alone or with GA at d i fferent molar 
rat io . were m ixed with ongo red ( final concentration 5 11M) ,  and the reaction 
samples were thoroughly  m ixed. The UV absorbance spectrum wa recorded from 
400 nrn to 600 nm in a spectrophotometer ( DU-800, Beckman-Coulter) u ing 1 0  
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mm quartz cU\ ettc ( l lcl lma nalytic - errnany) \11 n menc a- � n and ongo 
rl.!d alone \\ erc u 'ed a '  negat i \ e c ntrol . 
4.2. 1 J a-S� n d isaggregat ion a a. 
Recombinant a- ) n di  01\ ed in teri l i zed PB ( pII 7.4) \\ as aggregated at a 
c( ncentration of 25 11M as inui ated abo"\ e. The re u l ting aggregated a-syn was 
in ubated ei ther alone or with G at variou molar rat io (G  : a- yn molar ratio 
6: 1 ,  4: 1 and 2: 1 ) . It hould be noted that [or the purpose of the experiment, the 
oncentration of a- yn was a umed to be the same as that of the fresh a-syn. The 
'ample \\ I.!re incubated at -, 7° for 3 days on a thermomixer "\\ i th conti nuou 
shaking at 00 rpm. ample were col lected at regu lar intervals, and the Th­
fluorescence \\ a mea ured immediately .  
4.2.  J 2 ced i n g  poly m e riza t ion  a ay 
The aggregation of monomeric a-syn \\ i th or without seeding wa carried 
out a de cribed el e"\\h r ( OJ Giovanni ,  et aI . ,  20 1 0) .  Mature a-syn fibril were 
fragmented by sonication to obtain short fibri l s, which were employed as ' seeds' . 
1 00 �l 1 monomeric a- yn was seeded with 2 �lM eeds and incubated in  the 
pre ence or absence of GA ( 1  0 �lM and 50 11 1) at 37°C for 6 hour with 
continuous shaking. Fibri l lation wa monitored by Th- binding as described 
abO\ e .  
4.2 . 1 3  ize Exclus ion  C h roma togra p hy ( EC)  fo r separat ing  (1- y n  o l igomer 
and m o n o m e r  
EC was carried out u 1I1g  an  A KTA FPL system (GE Healthcare-
weden )  and a superde. 200 column at 4 0c. in order to separate the ol igomers 
generated from the aggregation of a-syn with G (GA: a-syn molar ratio of 4 :  1 ) . 
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on omen U-S) n at a c ncentration of 1 00 !l �1 wa aggregated in the pre ence f 
J \ for - days as descnbed ab \ e . t the end of the aggregation proce . the 
sample \'v as centri fuged for 45 min at 1 4 .000 '\ g at 4° gen rating a upernatant 
free from insol uble matenal .  Prior to injecting 80°'0 of the upernatant generat d,  
the column \'v a thor ugh I)  equi l ibrated v, i th an E running buffer ( I x  PB , pH 
7 .4)  and the flo\\ rate \\ a et t 0 . 1 ml/min (0 .5  ml fraction ).  u- yn elution was 
monitored at ab rbance \'v U\ elengths of 2 1 5  nm, 254 nm, and 280 nm. To 
determine the el ution t ime for monomeric (1- ) n, molecular weight standards 
( ferrit in 440 kDa, aldolase 1 7 1  kDa. albumin 68 kDa and chymotryp inogenA 25 
kDa) and monomeric (.l- ') n \\'ere o-injected into the column and eluted to the 
ame standard a mentioned above. The fractions e lut ing between 7-9 ml  V 
were combined and labeled a o l igomer ( amplc P I ), whereas the fractions 
e lut i ng in  the 1 3- 1 5ml  CV were combined and labeled as monomers ( ample P2) .  
The P I  and P2 fracti n were further characterized by \\Ie tern blott ing and TEM. 
4.2. 1 4  V ca n n i n g  
The P 1  and P2 amples, representing the ol igomeric and monomenc 
fraction of EC, re pectively, were concentrated using a peed vac (CentriVap, 
Labconco). The content concentration of protein  \ a est imated by using BCA 
a a) . The ab orbance pectrum was recorded from 200-600 nm in a 
pectrophotometer ( D  -800, Beckman-Coulter) using 1 0  mm quartz cuvettes 
( He l lma Analytic -Gern1any)  and employing equal concentrat ion of both P 1  and 
P2 .  Fresh monomeric (1- yn was used as a negative control . 
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" .2 . 1 5  '\ ;\l R  
For 1 R  tudic . rec mbinant 1 - - Iabelcd u- ) n \\ a e pre cd and 
pun lied a prc\ i 1I If de ribed (Bu sel l & El ie/er. 2003a: E l ie7er, Kut lua) , 
Busse l l .  & Brov, nc, 200 1 41). re u pended in PB at plI 6 .5 .  Two-dimen ional 
proton-ni trogen c nelati n 'pectra were a quired for u-syn at a 200 � 
concentration in  thc ab ence of G and in the presence of increa ing G : a-syn 
stoi hiometrie of 0 . 5 :  1 .  I: 1 ,  _ :  I ,  5 :  I and 1 0 : I .  Data \\ere col lected on a Varian 
600 1 1 Iz nit; I nova pectr meter equipped \\ ith a cold probe. 
-t.3 Re u l t  
-'.3. 1 T h e  effect o f  G A  on (J.- y n  fi br i l  fo rmat ion 
fo investigate the effect of GA on a- _ n fibri l lation, 25�M of u-syn was 
incubated \vi th G at varying molar ratio of G : u- yn of 4 :  L 2 :  1 and 1 :  I for a 
period of 6 day s. G inhibi ted the formation of a- ) n fibri l in  a con entrat ion­
dependent manner a ind icated by the Th- assay ( Fig. 4 . 1 A). Taking into 
account the l ack  of Th- ignal at the 4: 1 ratio, GA exhibited an excel lent 
inhibitory effect on a-s n fibri l lation, inhibit ing it complete ly dur ing the 6-day 
i ncubat ion ( Fig.  4 . 1 ). At a 2 :  1 ratio, GA 411 0 uppressed the fom1ation of fibri l 
to a great extent. and the Th- ignal was detected only after 4 day of incubation. 
\\ h i le  after 6 days, GA reduced the Th- count to approximately one fi fth of the 
control counts ( Fig.  4 . 1 A). Even at a I :  1 ratio, GA hindered the fibri l lation of a-
) n  but to a smal ler extent than the other ratios ( Fig.  4. I A).  The anti -fibri l logenic  
act iv i t} of GA wa further assessed by using a ongo red binding a ay. Congo 
red ( R)  i s  a dye with h igh affin i ty for amyloid fibri l s .  The maximum ab orption 
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of ' f  alone ( - p 1 )  wa. 490 nm. \\: hi le  when incubated \\-ith a- ') n am� loid 
fibri ls .  the maximum absorption hi fted to -0 nm ( Fig. 4. 1 B ) .Thi hift in the 
peal... absorpt ion \\ a\ e length repre 'ent the binding f R to the �- heet-ri h 
fi bri l s. 1 1 00\e\: er. this prominent h i ft \Va not observed r r the fre h a- yn ample 
or \\: hen a-s) n \\ a aged in  the pre ence of ( Fig.  4. 1 B ), indicating that 
inhibi ted the r 1111ation or structure \\ i th a �-sheet conformation . In  fact .  GA 
blocked the fonnation of �- heet in  a do e-dependent manner. s imi lar to the Th­
resu lb.  I t  wa' ob en ed that the lower the GA concentrat ion. the more prominent 
the peak absorbance \\ a\: elength shi ft was (485 nm, 493 nm and 500 nm for 1 00 
�lT\L  50  p 1 and 2 - p 1 . respective ly) .  E le  tron micro COP) image also 
c nfi rmed that G not on l )  affected the ext nt or fibri l lation in  a do e-dependent 
fa hion but also the morphology of a- yn fibril . I ndeed. instead of forming den e 
me he of long fibri l s  ( longer than 1 pm)  as ob erved in  aged a- yn alone (F ig .  
4. 1 ) , a-s) n aged in  the pre ence of 1 00 �lM ( Fig. 4. 1 D )  and 50 pM of G ( Fig. 
4 . 1 E) generated thin, sheared fibri l s  that were approximately 0 . 1 -0 .2 pm in 
l ength. a- yn aged in  the pre ence of 25 pM GA ( Fig .  4 . 1 F)  fom1ed longer fibri l s  
( approxi mate l y  0 .5  p m  long).  \ h i ch  were arranged i n  dense network . 
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Figur 4 . 1 .  G i nh ibi t  a- :; n  fibri l lation in  a concentration-dependent manner. 
ampl f a- yn (25  !lM )  were incubated alone or in the pre ence of GA (molar 
rati n of G : a- ) n 4 :  1 ,  2 :  L 1 :  1 )  for 6 da with continuous shaking at 37°C. 
Fibri l  � m1at ion wa estimated by Th- fl uore cence. The a say was performed in 
trip l icate (average f trip l icate measurement ± tandard deviation) .B .  Congo red 
binding for ample of a-syn (25 !lM )  incubated alone or in  the pre ence of G 
( molar ration of G : a- yn 4 :  L _ :  1 .  1 : ] )  for 6 da s with continuou haking at 
" 7°C. ample of a- yn ( 5  11M )  aged alone or with GA were mixed with Congo 
red at a fi nal concentration of 5 11M .  The reaction sample \""ere thoroughly  mixed 
and p laced in a 1 0mm quartz cuvette. The absorbance pectra were recorded 
from 400 run to 600 nm. C-F .  E l ectron microscopy image of negat ively stained 
ample of a- yn (25  11M )  aged alone or in the pre ence of GA ( molar ratio of 
G : a- yn 4 : 1 ,  _ : 1 ,  1 : 1 )  for 6 da with continuous shaking at 37°C. C.  Aged a­
yn alone.  D .  a- yn aged in the pre ence of G at a molar rat io of G : a-syn 4 :  1 .  
E .  a- yn aged i n  the pre ence of GA at a molar ratio of GA: a- yn 2 :  1 .  F .  a- yn 
aged i n  the pre ence of GA at a molar ratio of GA:  a- yn ] : 1 .  cale bar. 500 run .  
4.3.2 The effect of  GA on {l- yn ol igomerization ( ea rly aggregate ) 
To evaluate the effect of GA on a-syn o l igomer fonnation. samples of a-syn 
aged alone or in the presence of GA at d ifferent molar ratios were assessed for 
their o l igomeric content by o l igomer-specific E L I  A and imm unoblotti ng. For the 
detect ion of a-syn o l igomeric species in the samples. we employed a novel EL I  
developed i n  our laborator a t  the UAEU ( E l-Agnaf, e t  aL 2006). which 
pec ifical l y  recognizes the o l igomeric species pre ent in the samples. The E L I  A 
resul t  (F ig .  4 .2  A )  indicated that GA could only i nh ibit  the fom1ation of a-syn 
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ol igom r \\ hen employed at the highe t oncentration namel) 1 00 )..l�f .  
I ntere t ingl ) . a t  lov. r concentration . app ared to enhance u- ) n 
l ig  m rization a compar d to th control ( Fig .  4.2 ) .  TI1e ample of u- ;n 
aged in  the pre ence of 25 )..lM and 50 )..lM G exhibited gradual ly  increa ing 
l igomeric content vv hich wa much higher than the control ( Fig.  4.2 ) .  
im i larly. immunoblotting of the arne ampl (F ig .  4.2 B) indicat d a 
de rea e in  th l igomeric pecies v" hen u- yn wa aged with 1 00 �lM GA (F ig. 
4.2 B) .  \\ h i l  there wa a characteri t ic increa e in the band corre ponding to 
d imeric u- yn ( Fig .  4 . 2  B ) .  The arne ample wa also characterized b the 
pre ence of trong monom ric and trimeric (approximately  50 kDa) bands and the 
ab ence of the band corr sponding to larger u- yn aggregates with a high 
molecular weight. However. in  the pre ence of 50 )..lM and 25 )..lM GA. the bands 
corre ponding to the o l igomeric peCle  were much stronger. with a 
conc ntration-dependent decrea e i n  the band corre ponding to the monomeric .  
d imeric and trimelic pecie . dditional l y. the inten it of the band corre ponding 
to larger u- yn aggregate increa ed i n  a dose-dependent man er. These data 
i nd icate that G at low concentration may have the abi l i ty to tab i l ize u-syn 
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Figure 4 .2 .  G A  i nh ibits a-syn o l igomerization at a high concentration. but at lower 
concentrations it promote ol igomerization. A .  amples of  a-syn (25 )lM )  aged 
alone or i n  the pre ence of GA at d ifferent molar ratios for 6 days with cont inuous 
shaking at 3 7°C were assessed for their abi l i ty to inhibit the formation of 
o l igomers by the o l igomeric E L I  A assay. The assay was performed in dupl icate 
( average of dupl icate measurement ± standard deviations). B. I mmunoblot 
analysis of the effect of GA on a-syn ol igomerization. Fresh or aged a-syn 
samples alone or in the presence of GA at molar ratios of GA : a- yn 1 :  1 .  2: 1 and 
4 : 1 i ncubated for 6 days with continuous shaking at 37°C were eparated by 
e lectrophoresis in a 1 5% D -PAGE gel .  Lane 1 :  fre h a-syn;  lane 2: aged a- yn;  
l ane 3 :  G : a- yn molar ratio of 4 : 1 .  lane 4 :  GA:a-syn molar ratio 2 : 1 and lane 5 :  
GA :a-syn molar ratio 1 :  1 .  
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-t.3. The effect of 
J \  en that 
00 p reformed u- ) 0 amyloid fibr i l  
\\ a h0\\11 to be uch an effective i nh ibitor of u- yn 
fibri l lat ion. \\ inve tigated \\- hether it could al 0 re, er e fibri l l ation. Ther fore. 
2 - 11M of pre£< rmed u- ) n fibri l ( Fig .  4 .3  ) were incubated at  3 7°C in  the 
pre ence of G at m lar rat io of G : u- yn of 6 :  1 .  4 :  1 and 2 :  1 for a period of 48 
h ur . By mea uring the Th- fluorescence count ( Fig .  4.4 ) we e timated the 
fibri l content at the indicat d t ime points. t ime 0, the Th- count were 
approximately 8000 for a l l  ample ( Fig.  4.4 ) .  The a-s, n fibri l that were 
i ncubated alone cont inu d to aggregate further. a indicated by the increa e in  
Th- count ( Fig .  4 .4  ) .  However. the u- yn fibri l that were i ncubated in  the 
pre ence of G d isaggregated over t ime a hown b the decrease in  the Th­
count ( Fig .  4.4 ). It i noteworthy that after 24 hour of incubation, a- yn fibri l s  
incubated without G gave approximate I 1 8 .000 Th- counts. v. hi le  the fibril 
incubated with a l l  concentrations of GA te ted produced less than 2 .000 Th­
counts ( Fig .  4.4 ) .  Thu , GA di aggregated preformed a- yn fibri l  i n  a do e­
dependent fashion. Furthermore. im i lar re ults were obtained when the 
experiment was performed u ing u-synuclein fibri l s  after reaching a p lateau in Th-
a ay ( Fig .  4 . 3  B) .  
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F igure 4 . 3 .  GA di saggregates prefom1ed a-s n fibri l s  (after reaching plateau) .  A.  
amples of a-syn (25  j.lM )  were incubated alone for 5 days with continuous 
shaking at 3 7°e. F ibri l formation was estimated by Th-S fl uorescence. The assay 
was performed i n  tripl icate ( average of tripl icate measurement ± standard 
deviation). B .  Samples of aggregated a-syn were incubated for 48 hours at 37°C 
i n  the absence or presence of various concentrations of GA (GA:  a-syn 6 : 1 ,  4 : l .  
2 :  1 ) . The fibri l content was then measured by the Th-S binding assay. The assays 
were performed i n  tripl icate ( average of tripl icate measurements ± standard 
deviations). 
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fter 48 hour of incubation. the ample were al 0 te ted for th ir  R 
bind ing ( ig .  4 .4 B ) . . pected. a- ) n fibri l incubated in  the pre ence of G 
pr duccd pectra with a peak ab orbance � a\ l ength that \'vas h ifted l ight ly 
c mpared to th control . indicating minimal P- heet content. In  contra t. the 
fibri l of a- ) n that \\ ere incubated alon produced a p ak ab orbance at 550 nm. 
indicating a h igh P- h et c nt nt ( Fig.  4.4 B ) . The finding were confirmed by 
(F ig .  4 .4 ) .  I I  ample at a were characterized b the presence of  d n e 
me he of fibri l longer than 0.5 11m .  Ho\vever. the a-syn fibri l s  incubated in the 
pre en e of G gradual ly  became thinner and horter and appeared fragmented. 
i olated and car . unl ik  the control .  which continued to demon trate net\\'ork 
of I ng fibri l ( Fig .  4 .4 ) .  
To a e whether GA di aggregation of a-syn fibri l  was accompanied by 
a decrea e i n  a- yn toxic i ty. we then e aluated the toxic ity of the a- n pecie 
that re u l ted from the d i  aggregation experiment on human neurobla toma BE(2 )-
1 - 1 7  cel l s  ( Fig .  4 .4 D) .  The anlples were d i luted to a final a-syn concentration 
of 0.5 11M .  1 11M and 5 11M .  Preformed a- )'n fibri l s  incubated for 6 day in the 
ab ence of GA decreased cel l  viabi l ity  in a dose-dependent manner. Ho\ ever. 
preformed a- yn fibri l  incubated with G for 6 days generated species that were 
Ie s toxic compared to the contro l .  This trend was most prominent for 5 11M a­
syn. which.  when i ncubated in  the absence of GA, i nduced the death of 45% of 
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Figure 4 .-l .  G d i  aggregates prefonned a-syn fibri l s  in a concentration­
dependent manner. A .  amples of aggregated a-s n were incubated for 48 hours 
at 3 7°C in the ab ence or presence of ariou concentrations of GA (GA:  a- yn 
6: L 4: 1 .  2: 1). The fibril content was then measured by the Th- binding as ay. 
The a ay were performed in trip l icate (average of trip l icate measurements ± 
tandard deviation ) .B .  Congo red binding to amples of pre-aged a- n (25 �M) 
incubated alone or in  the pre ence of GA ( molar rat io of GA: a-syn 6 :  1 .  4 :  L 1 :  1 )  
for 72 hour with continuous haking at 3 7°C. amples of a-syn ( 5  �M) incubated 
alone or with GA at d ifferent molar ratios were mixed with Congo red. at a final 
concentration of 5�M.  The reaction samples were thoroughly mixed and placed in 
a 1 0mm quartz cuvette. The UV ab orbance pectra were recorded from 400 nm 
to 600 nm. C .  E l ectron microscopy images of negatively stained amples of pre­
aged a-syn (25 �M)  incubated alone or in the presence of GA for 72 hours with 
continuous shaking at 3 rc.  1 .  a- yn aged alone. 2 .  a- yn aged in the pre ence of 
G at a GA:a-syn molar ratio of 6 : 1 .  3 .  a- yn aged in  the presence of GA at a 
GA:a-syn molar rat io of 4 :  1 .  4 .  a- yn aged in the presence of GA at a GA: a-syn 
molar rat io of 2: 1 .  cale bar. 500 nm .  D. The d isaggregation of prefonned a- yn 
fibri l s  by GA generated species that were less toxic to the cel ls .  The iab i l ity of 
BE(2 )-M- 1 7  human neuroblastoma cel ls  was assessed by the MTT a ay. The 
re ults are expressed as percentages of the control average ( i .e . ,  untreated cel ls) .  
The a-syn species generated by 72h incubation of prefonned a- n fibri l s  in the 
pre ence or absence of GA were added to the ce l ls  48 hours prior to MTT addit ion 
( average of 3 wel l s  ± SD. tat ist ical analysi was perfom1ed u ing two tai led 
unpaired t-test, * * * .  p< 0 .00 1 ; * * .  p< 0.0 1 ) . 
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4.3.4 The effect of on t h e  eed ing of Q- yn aggregation 
I t  ha be n pre\ iou I )  hov" n that th proce of am) loid fibri l formation 
� 11 \\ a nucleation-dependent polymerization (Jarr tt and Lan bury. 1 992). 
rding to thi modeL oluble pecle generated via the nucleation of 
l i g  menc pecle  ( nu leation or lag t ime pha e). \\ hich in  tum polymerize 
( p  Iymerization or gro\\1h pha e) to generate fibri l . thu reaching a final plateau 
known a the equi l ibrium pha e ( Harper et a l . .  1 999). Small  aggregate or eed 
ha\ e been hown t accel rate the nucleation pha e of am loid formation both in 
rifro and in \'i1'O b) a proce kno\\TI a eeding ( Jarrett and Lan bury. 1 993 .  Luk 
et al . . 20 1 2 . Harper and Lan bury. 1 997. olpicel l i -Daley et a l . .  20 1 1 ) . Given that 
G i nhibited both a- yn fibri l lat ion and d isaggregated preformed a-syn fibri l ; we 
ought to i d  nt i fy the effect of this ph nolic acid on the seeding of a-syn 
aggregation. More pecifical l y. mature a- n fibri l s  were fragmented b 
onication to obtain hort fibril . which were employed as ' seed 
. 
( Fig .  4 .5 B) .  
The e hort fibri l lar ' eeds '  were then added to monomeric a-syn. which wa 
a l lowed to aggregate a de cribed above. As expected. the addi tion of hort 
fibri l lar eeds accelerated the fibri l lation of a- yn as indicated by the increa ed 
Th- count . I ndeed. with eeding. the extent of a- yn fibri l lation after 6 hour of 
incubation wa comparable  to the fibri l lation of the protein i ncubated for 72 hour 
without seeding ( Fig .  4 . 5  B and F ig .  4 . 1 .  respectively) . 
I n  order to asses the effect of GA on the seeding of a-syn aggregation, 1 0  
and 50 11 M  GA was added to 1 00 11M monomeric a-syn containing seeds at a final 
concentration of 2 11M.  and the m ixture was i ncubated with continuous mixing at 
3 7°C for 6 hours. GA at 50 11M inhibited the seeded fibri l lation of a-syn by 
approximately 90% as i ndicated by the extremely low Th-S counts. At lower 
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concentrat ion 1 0  11M ). GA aI 0 had an i nhibitory effect on the seeded fibril l at ion 
of a- ) n but to a mai ler extent. t 1 0  11 . G inhibited eeded fibri I Iat ion by 40-
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Figur of .  inhibit  the e ded fibri l l ation of  u- ) n. ample of  u- yn 
( l OOj.lM eeded v. ith hort fibri l lar u- )- n (2 j.l 1) w re incubated in th pre enc 
r ab enc f at d ift! rent concentration ( 1 0  j.lM and 50 j.lM)  for 6 hour with 
c ntinuou haking at " 7° . The e, tent of fibri l l at i  n \\ a e t imated by the Th­
binding a ay. The a aJ v. ere p rfonned in  tripl icate (average of tripl i cate 
m a urement ± tandard de\ iation ) .  B .  Electron micro copy imag of 
negat i\- e l)- tained ample of eed alone and u- n eed incubated alone or in  
th pre ence of (50  j.lM )  fi r 6 hour with continuou haking at " 7°C. cale 
har repre\'en! 1 000 nm. 
4.3.5 The effect of G on 0.- y n  aggrega te  - induced toxicity 
I t  ha been reported that the o l igomeric intermediate are the neurotoxic 
pecie in  the am) I id fibri l lation pathway ( I I  op et a! . .  200 1 :  Argyriou et a l . .  
yer  kyo 20 1 2 : Col la  e t  a l . .  20 1 2 : E I -Agnaf. agala. Patel .  
u ten. 200 1 : E l - gnaf. t a1 . .  2006; Vendru colo. Pac i .  Dobson. & Karplus. 
200 1 : Wal h et al . .  2002) .  de  cribed above. a t  h igh concentration (4 :  1 ) . GA 
i nh ibi ted both ear ly  and late aggregate fom1ation. whereas a t  low concentration 
( 2 :  1 and 1 :  1 ) . it tab i l ized u-syn o l igomers ( Fig. 4 .2 A) .  To detem1ine the 
effect of G on the toxic i ty conferred b u- yn aggregates. a ce l l -based toxic i ty 
a ay. the MTT a ay, wa conducted with human neuroblastoma B E(2)-M- 1 7  
ce l l . The san1ple were d i luted to final a-syn concentration of 5 j.lM and 0 .5  j.lM. 
The MTT a ay showed that a-s n aged i n  the absence of GA decreased cel l  
\ iabi l ity in a dose-dependent manner (F ig. 4 .6) .  However. when a- n was aged 
i n  the presence of a high concentration of GA (4 : 1). there wa isible 
neuroprotection of the cel l s  observed (F ig. 4 .6) .  At low concentrations (2:  1 and 
I :  1 ) . GA exhibi ted a minor protective effect against a-syn toxic i t  • po sibly due 
to the increase in o l igomers a demonstrat d by the E L I  A re ult and the 
i mrnunoblotting analysi ( Fig .  4 .2 .  A and B.  re pect i  e ly) .  Our results clearly 
demonstrate that GA reduced the toxicity of a- yn at a h igh concentration ( 1 00 
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� M )  bJ i gnificantly inhibi t ing the formation of toxic a-syn ol igomer . The 
tox ic i ty of the o l igomer resul ted from a-s n :  G 1 :4 was compared with a-syn 
o l igomers prepared in  the absence of GA as described in the materials and 
methods section b using MTT a say ( Fig.  4.6 B) .  Both san1ples were 
characterized for the presence of o l igomers by using D PAGE ( Fig.  4 .6 C )  and 
native PAGE ( Fig.  - L6  D) .  It was c lear, that the o l igomers result ing from the 
incubation of a- n with GA were not toxic comparing with ol igomers in absence 
of G , Moreover, these ol igomers were stable under denaturing conditions (F ig. 
4.6 C) comparing with those formed in the absence of GA. 
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Figure 4 .6 .  Effect of GA on the toxic i ty of aggregated a-syn. A.The viabi l ity of 
BE(2) -M- 1 7  human neuroblastoma cel l s  was estimated by the MTT assay. The 
resul ts are expressed as the percentage of the control average ( i . e . ,  untreated 
ce l ls ) .  The cel ls were treated with aggregated a-syn with/wi thout GA for 48 hours 
prior to MTT addition ( average of 3 wel l s  ± standard deviation. Stat ist ical  
analysis was performed using two-ta i led unpaired t-test, * * *, p< 0.00 1 ; * ,  p< 
0.05 ) .  B .  The viab i l ity of BE(2 )-M- 1 7  human neuroblastoma cel l s  was estimated 
by the MTT assay. The cel l s  were treated with a-syn o l igomers in absence or 
presence o f  GA for 48 hours prior to MTT addition ( average of 3 wel l s  ± standard 
deviation. C. lmmunoblot analysis of a-syn ol igomers generated in presence or 
absence of GA, separated by e lectrophoresis i n  a 1 5% SDS-PAGE gel .  D.  
98 
l mmunoblot analy i of a- )'n ol igomers generated in  presence or absence of GA. 
eparated by electrophore i in  a 3- 1 2% ati \ e-P GE gel .  
4.3.6 GA i n h i b it ion of u- n fibr i l lat ion i med i ated via b ind ing  to the  
i n te rmed i ate pec ie  a n d  fo rm ing table  o l igomer 
The trong inhibitory effect that GA exerted on fibri l lation together with the 
t imulat ing effect it had on a- yn o l igomerizat ion at lower GA concentrat ions. 
prompted u to in  estigate further the i nteraction of GA with a-syn ol igomers. For 
this purpose. monomeric a-syn ( 1  00 �M)  was aggregated in the presence of GA 
(GA:  a- yn 4: 1 ) . After 5 da s of incubation the samples were centri fuged and the 
upernatant was injected in  a superdex 200 SE column. The elution volume for 
monomeric a- n was detennined by a molecular weight standard ( Fig.  4.7 A) ,  
and was eluted to a peak corresponding to a column volume of 1 3 - 1 5  mL (Fig .  4 .7  
B ) .  whi l e  o l igomeric a-syn eluted i n  a peak corresponding to  colunm volume of 
approximately  7-9 ml ( Fig.  4 .8  A) .  The fractions corresponding to the ol igomeric 
and monomeric a- yn peaks were pooled together giving rise to P I  and P2 
amples. respectively ( Fig .  4 . 8  A ). which were concentrated using a speed vac . 
The a-syn species i n  samples P I  and P2 were characterized by western blott ing 
( Fig.  4 . 8  B ) .  According to the western blotting results. the o l igomers generated 
during the i ncubat ion of a-syn with GA are stable under denaturing conditions 
( Fig .  4.6 C and 4.8 B ) .  E lectron m icroscopy of the san1e san1ples indicates the 
presence of d ifferent species of o l igomers in P 1  (F ig. 4 . 8  D). which agrees with 
the imunoblotting results ( Fig. 4.8 B). In order to detect the i ncorporated GA in  
the P I  and P2  samples, we  exploi ted the property of GA to  produce UV 
absorbance spectra with two peaks. one a t  225 nm and one a t  260 nm. I n  the 
sample containing GA:  a-syn at 4: 1 molar ratio, we detected GA only in the 
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ol igomeric P 1 amples ( Fig .  4 .8  C) .  The e fmding upport the hypothe i s  that 




















-- MW standard 
5 e lution vb�me (mil 15 20 
-- monomeric a-syn 
5 10 15 20 Elution volume (mil 
F igure 4 .7 .  Size Exclusion Chromatography : A: Gel -fil tration profile of MW 
standard contain ing Ferrit in  440 KDa, Aldolase 1 7 1 KDa, A lbumin 68 KDa and 
Chymotrypsinogen A 25 KDa using Superdex 200 column at 0. 1 m1lmin flow rate 
(0 .5  m11fraction) .  B :  Gel-fi ltration profile for monomeric a-syn using Superdex 
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F igure 4 _8 _  GA binds to a-syn o l igomers (GA:  a-syn molar rat io of 4 : 1 ) . A Gel 
fi ltration profile of the 5 -day aggregated a-syn in  the presence of GA at a GA: a­
syn molar ratio  4 : 1 (a-syn concentration = 1 00 11M )  -using a superdex 200 SE 
column. P I  sample contains the iso lated fractions corresponding to the o l igomeric 
peak and P2 the isolated fractions corresponding to the monomeric peak. The 
e lut ion was monitored at the absorbance wavelength of 2 1 5  nm . B. I mmunoblot 
analysis of the sanlples P I  and P2 separated by electrophoresis in a 1 5% SDS­
P AGE gel .  C .  UV absorbance spectra of samples P I  and P2 .  The UV absorbance 
was recorded between 200-600 nm employing a 1 0  mm quartz cuvette. D.  
E lectron microscopy images of negatively stained samples P I  and P2 of a-syn in 
the presence of GA (molar ratio of GA: a-syn 4 : 1 )  purified by SEC. Scale bar 
represents 1 000 nm .  
To further evaluate whether GA interacts with a-syn monomers, we 
monitored a t itration of GA into a solution of monomeric a-syn using two-
dimensional N M R  spectroscopy, which provides signals covering the entire amino 
acid sequence of a-syn ( Fig.  4 .9 ) .  At stoichiometries of up to 1 0 : 1 GA: a-syn we 
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ob erved no signi ficant chemical h ift or re onance inten ity changes ( Fig.  4. 1 0  
-E) .  confi rming that G does not interact s ignificantl with monomeric a- yn. 
Thi re ult  i s  J argely in agreement with MR studies of related compounds 
Entacapone. ToJcapone and Quercet in (D i  Giovanni .  et a l . .  20 1 0 ) .  
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F igure 4 .9 .  Analysis of GA binding to monomeric a-syn by NMR spectroscopy. 
Proton- itrogen correlation ( H SQC) spectra of monomeric a-syn i n  the presence 
of i ncreasing ratios of GA: a-syn demonstrating that there are no significant 
changes in the positions of the N M R  resonances, indicating the lack of an 
interaction between GA and monomeric a-syn. Protei n  concentration was ca. 200 
�M.  
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Figure -+ . 1 0 . Analysis of GA binding to monomeric a-syn by NMR spectroscopy. 
Ratios of MR resonance i ntensities from proton-nitrogen ( HSQC) correlation 
spectra in the presence of increasing ratios of GA: a-syn (A - 0 .5 :  I ,  B - 1 : 1 ,  C -
2 :  L D - 5 :  L E - 1 0 : 1 )  to intensities observed in  the absence of GA. The absence 
of any significant i ntensity changes in the presence of GA again confirms the 
lack of an interact ion between GA and monomeric a-syn. 
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4.3.7 I n ve t ioat ing  the  truct u re-act iv ity rela t ion hip of G A  i n h ib i t ion of ({_ 
yn fi br i l la t ion 
To define the most ffective molecular caffold against a-syn fibri l  
formation and e tab l i  h a tructure-act ivity relationship for GA. we exploited the 
tructural d i\ ersi ty of benzoic acid derivat ives ( i .e . ,  hydroxybenzoic acid ) .  
Twelve hydroxybenzoic acid . including GA. sal icyl ic acid and genti ic ac id ( see 
Table  -t . 1 )  were assessed [or their ant i -fibri l logenic propert ies by the Th-S binding 
a ay ( Fig.  4 . 1 1 ) . 
Table -t . 1 .  De cription and names of the tested benzoic  acid derivatives. 
N ame of compound MW 
Benzoic acid 1 22 . 1 2  
2-Hydroxybenzoic acid ( sal icyl ic acid )  1 3 8 . 1 2  
3 -Hydroxybenzoic acid 1 38 . 1 2  
4-Hydro 'ybenzoic acid 1 38 . 1 2  
2 .3-dihydroxybenzoic acid  1 54 . 1 2  
2A-dihydroxybenzoic acid 1 54 . 1 2  
2 .5-dihydroxybenzoic  acid 1 54 . 1 2  
2 .6-dihydroxybenzoic acid 1 54 . 1 2  
3 A-dihydroxybenzoic acid 1 54 . 1 2  
3 .5 -dihydroxybenzoic acid 1 54 . 1 2  
2A.6-trihyclroxybenzoic acid 1 88 . 1 3  
3 ,4 .5 -trihydroxybenzoic acid (GA) 1 70. 1 2  
3 .4 .5-tr ihfluorobenzoic acid 1 76.09 
3 A,5-trimethoxybenzoic acid 2 1 2 .20 
4-methoxybenzoic acid 1 52 . 1 5  
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The tnlcture of the h droxybenzoic acids tested was characterized by the 
pre ence of a phenyl ring that has a carbo yl group, and hydrox 1 moietie (OH)  
attached to  the ring a t  different positions. The selection of  the compounds 
e amined in the present study was based on the number (between 0-3 )  and 
position of the hydroxyl groups attached to the phenyl ring ( see Table 4 .2 ) .  
Table 4 .2 .  The compounds were di  ided i nto four groups based on the number of 
h drox I groups attached to the phenyl r ing. 
:-';0 hydroxyl group Single hydroxyl group 
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Three h�'droxyl groups 




• 3,4,5·tnhydroxyb�nzO!c aCId 
� HO 0+-4 
OH 
The kinetic of a-syn fibri l l ation was studied over a period of 5 day in  the 
pre ence or ab ence of the phenol ic  acid . Based on the Th- a ay results ( Fig.  
4 . 1 1 and Table 4.3 ) .  the effect of the twel e phenol ic acid on a-syn fibri l lat ion 
varied greatly .  The extent of the i nh ibition of a-syn fibri l l ation was - 99% for 
GA. - 72% for 2.4,6-trih drox benzoic acid. - 60% for 3 ,'l-dihydroxybenzoic 
acid  � 30% for five compounds inc luding 2,6-dihydroxybenzoic acid and 4-
hydrox benzoic acid  and only 5% for benzoic acid ( see Fig. 4. 1 1 and Table 4 . 3 ). 
Table  4 . 3 .  ummary of Th- resul ts showing the percentage of inhibit ion of fibri l 
formation comparing with number of OH groups around the phenyl ring. 
ymbol Compound 
OH I nh ibit ion% of a-syn 
group aggregation 
PA l 3 .4.5-trihydroxybenzoic acid 3 99% 
PA2 2.4.6-trihydroxybenzoic acid 3 72% 
PA3 2.3 -dihydroxybenzoic acid  2 44% 
PA4 2,'l-dihydroxybenzoic acid  2 35% 
PAS 2,5-dihydroxybenzoic acid 2 30% 
PA6 2 .6-d ihydroxybenzoic acid 2 1 6% 
PA7 3 .4-dihydroxybenzoic acid  2 60% 
PA8 3 .5 -dihydroxybenzoic acid  2 0% 
PA9 2-hydroxybenzoic acid 1 0% 
PA l O  3 - Hydroxybenzoic acid  1 0% 
PA l l 4-Hydroxybenzoic acid  1 9% 
PA P Benzoic acid  0 5% 
PA l 3  4-methoxybenzoic acid  0 0% 
PA 1 4  3 .4.5 -trimethoxybenzoic acid 0 0% 
PA I S  3 ,4,5 -trifluoro benzoic acid  0 0% 
Moreover, three compounds, 2-hydroxybenzoic acid  ( sal icyl ic acid ), 3 -
hydroxybenzoic acid  and 3,5 -dihydroxybenzoic acid, fai led t o  i nhibit  a-syn 
fibri l l at ion. with sal icy l ic  acid  appearing to enhance the aggregation of a-syn 
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F igure 4 . 1 1 .  Effect of d ifferent benzoic acid derivatives ( phenol ic acids, PA) and 
the effect of methoxy and flu oro groups in benzoic acid derivatives on a-syn 
fibri l logenesis. Samples of a-syn (25 )lM )  were incubated alone or in the presence 
of different benzoic acid derivatives ( PA :  a-syn molar ratios of 4: L 2 :  1 ,  1 :  1 )  for 6 
days vv'ith cont inuous shaking at 3 7°C. The fibri l formation was measured by the 
Th-S binding assay and expressed as a percentage of the fibri l content of a-syn 
aged alone. The assay was performed in tripl icate (average of tripl icate 
measurements ± standard deviations) .  
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4 . 4  D i  c u  IO n  
The formati n f <lin} I id aggregate ha long b en considered responsible 
11 r the pathogene i r everal neurodegenerative disorders (Dorval & Fra er, 
2007:  Taylor, Hard) , & Fischbeck, 2002; Vekr l I is, Xi louri, mmanoui l idou, 
Rideout, & teran i . 20 I 1 ) . Al though runyloidogen ic proteins. such as a-syn, ar e 
u ual l )  Ii und unfolded in their nat ive state ( Fauvet et aL 20 1 2 ; Uversky, 2008), 
in  \\ hich th y nre o luble and non-toxic, the can undergo misfolding resul t ing in 
the formation of in o luble aggregates ( I rv ine, et aI . ,  2008; Kahle ,  2008; Seidler et 
aL 1 996; tefani , 20 1 2 ; Veldman, Wijn, Knoers, Praamstra, & Horst ink, 1 998) .  
These aggregate d posit in \'arious regions of the brain, consti tu ting the main 
neuropathological feature of several neurodegenerative diseases such as PD, DLB, 
M and approximately 50% of Alzheimer 's  cases. I n  the case of a-syn, 
pathological , biochemical,  genet ic and animal model ing studies provide 
compe l l ing eviden e that a-s n aggregation plays a pivotal role in  the 
pathogenesis of PD and related synucJe inopathies. As a consequence, the 
identification of compounds that can block or reverse the aggregation process of 
a-syn is considered a ital therapeutic strategy against these di seases. 
To th is end, we as essed the effect of the phenol ic compound GA (3 ,4 ,5-
trihydroxybenzoic acid) on a-syn aggregation and toxic ity, and we establ ished a 
structure-act ivity re lationship for GA. By employing an alTay of biophysical and 
biochemical techniques, we showed that at a high concentration ( 1 00 IlM, 
represented by the molar ratio of 4 :  1 ), GA exerts signi ficant inhibi tory effect on 
both a-syn fibri l l at ion ( Fig. 4 . 1 .  A and B) and ol igomerization ( Fig. 4 .2 ,  A and B), 
as wel l as seeded fibri l lation of a-syn ( Fig. 4 . 5  A). In accordance with these 
findings, TEM images revealed that a-syn in the presence of GA at a high 
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c nccntrat ion nly formed a few short .  thin fibril that had a fragmented 
appearance ( Fig.  4 . 1 D) accounting for the 10\ Th- counts ( Fig. 4 . 1 ) and a 
minor wavelength hi n in the R binding as a ( F ig. 4. 1 B). At lower GA 
conccntrati n ( specia l ly at 1 :  1 molar rat io . ho\ ever. the abi l i ty of the G to 
inhibit a- yn fibri l lati n was I e  dramatic and accompanied by a striking increas 
in the o l ig  meric content ( Fig. 4 .2 ). indicating GA may stabi l ize the ol igomeric 
tructure. ize exc lu  ion chromatograph combin d with UV spectroscopy for 
detection of the GA incorporated in a-syn con fimled that GA binds to a-syn 
ol igomer ( Fig .  4 . 8  C) .  Furthenl1ore, GA \ as able to di saggregate preformed a-
) n fibri l s  ( Fig. 4 .4 ,  -C), generat ing species that possessed a decrea ed �-sheet 
content ( Fig.  4 .4 B )  and were less tox ic to cel l s  ( Fig. 4 .4 D). Previous studies have 
al 0 hO\vn that the phenol ic  flavonoid compound baicalein, as wel l  as other 
antioxidant compounds inhibit  a-syn fibril lation and di saggregate pre-aggregated 
fibri l ( Ono & Yamada, 2006; Zhu et a l . .  2004) .  GA was also shown to al leviate 
a-syn aggregates associated-tox ic ity in neuroblastoma BE(2)-M- 1 7  cel l ( Fig. 4 .6  
A and B) .  
These results are in agreement with previous stud ies indicating that GA possesses 
ant i -fibri l lation. o l igomer-stabi l izing and neuroprotective propert ies against a-syn 
and A� cytotoxic i ty (O i  Giovanni ,  et a ! . ,  20 1 0) .  I ndeed, GA was shown to 
stabi l i ze biotinylated A � I -42 o l igomers ( LeVine, Lampe, Abdelmoti, & Auge l l i -
zafran. 20 1 2) and to  inhibit  the in  vitro conversion of low molecular weight A� 1 -
� 2  protofibri l s  into fibri l s  by  50% (Di  GiovaImi ,  e t  a ! . ,  20 1 0) .  Addit ional ly,  GA 
was reported to block the fibri l lation of a-syn in vitro and to suppress the abi l i ty 
of short a-syn fibri l s  to seed the aggregat ion of monomeric a-syn ( Oi Giovanni ,  et 
al . 20 1 0) .  Furthennore, GA exerts a neuroprotect ive effect on cel l s  agai nst the 
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c t tox ic i ty of CL-S) n and B l -l2 ( Oi Gio\'anni .  et a1 . ,  20 1 0) .  pos ibl )  due to the 
inhibition f the am) lo id aggregat ion but potential ly also due to the ant i ­
inflammatory ( D. I I . K im et  a ! . .  20 1 1 ). anti-ox idant ( Ban et  aJ . ,  2008;  . Y .  Hong, 
Je ng, & Jun.  20 1 2) and anti -apoptotic properties it po esses ( , Y. Hong. et a 1 . ,  
20 1 2 ) .  
Ba ed on our finding u ing both EC and MR, as wel l  as previou reports, G 
inhibi ts  a- yn fibri l lation not by interacting with the monomeric a-syn - sim i lar to 
man other phen l i e  compound ( reviewed by ( Porat, et al . .  2006), and preventing 
it from polymerizing but rather by stabi l i zing the structure of o l igomeric a-syn 
( Fig .  4.2 B. 4.8 C) \.\ hich appears to be non-toxic  ( Fig.  4 ,6) .  These findings are in 
accordance w ith pre\. ious studie indicat ing that polyphenol ic compounds, such as 
baicale in .  curcllmin and epiga l locatechin gal late ( EGCG) induce the formation of 
soluble, non-toxic o l igomers ( Masuda et a I . ,  2006; Zhu, et a! . .  2004) .  From a 
therapeutic point of view, th is  represents a major advantage, as GA may not 
interfere with the physiological funct ion of the monomeric a-syn ( Wagner et a I . ,  
20 1 3 ) . I t  has  been reported that phenol ic  compounds such as  curcumin inhibit A� 
aggregat ion due  to  confom1at ion-dependent binding (F .  Yang e t  a I . ,  2005) .  
Consi stent wi th  th i s  model of inhibit ion, GA also inh ibited the seeding abi l i ty of 
short fibri l lar a-syn. Although the presence of  o l igomers can be transient as  they 
assemble into fibri l ( Fink 2006; Kaylor et aI . ,  2005a), there are studies reveal ing 
that in  the presence of the polyphenol ic compound EGCG, they can shift off­
pathway from fibri l l at ion ( D. E .  Ehmho e fer , et a ! . ,  2008) .  I ndeed, EGCG was 
shown to promote the formation of less toxic ol igomers that were exceedingly 
stable and incapable of contribut i ng to the aggregat ion process (D.  E .  Ehrnhoefer, 
et a l . ,  2008) .  As it is  a lso a phenol ic  compound GA may interact with a-syn 
1 10 
l igomers b) a me hanism imi lar to that of EG G.  acc lerating the formation of 
ff-path\\ a) o l igomer and lead ing to the accumulation of non-toxic ol igomer 
and the interruption of the fibri l lation process. 
To gain insight into the mechanism of action of G and to establ ish a 
structure-function relat ionship for this phenol ic  acid, we evaluated the effect of 
various structura l ly  s imi lar phenol ic acids on a-syn fibril lation. The resul ts  
generated from this approach point towards a structure-related e ffect on a-syn 
fibri l lation in which the better inhibitor were observed to have a greater number 
of -OH groups attached to the phenyl ring that were direct ly conj ugated to the 
carbox. l i c  ac id arm ( see Fig .  4 . 1 1 ) . In fact, the ranking of the ant i -fibri l logenic 
potency of all the phenol ic  compounds tested could be represented as fol lows : 
trihydroxybenzoic acid>dihydroxybenzoic ac id>monohydroxybenzoic acid = 
benzoic acid .  This finding is  in  accordance with previous studies indicat ing that 
the potency of certain  polyphenol ic  compounds to i nh ibi t  and disaggregate a-syn 
o l igomer correlates with the mmlber of vic inal - OH groups present on a single 
phenyl ring (Caruana et a \ . ,  20 1 1 - Masuda, et al . ,  2006) .  The significance of the 
pre ence of the hydroxyl group on the pheny l ring was further stressed by the fact 
that the compounds that possess appendages other than hydroxyl groups on the 
pheny l rings fai led to inhibi t  a-syn aggregation.  At this point, it is more than idle 
specu lat ion to suggest that the inhibit ion capaci ty of the phenol ic  compounds i s  
not only dependent on the number of hydroxyl moieties but also on the ir position 
and conj ugation with respect to the benzoic acid  appendage. Comparison of the 
two trihydroxybenzoic ac ids tested in  this study, GA ( 3 ,4,S -trihydroxybenzoic 
ac id) and 2 A.6-trihydroxybenzoic acid, indicates that al though both compounds 
have a total of three - OH groups, the former is a much more potent inhi bitor of a-
1 1 1  
yn fi bri l lation c mpared to th latter, strongly uggesting that it i not only the 
t tal numb r of - H groups present in  the molecule but a lso their posit ion that i s  
imp rtant . Additional ly ,  compari on of the dihydrox benzoic ac ids empl yed in  
the present stud} reveal that the pre ence of -OR groups in two consecutive 
po it ion and conjugated with the carboxyl group e .g  . .  3 ,4-dihydroxybenzoic acid 
(600/0 inhibit ion and 2.3-d ih drox benzoic acid (44% inhibit ion)) renders the 
comp unds more acti e compared to those that have hydroxyl groups in non­
consecutive po it ions (e .g. ,  2,5-dihydroxybenzoic acid ( 30% inhibit ion) and 3 ,5-
dih} drox} b nzoic ac id (0% inh ib i t ion) ( see Fig. 4. 1 1  and Table - L 3 ) .The 
importance of the 4 - OR moiety i s  emphasized by the fact that of the three 
hydro 'ybenzoic acids te ted, only 4 -hydroxybenzoic ac id could part ia l ly  inhibit 
a-syn fibri l lat ion. Among the d ihydro ybenzoic ac ids, 3A-dihydroxybenzoic acid 
\vas the most potent of a l l ,  i nh ibit ing fibri l lation by 60% (Table 4 . 3 ) .  Taken as a 
whole, these data show that the total number of - OR groups present i n  the 
molecule i important for the compound act iv i ty and that the position of the 
overal l -OR groups a lso affects activi ty, with a hydroxyl group at position 4 
appearing to play a significant role .  Thus, the presence of three ic inal hydroxyl 
groups, as in 3 ,4,5 -trihydroxy benzoic acid eGA), or the three homo-vicina l  
groups, as in  2A.6-trihydroxy benzoic acid,  wi th  one - OH group at  position 4,  
enhances the compounds able to i nhib i t  a-syn fibri l lation to a great extent. 
Gi en that al l the compounds tested in this study have a phenyl ring in 
their structures, the phenyl structure i tsel f  i s  c learly not sufficient to inh ibit a-syn 
aggregat ion. Consequently, the i nh ibit ion abi l i ty of such compounds must be 
achieved by the presence of addi t ional - OH groups attached to the phenyl ring. 
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The c nj ugated hydrox) I group \\ ith the carboxyl ic acid appendage can ea i ly  
form quinone structures ( e  Fig. 4 . 1 2 ) .  I t  i \\ orth mentioning that quinone 
fonnati n has been pre\ iousl)  reported a the potential mechani m for the 
inhibit ion of a- )'n fibri l lat ion b the phenol ic  compound (Zhu, et a I . ,  2004) .  The 
r rmation of uch oxidized derivat ive can increase the stabi l ity of the compound 
binding to the a- ) n fibri l (Taniguchi et a l .  2005 ), possibly accounting for the 
increased inhibitory potency of the compounds with more - OH groups present in 
their tructures .  Quinone are l ikely to interact with the aromatic residues of a­
syn, interfering with their n-11: stacking ( Ebrahimi & Schluesener, 20 1 2; Han1 le , 
20 1 2 :  Porat, et a l . ,  2006) .  Moreo er, qui nones have a planar orientat ion that 
al lo\\ them to a l ign with the hydrophobic groove of a-syn fibri l s, which po sess 
an in-register organization of side chains in the regular cross-�-sheet structure 
( Ebrahimi  & chluesener, 20 1 2 ; Hamley, 20 1 2 ; Porat, et a1 .  2006 ) .  Therefore, the 
inhibit ion of a-syn fibril lation by GA and 2,4,6-trihydroxybenzoic ac id could be 
attributed to the combined properties of their three -OH groups and quinone­
forming structures. Based on these results, we propose a plausible model to 
interpret the inhibitory and disassembl ing effects of GA. Two dominant l i gand­
protein i nteractions contribute to i nh i bitor potency, (a) the dipole-dipole 
i nteractions of the quinone and (b )  the dipole-dipole interactions of the diquinone 
group. The most potent i nhibi tors, with 3 ,4,5 -trihydroxy and 2,4,6-trihydroxy 
subst itution patterns eGA and 2,4,6-trihydroxy benzoic acid, respectively),  ( see 
Fig .  4 . 1 2  c) ,  enable both hydrophobic and dipo le-dipole i nteractions. The nil: 
stacking is known to play a role  in the binding affinity of inhibitors to aggregates ;  
increasing the potential for quinone formation of each compound general ly leads 
to increased binding affinity and, therefore, increased inhibitor potency. 
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'onsi tent \\i th lhi interpretation. ortho- and meta-h) droxybenzoic acid. as wel l  
a benzoic ac id ( ee Fig. 4 . 1 2  f) showed no inh i bition compared to their para- and 
ortho-parad ihydrox ( F ig.  4 . 1 2  a)  counterparts due to the inabi l i ty of the former to 
fom1 quinone- l i ke l igand ( F igA. 1 2  [, d) .  
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F igure 4 . 1 2 . Mechanistic i nsight for the mechanism of quinone formation. 
Although monocycl ic compounds such as phenol ic acids were previously 
shown to be very poor inhibi tors of aggregation ( Reinke & Gestwicki,  2007), later 
studies revealed that monocyc l ic  compounds could suppress amyloid assembly by 
interact ing with o l igomers, stab i l izing their structure and conformation, thus 
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inhibi t ing the transit i  n to �- heet structure ( Levy- akin. hreberk. Daniel ,  & 
Ja7it .  2009). I t  i s  therefore l ikely that phenol i  acid . especial ly  GA. act in a 
s imi lar \ ay. interact ing with o l igomers and stabi l i zing their structure through the 
I [ groups, preventing the tran i t ion to �-sheet-rich structure . This may e plain 
the increased ol igomeric content detected at low GA concentrations and the low 
�- heet content of o,-s) n spec ies generated in the presence of G . 
In  ummary, we conducted a systematic stud of the effect of G on a- yn 
fibri l lation. o l igomerization and toxic ity. and we conc lude that GA inh ibi ts a-syn 
fibri l l at ion and tox ic i ty b stabi l iz ing the non-toxic o l igomeric structure of a-syn 
through o l igomer binding. Our study points toward a structure-related inh ibit ion, 
\\ i th th number of - Oi l moieties and their  posit ion around the phenyl ling 
play ing a fundamental role .  Based on the above experimental results, we propose 
a model to interpret the i nh ibi tory and di sassembling effects of GA derivatives on 
o'-syn aggregation ( ee Fig.  -U 2) .  a-Syn aggregat ion is a sequential process in  
which unstructured o'-syn monomers undergo conformational transition and re­
ordering to form o l igomers and then final ly amyloid fibri l s  ( routes a � b � c � 
d. Fig .  -t . 1 2 ) .  The analysis of the results obtained from this study shows that GA 
derivatives can prolong the nucleation process, suggesting that these scaffolds can 
bind to unstructured o'-syn o l igomers and prevent protein  association ( F ig. 4 . 1 2 . 
route a � f) and/or slo\ down the conformational transition to structured 
o l igomers, the precursors of amyloid fibri ls .  GA derivatives i nteract with a-syn 
monomers and/or o l igomers through IHt stacking. leading to the fOlmation of an 
energy barrier that prevents the association of a-syn molecules. Meanwhi le.  GA 
derivatives through their respective quinone ox idation products could induce 
structural disruption to the local �-sheet of a-syn fibri l s  via strong binding to the 
115 
�- heet groove region of a- ) n  fibri l s. leading to fibri l di aggregation Cd ----- e ) . I t  
hould b e  noted that due to the hydrophobic aromatic nature and planar tructure 
f quinone . the might interact with a- n fibri l s  by relatively non pecific 
dipole-d ipole interactions with �- heet-rich side chains. This  b inding mode 
impl ie that quinone could have a general i nhibitory effect on the aggregation of 
a- yn. chematic model for the ant i-aggregation and disassembl effect of GA 
derivatives on a-syn is hown in ( Fig.  4 . 1 3 ) .  
d) lo'Ue �Iold fThnh. 
InhibllOf 
(C) Son-to"Oc stable oilp-omm 
Flbrillzatloo IDblbl'rd 
Figure 4 . 1 3 . Schematic model for the antiaggregation and di sassembly effect of 
GA deri atives on a-s n .  
B companng the structures o f  the most effective and least effective 
compounds. we concluded that better i nh ibit ion of fibri l l ation is  observed when 
there are a l arge number of hydroxyl groups (- OH)  attached to the phenyl ring of 
the compound. Moreover. the positions at which the hydroxyl groups are attached 
to the phenyl ring also appear to p lay a critical role .  GA has hydroxyl groups 
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attached at po it i  ns 3 ,  4 and 5 ( ee Table 4 .2 )  and is much more effe t i \  e than 
2A,6-trihydroxy benzoic acid, \vhich also bear three - OH group but at d i fferent 
po i t i  n ( Fig. 4 . 1 1 ) . I ntere t ingl) , 3A-dihydroxybenzoic acid, which only lacks 
an - OH group at position 5 compared to the very effective GA. i s  the third best 
inhibitor of a-syn fibri l l ation ( Fig.  4. 1 1 ) . mong a l l  the dihydroxybenzoic acids 
te ted, the one vv ith - OH groups at two consecutive posi tions, i .e . ,  3 ,4-
dihydroxybenzoic acid ( 60% inh ibit ion) and 2J-dihydroxybenzoic acid (44% 
inhibiti n ), are more potent inhibitors compared to those that have -OH groups at 
non-con ecutive position , i . e  .. 2 ,5-dihydroxybenzoic ac id ( 30% inhibit ion) and 
3 ,5 -dihydroxybenzoic acid ( 0% inh ibit ion) ( Fig. 4 . 1 1 ) . Additional ly ,  al l 
compounds with one -OH group, as wel l  as the benzoic ac id \ i thout an OH 
group, fai led to  show any inhibitory effect on  a-syn aggregat ion ( Fig.  4 . l 1 ) . 
To further invest igate the sign ificance of the ( -OH) moieties on the 
activ ity of the GA and the other active phenol ic  acids, three addit ional compounds 
with either fluorides or methoxy groups rather than hydroxyl groups attached to 
their phenyl rings (4-methoxybenzoic acid, 3 ,4.5 -trimethoxybenzoic acid and 
3 Aj-trifluorobenzoic acid )  ( see table 4 .2 )  were tested for their abi l i ty to inhibit a­
syn fibri l formation. As expected, none of the three tested compounds in any of 
the three molar ratios tested (compound:  a-syn 4 : 1 ,  2 : 1 and 1 : 1 )  could inhibi t  a­
syn fibri l lation (F ig .  4 . 1 1 ) . This fi nding provides addit ional support for the 
importance of the presence of the hydroxyl group in the phenyl ring. 
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5 C ha pte r 5 :  Gin eno ide Rb I inhibit fib rillation and 
To xicity of al p ha-syn uclein and disagg regates 
p refo r med fib ril 
5. 1 I n t rod uct ion  
a- yn  aggregat ion proce d through the format ion of  o l igomers (early 
aggregate ) ,  ,",v hich ult i mately convert into wel l -ordered fibri l s  ( late aggregates) 
( vel' ky. Lee. L i .  Fink, & Lee, 200 1 ) . Recent studies i ndicate that early 
aggregates of a-syn, the so-cal led sol uble ol igomers, fom1 the pathogenic species 
that driye neurodegeneration and neuronal cel l death rather than mature amyloid 
fibri l s  (Conway et a! . ,  2000b· E I -Agnaf, et a ! . ,  2003; Wilmer et a I . ,  20 l l ) . 
The drugs cunently avai lable for the treatment of PD provide symptomatic 
rel ief  but do not a l ter the course of the d isease ( He et a I . ,  20 1 3 ) .  However, the 
effectiveness of these drugs diminishes after several years of treatment. Together 
"", ith the increasing incidence of PD due to an aging population, these facts 
i ndicate the compel l ing need for more effect ive drugs and treatments for PD.  
A lthough modem therapeutic options that target disease modi fications are on the 
rise, the mult ip le mechanisms involved in  the pathogenesis of PD create 
considerable d ifficul t ies in producing effective treatments. Hence, the inhibition 
of a-syn aggregation may represent a viable strategy for therapeutic intervention 
in  PD and rel ated disorders. I t  is therefore essential to identify compounds that 
can serve as potent i nh ib i tors and intenupt the early stages of aggregation. 
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Ginseng is a wel l -known medicinal herb that has been used for more than 
two th usand year in hina, Korea and Japan to promote \ve l l -being and al leviate 
fatigue. I though there are eleven di fferent pecies of ginseng that belong to the 
genus Panax of the ral l i aceae fan1 i ly, the most commonly used spec ies are 
Pan a ginseng ( ian or Korean Ginseng), P. quinquefol ius ( American Ginseng), 
P .  jap nicus ( Japanese Ginseng) and P. notoginseng ( Chinese otoginseng or 
anch i )  ( F . Chen, ckman, & Eckman. 2006) .  amed after i ts  abi l i ty to treat 
everal condit ions - panax means panacea in Greek gi nseng is nov a wel l ­
documented anti -carcinogen ic, ant i -diabet ic, ant i-oxidant and vasorelaxing agent 
that exhibit  imm unomodulatory propert ies and improves the function of the 
central nervous sy tem (LlL Yao, & Chen, 2009) .  The numerous pharmacological 
propert ie of ginseng are attributed to its biological ly active ingredients, the 
ginseno ides ( reviewed by ( 1m & ah, 20 1 3 ) ,  which can be extracted from many 
parts of th ginseng plant, including the root, the leaves and the ben-ies ( Attele, 
Wu, & Yuan, 1 999 ). Ginsenosides, which are a lso referred to as ginseng saponins, 
are derivatives of triterpenoid dammarane with a four-ring, steroidal structure 
bearing sugar moieties and an a l iphat ic side chain ( Wee JJ, 20 1 1 ) . The variations 
in  the structure of ginsenosides, namely the type of aglycone ( triterpene), the type 
of sugar moieties (g lucose, maltose, fructose, saccharose etc) ,  their number and 
their site of attachment ( Wee JJ, 20 1 1 ), give rise to three categories of ginseng 
saponins. the panaxad iol group, the panaxatriol group and the oleanol ic acid 
group ( Kim et al . ,  20 1 3 ) .  More than 1 00 ginsenosides have been ident ified so far 
(Nag, et a l . ,  20 1 2 ), but the most frequently studied ones are Rb I ,  Rg l ,  Rg3 , Rd, 
Re. Rh 1 and Rh2.  
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Gi nseno ide have been hov. n to affect yoHage-gated ion channels. such a 
the Ca2 a . K+ channel . as wel l  as the l igand-gated ion channels. uch as the 
5- 1 1 1 3- .  the a7 nicoti nic acel Icholine and the -methyl -d-aspartate MD )-
gated channel ( r  viewed by ( ag et a1 . .  20 1 2 : Radad. 101dzio. & Rausch, _0 1 1 ) . 
Thi s  propert of ginseno ides appears to underl ie many of the pharmacological 
effe t of ginseng inc luding neuroprotection ( 1 .  H .  Kim et a I . ,  2007), since it has 
a benefic ial effect on many neurological conditions. including neurodegenerative 
diseas s such a PD ( reviev,'ed by ( Cho, 20 1 2;  H .  1. Kim. Kim.  & hin. 20 1 3 ) . 
I Io\vever. despite numerous tudies exploring the effect of various ginsenosides 
on the nervou system. there are no reports on the effect of ginsenosides on the 
aggregation propensity of amyloidogenic proteins such as a-syn. As a 
consequence, we sought to determine the potent ial of the most frequently used 
and studied ginsenosides, name ly Rb I ,  Rg l and ( 20S)-Rg3, i .e .  the stereoisomer 
of Rg3 with its C-20 OH being spatial ly  c lose to the C- I 2  OH group ( cheme. 
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.'cheme 5 . 1 .  Chemical structure of gin enoside Rb I .  ginsenoside Rg l .  
gin enoside Rg3 . 
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5.2 E x pe r i m e n ta l  p roced u re 
5.2 . 1 E ' p re ion  a n d  p u rificat ion of  recom b i n a n t  h u m a n  a..- y n .  
descri bed the experimental procedure 3 .2 . 1 
5.2 .2  u-Sy n p u ri ficat ion  and characte rizat ion .  
As de cribed the experimental procedure 3 .2 .2  
5.2.3 Aggrega t ion  of  a.-sy n ill vitro. 
Protein purity \Va est imated to be >95% u mg an DS gel .  The 
gin enosides \-vere purchas d from the ational In  t i tute for the Control of 
Pharmaceut ical and Biological Products, China (NICPBP) .  Ginsenosides stock 
solution ( 1 0  m1\ l )  \\'ere prepared in 1 00% DMSO such that the final amount of 
DM 0 in the sample solutions was 1 %. Samples of 25 11M a.-syn in PBS were 
aged alone or \\ i th ginsenosides at various molar ratios (g insenoside: a-syn molar 
ratios of -+ :  1 .  2: 1 and 1 :  1 ) . The samples were placed in 1 .  5 ml steri le  
polypropylene tubes. drops of mineral o i l  were added to prevent sample 
evaporation. and the tubes were then sealed with parafilm and incubated at 37°C 
for 5 days with cont inuous shak ing at 800 rpm in a them10mixer ( Eppendorf) . 
amples \\-ere col lec ted at the indicated intervals, and a thiofla in-T assay was 
perfom1ed immediate ly  at each t ime point ,  whi le  the rest of the samples were 
stored at -80°C unti l  required for further analyses. 
S.2A T h i oflav i n -T (Th-T )  assay 
0.- yn fibri l  formation was monitored by Th-T binding assay. Th-T is a 
fluorescent dye that interacts with fibri l s  containing a �-sheet structure . A total of 
1 0  II I of  each sample was d i luted in  40 II I of Th-T in  PB . Fluorescence was then 
measured in a 3 84-wel l .  untreated black micro-we l l  plate (Nunc, Denmark) using 
a microplate reader ( V ictor X3 2030 Perk in E lmer) with the exc itation and 
1 2 1  
emi sion wavelength set at 450 and 486 nm. re pect ive l) . To al lo\\ for 
backgr und O uore cenc . the fluore cence intensit) of a blank PB olution was 
subtracted from a l l  readings. 
5.2.5 T ra o  m i  ion elect ron micro copy (T E M ) . 
described in  the experimental procedure 3 .2 . 8  
5.2.6 l m m u n o blott i n g. 
de cribed in  the c. perimental procedure 4 .2 .6 
5.2.7 Congo red b i n d ing as ay. 
described in  the experimental procedure 4 .2 . 1 0  
5.2.8 P rotei n a  e K ( P K )  d igest ion.  
amples of a-syn (25  flM ), aged alone or with Rb I ,  Rg J or Rg3 ( a-syn:  
compound molar rat io 0 f 1 :  1 )  'were incubated for 1 5  m ins at  37°C with PK 
( igma- ldr ich.  U A) to a 2 . 5  �lg/ml .  The reaction was stopped by the addit ion of 
�x sample loading buffer ( 250 mM Tris-HC l ,  pH 6 .8, 30% glycero l .  0 .02% 
bromophenol b lue. 8% D ,  5% beta-mercaptoethanol ) ,  and then heated for 1 0  
mins at 95°C . The samples were loaded and nm into 1 5% SDS-PAGE gel s  which 
were then s i l  er stained. 
5.2.9 T i  sue c u l t u re of B E( 2 )- M- 1 7  h u m a n  n e u roblastoma cel ls. 
As described the experimental procedure 3 .2 . 1 0  
5.2. 1 0  M ea s u re m e n t  of cel l v i a b i l i ty .  
As described i n  the experimental procedure 3 .2 . 1 3  
5.2. 1 1 I m m u n ocytoch e m istry s ta i n i n g. 
BE(2 )-M- 1 7  cel l s  expressing wt- a-syn were plated on 1 2-mm covers l ips in 
24-we l l  p late for 24 hours. The cel l s  were then washed !\vice with PBS and fixed 
with 4% paraformaldehyde for 1 5  mins at room temperature. Following two 
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w ashe ( 5  mins each \'\' l th PB ) the cel l s  were permeabi l ized b) incubating for 1 0  
min at room temperature \\. ith PB - 1  % Triton and then incubated in  a blocking 
buffer [ 5% normal goat serum ( G ) in  PB + I % Triton] for 1 h ur at  room 
temperature. Fixed cel l s  were incubated with anti a-syn 2 1 1 Ab for 3 hour at 
room temperature and then " ashed three times \ ith PB . F ITC conjugated goat 
ant i-mouse s condar b ( igma) was added to the cel l s  for 1 hour at room 
temperature, and after three \ ashes with PB the cel l s  were counterstained with 
D PI  to reveal nuc lei ,  and mounted in  hand on immu-mount (Thermo 
cient i fic ) .  F luore cent images were taken with an in erted Axiovert 40 CFL 
fluorescence microscope ( ar l  Zeiss), equipped with Ax ioCam H Rc (Carl Zeiss) 
u ing the 6 x oil objecti e. 
5.2. 1 2  a,- yn di aggregat ion assay. 
a- yn solution in  PB (pH 7.4) was aggregated at a concentration of 25 �M 
a indicated abo\'e. The result ing aggregated a,- yn was incubated ei ther alone or 
with Gn Rb 1 at various molar ratios (Gn Rb 1 :  a-syn molar rat ios of 6 :  1 ,  4 : ] and 
2 :  1 ) . It hould be noted that for the purpose of the experiment, the concentration 
of a-syn taken i nto account was the concentration of fre h a-syn. The samples 
wer incubated at 3 7°C for 48 hours on a thermomixer with continuous shak ing at 
800 rpm. Samples were col lected at regular t ime points, and Th-T fluorescence 
was measured immediatel . 
5.2 . 1 3  Seed i n g  polymerization assay. 
The aggregat ion of monomeric a-syn with or without seed ing was 
performed as described el sewhere CDi  G iovanni ,  et aI . ,  20 1 0) .  The seeds were 
prepared by fragmenting the mature a-syn fibri l s  by sonication to obtain short 
fibri l s  which were employed as ' seeds . Monomeric a-syn at a concentrat ion of 
1 00 �M was seeded with 2 �M of seeds and i ncubated in the presence or absence 
of Gn Rb 1 ( 1  0 �M or 50 �M) at 3 7°C for 6 hours with continuous shaking. The 
fibri l l ization was monitored by Th-T binding assay a described above. 
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5.2. 1 4  , ize Exc lu  ion C h roma togra phy ( EC ) fo r epa rat ing  a- yn ol igomer 
and m onomer . 
s de ribed in the experimental procedure 4 .2 . 1 3  
5.2 . 1 5  UV ca n n ing. 
de cri bed in the experimental procedure 4 .2 . 1 4  
5.2 . 1 6  M R  t u d ie . 
As de crib d in the e perimental procedure 4 .2 . 1 5  
5.3 Res u l ts 
5.3. 1 T h e  effect of ginsenoside on a-sy n fibr i l la t ion 
25 �M solution of a-syn , which was pur i fied by reverse-phase HPLC 
chromatograph and its purity was estimated by SDS-PAGE and immunoblott ing 
( cherne 3 . 1  B and C )  was incubated at 3 7°C with continuous shaking for 5 days, 
leading to fi bri l formation, which was monitored by Th-T fluorescence at regular 
t ime intervals .  a-Syn was incubated with Gn Rg I ,  Gn ( 20S)-Rg3 and Gn Rb I at 
molar rat ios of 4: I ,  2: 1 and I :  1 (molar ratio ginsenosides: a-syn) with a constant 
a-s n concentrat ion of 25 11M.  From the three tested compounds, only Gn Rb I 
exhibited a s ignificant i nh ib i tory effect on a-syn fibri l lation as indicated by the 
reduced Th-T fl uorescence at all tested concentrations ( Fig .  5 . 1 A). 
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D Gn a- syn 4 I Gn' rJ.-syn 2 I 
Gn Rh i  
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Gn Rg3 
aged a-syn alone 
F igure 5 . 1 .  Gn Rb i i nh ibits a-syn fibri l lation. A. Samples of a-syn (25  � M) were 
incubated for 5 days at 3 7°C with continuous shaking in the presence of vaIious 
concentrations of the ginsenosides Rb 1 ,  Rg 1 and (20S)-Rg3 ( 1  00 �M, 50 �M and 
25 �M) .  F ibli l format ion was measured by Th-T binding assay. The assay was 
perfomled i n  tripl icate, and the means ± standard deviations are shown. B .  Congo 
red binding for Gn Rb I ,  Gn Rg l and Gn (20S)-Rg3 . a-Syn ( 5  � M )  aged alone or 
in the presence of d ifferent concentrations of ginsenosides was mixed with Congo 
red ( fi nal concentration of 5 �M) .  The UV absorbance spectrum was recorded 
from 400 to 600 run in a spectrophotometer. C. S i lver staining for 1 5% SDS gel of 
a-s n monomers, a-syn aged alone or in the presence of Rb I ,  Rg l and Rg3 at 
molar rat io 1 :  1 after 2 . 5  �g!ml PK digest ion. D. E lectron microscopy images of 
negatively stained samples of a-syn (25  �M)  aged alone or in  the presence of the 
ginsenosides (g incenoside: a-syn molar rat ios of 4 :  1 ,  2: I ,  and 1 :  1 )  for 5 days with 
continuous shaking at 3 7°C.  Scale bar, 500 run 
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[his effect \\ as observed as early as after 2 da) of incubation, \\ hen the 
inhibi t ion percentage wa approximately  90%. fier 5 days of incubat ion, the 
fibri l lation of «-S) n was reduced by approximately 80%. In contra t, Gn Rg3 
h wed a partial inhi bi tof) effect. which was most prominent on the third day of 
incubat ion. After 5 days of incubat ion. Gn Rg3 inhibi ted the fibri l lation of a-syn 
by appro. imatel )  25°'0, ( F ig .  5 . 1  ) .  The extent of inhibit ion was comparable for 
a l l  c ncentrations te ted . The th i rd compound tested, Gn Rg l ,  had no signi ficant 
effect on a- yn fibri l l at ion given the comparable Th-T measurements produced by 
the Gn Rg 1 contain ing samples and the control ,  that is the a-syn solution aged 
alone ( Fig . 5 . 1 A) .  
The abi l i ty of the three ginsenosides to block a-syn fibri l formation was 
further assessed by the Congo red (CR)  binding assay. CR i s  a dye with high 
affinity for amyloid fibr i l s  (Groelm ing, 20 1 0) .  Upon binding to a-syn fibri ls .  the 
absorption max imum of C R  sh i fts from 490 to 508 nm. This shift  was quite 
pronounced for the a-syn sample incubated in the absence of any of the three 
compounds ( i .e .  contro l )  ( F ig .  5 . 1  B ) .  However, th is charactelistic shi ft was not 
ob erved for a- yn samples aged in the presence of Gn Rb I ,  indicat ing that this 
compound i nh ib i ted the formation of amyloid fibri l s  ( Fig .  5 . 1 B) .  I ndeed. the 
absorption maximum of C R  bound to the a-syn samples conta in ing Gn Rb I (at a l l  
concentrations tested) only shifted a few nm and did not  exceed the wavelength of 
495 nm ( Fig .  5 . 1 B) .  I nterest ingly, the CR shi ft  was comparable to the sh ift 
observed for monomeric a-syn. I n  contrast, the samples incubated in  the presence 
of Gn Rg 1 and ( 20S)-Rg3 behaved s imi larly to the control  sample, exhibit ing the 
characteristic shi ft  from 490 nm to approximately 508 nm. To test if the formed a­
syn aggregates i s  resistant to P K  digest ion, samples of a-syn aggregated alone or 
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in the pre ence of Gn Rb L Rg I and Rg3 at molar ratio of 1 :  1 were treated \\ ith 
2. � !J.g/ml  PK: the dige ted ample were then run on 1 50 0 D -P GE and the gel 
was s i lver stained as described in the materials and methods. The a-syn aged in 
the pr ence of Rb I \\- a ea i ly digested by PK and behaved exactl as the 
monomeric a- ) n ( Fig.  5 . 2  ) ,  whi le the samples of  aged a-syn alone or  in the 
pre ence of Rg l and Rg3 were resistant to dige tion ( Fig. 5 . 2  C) possibly due to 
pre nee of �-sheets in these amples ( Fig .  5 . 1 , B ) .  
These findings were further confirmed by electron mlcroscop . TEM 
images of a- yn aged in the presence of Gn Rb 1 showed that a-syn formed thin, 
hort, rod- l ike fibri ls, with a fragmented appearance ( F ig.  5 . 1  D), unl ike the dense 
me he of long fibri l s  formed by a-syn aged alone ( Fig. 5 . ! ) . For both Gn Rg I and 
Gn (�O )-Rg3 , TEM confirn1ed that there was l i tt le or no change in fibri l 
morphology compared with the control ,  consi tent with the Th-T fluorescence and 
CR binding findings ( Fig .  5 . 1 D) .  
5.3.2 The effect of gi nsenosides on a-sy n o l igomeriza t ion  
The effect of the Gn Rg l ,  Gn ( 20S)-Rg3 and Gn Rb I over o.-syn 
ol igomerization was assessed by western blotting. The samples of a-syn aged 
alone or in the presence of the three ginsenosides were centr ifuged ( 1 4,000 rpm 
1 5  mins, 4°C) and the supernatants were separated on 1 5% SDS gels, transferred 
onto nitrocel l ulose membranes and probed with an antibody that recognizes the 
amino acid  residues 1 2 1 - 1 25 of o.-syn (anti -o.-syn c lone 2 1 1 ) . Gn Rb 1 ,  which was 
shown to i nh ibi t  a-syn fibri l l ation, was a lso a potent inhibitor of o.-syn 
o l igomerization at a l l  molar rat ios ( Fig .  5 .2  A). More spec ifical ly, Gn Rb I 
i nh ibi ted the formation of larger aggregates ( M W  >250 kDa) and high MW 
ol igomers, generat ing a prominent monomeric band and a weak dimeric band 
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( F ig .  5 .2  ) .  Densi tometric anal} sis of the monomeric bands revealed that On 
Rb I hi ndered a- yn ol igomerization to the same extent In  a l l  tested 
concentrations. ( Fig.  5 .2  A) .  It should be noted that e en at the lowe t 
concentration, On Rb 1 " as able to i nhib i t  the formation of larger aggregates. 
The other tv .. o ginsenosides, On Rg l and On (20 )-Rg3 , fai led to inhibit  a­
syn o l igomerization, imi larly to their effect  on a-syn fibri l lation. In fact, in  the 
pre ence of On Rg l ,  a-syn o l igomerization was enhanced compared with the 
controL a indicated by the detection of numerous strong bands corresponding to 
the o l igomeric species ( Fig .  5 . 2  B ) .  Densi tometric analysis of the monomeric 
bands showed that On Rg l st imulated a-syn o l igomerization to the same extent at 
a l l  concentrat ions tested (F ig .  5 . 2  B) .  In the case of On ( 20S)- Rg3 , at e ery 
concentrations tested of the compound, the separat ion of a-syn in the gel 
generated bands comparable with that of the control ,  indicating that On ( 20 ) -Rg3 
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Figure 5 .2 .  lmmunoblot analysis showing the effect of ginsenosides on a-syn 
o l igomerization. a-Syn alone or in the presence of ginsenosides at ginsenoside: a­
syn molar ratios of 1 :  1 .  2 :  1 and 4: L was incubated for 5 days. Lane L 
ginsenoside: a-syn 1 :  1 .  lane 2 ,  ginsenoside: a-syn 2 :  L Iane 3 .  ginsenoside: a-syn 
4 : 1 ,  A: aged a-syn and M: fresh a-syn. A. Gn Rb I ,  B. Gn Rg l ,  C. Gn Rg3 . The 
amount of the monomeric a-syn in the samples was quant ified using ImageJ 
software. D. I mm unoblott ing for aged a-syn samples under denaturing and non­
denaturing conditions. 
5.3.3 The effect of ginsenosid es on a-syn-ind uced cytotoxicity 
B E( 2 )-M - 1 7  human neuroblastoma cel l s  were treated with aged a-syn 
sol utions at three d ifferent concentrations, 0.5 11M,  1 IlM and 5 11M,  either alone 
or in the presence of Gn Rb I ,  Gn Rg l and Gn Rg3 and the v iabi l ity of the cel l s  
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wa determined by TT a ay. Prior to the e. periment \vith a-syn and 
gm eno ide . \ve a se ed th effect of the gin enosides alone on cel l  viab i l i ty 
( Fig.  5 . 3  left panel ) ,  employing the same non-toxic ginsenoside concentrations 
that were later employed for the experiments with aged a-syn . 
show1  in  Fig.  5 . 3  A-C, aged a- yn inhibi ted the reduction of MTT in a 
do e-dependent fash ion. Gi  en that MTT reduction is direct ly proportional to the 
number of urviving cel l s, it becomes apparent that fewer cel ls survived at higher 
cone ntrat ion of aged a-syn ( Fig .  5 . 3  A-C). 
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Figure 5 . 3 .  The effect of the ginsenosides on the toXiC i ty induced by the 
aggregate of a- n. The viabi l i ty of B E( 2 )-M- 1 7  human cel l s  was evaluated by 
MTT assay. The results are expressed as percentages of the average of the contro l  
( I. e .  untreated cel l s) .  The cel l s  were treated with ei ther ex.-syn aged with or  without 
the A. Rb i .  B. Rg l ,  and C. Rg3 for 48 hours prior to the addit ion of MTT. The 
graphs appearing on the left panel i l lustrate the toxic i ty of the compounds alone 
( average of 3 wel l s  ± standard de iation). Stat ist ical analysi s was performed using 
a two-tai led unpaired t-test . * * * ,  p< 0.00 1 ;  * * .  p< 0.0 1 ;  *. p< 0 .05 .  D .  
I nllnUnOC)10chemistry against a-syn of  BE (2)-M- 1 7  cel l s. a. The cel l s  were either 
non-treated or treated for 48 hours with 5 f-lM of b. aged a-syn alone. or with 
ginsenoside c. Rb I .  d. Rg 1 ,  e. Rg3 . at a molar ratio of aged a-syn : compound 1 :4 .  
Scale bar 30  f-lm .  
However, the a-syn aged in  the presence of Gn  Rb  1 was less toxic to the 
cel l s. as indicated by the increase in MTT reduction (F igs. 5 . 3  A). I ndeed. at 5 
f-lM.  the aged a-syn resul ted in  a decrease in  the number of viable cel l s  by almost 
50%, whereas in the presence of a l l  concentrations of Gn Rb 1 ,  the viabi l i ty of the 
cel l s  increased by approximately  30%, with approximately 80% of the cel l s  
surviving ( Fig .  5 .3 A) .  A simi lar trend was observed in  the case of 1 f-lM aged a-
syn; in al l concentrations used. Gn Rb 1 improved the viabi l ty of the cel l s  treated 
with 1 f-lM aged a-syn by approximately  30 % ( Fig.  5 . 3  A) .  Gn Rg 1 and Gn 
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( 20 )-Rg3 . howe\'er. did not ho\\ any protective effect on neuroblastoma cel l  
again t the toxic i ty of aged a-syn ( Fig .  5 .3 B.  C). po ib ly due to their inab i l i ty to 
i nhibit  a- n fibri l lation ( Fig.  5 . 1 )  and o l igomerization (F ig .  5 .2) .  To confirm the 
toxic ity effi ct ob erved in  the MTT assay. BE(2)-M- 1 7  neurobla toma cel l were 
expo ed to 5 JlM a-syn aged in the presence or absence of the ginsenoc ide at a 
molar rat io of 1 :4 (a-syn:  Gn) and subjected to i mmunostaining for a-syn. 
F luorescence microscopy revealed that, whereas untreated cel l s  were healthy and 
displa ed diffu e cytoplasmic a- n tain ing ( Fig .  5 . 3  D a). the cel l s  treated with 
aged a- yn 10 t their neuronal shape. appearing rounded and unhealthy, with 
aggregated fibri l accumulating at the cel l membranes ( Fig.  5.3 D b) .  This  effect 
v,as dramatical l y  reversed when the cel l s  were treated with a-syn aged in the 
pre ence of Gn Rb 1 ,  with no apparent aggregates detected on the cel l  membranes 
( Fig .  5 . 3  D c) . I n  contrast. the cel l s  treated with the a-syn aged in the presence of 
Rg l and Rg3 . which were shown above not to i nhib i t  a-s n aggregation. appeared 
rounded, unhealthy and bearing extrace l lul ar, membrane-bound aggregates ( Fig .  
5 .3  D d. e) .  
5.3A The effect of Gn RbI on prefo rm ed a-syn a my loid fibrils 
Due to i ts  h igh efficiency in  i nh ibit ing a-syn fibri l lation, Gn Rb I was also 
assessed for its effectiveness i n  reversing fibri l lation. Hence, 25 11M of preformed 
a-syn fibri l s  were incubated at 3 7°C in the presence of Gn Rb I at molar ratios 
representing Gn Rb I :  a-syn of 6: I ,  4: 1 and 2: 1 for a period of 48 hours. By 
measuring the Th-T fluorescence counts, the fibri l content was estimated at 
d ifferent i ntervals. Even at t ime O. the Th-T counts for a-syn incubated alone 
were much h igher compared to the Th-T counts of the samples containing Gn 
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Rb 1 .  e pec ial ly  the one with the highest concentration of that part icular 
gin eno ide ( Fig.  5 .4  A) .  During the course of the experiment the a- yn fibri l s  
that \\ ere incubated in  the absence o f  G n  Rb I continued to aggregate further. as 
indicated by the i ncrease in Th-T counts ( Fig.  5 .4 A), whereas the fibri l s  
incubated in  the pre ence of the ginsenoside disaggregated in a dose-dependent 
fa h ion, given the decrease in Th-T counts ( Fig.  5 .4 A) .  This  trend was apparent 
after 4 hours of incubation, with the Th-T counts for the Gn Rb I containing 
ample with approximately 1 15 of the Th-T counts of the control 
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F igure 5 .4 .  The effect of Gn Rb I on prefonned a-syn fibri l s  and on the seeded 
polymerization of a-syn. A. Samples of aggregated a-syn were incubated for 48 
hours at  3 7°e i n  the absence or  presence of various concentrations of Gn Rb 1 (Gn 
Rb l :  a-syn at 6 : 1 ,  4 :  L and 2 : 1 ) . The fibri l  content was then measured by the Th-T 
binding assay. The assay was perfonned in t rip l icate ( average of trip l icate 
measurements ± standard deviations) . B. E lectron microscopy images of 
negatively stained samples of the pre-aggregated a-syn incubated alone or in  the 
presence of Gn Rb I ( 1 :4 )  for 0 and 48 hours with continuous shaking at 37°C. 
Scale bar, 500 nm. C.  Samples of a-syn monomers ( 1 00 �M) were seeded with 2 
�M sonicated a-syn fibri l s, which were incubated i n  the presence or absence of 
Gn Rb I at d ifferent concentrations ( 1 0  and 50 �M) for 6 hours with cont inuous 
shaking at 3 7°C . The extent of fibri l l ation was estimated by the Th-T binding 
assay. The assay was perfom1ed in  tripl icate ( average of trip l icate measurements ± 
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tandard deviations) .  D .  E lectron micro copy image of negat ively tained 
ample of the a- yn seed alone and of the seeded a-syn incubated in the ab ence 
or pre ence of Gn Rb 1 ( 50 11M )  for 6 hour with continuous haking at 37°C. 
. cafe bar. 1 .000 nm. 
5.3.5 Gn Rb I i n h i bit ion of a- yn fibri l lat ion i mediated ia b inding to the 
in termediate pecie and fo rmation of table ol igomers. 
The trong inhibitory effect that Gn Rb 1 sho ed on fibri l lation. prompted 
u to inve t igate further the interaction of Gn Rb 1 with a-syn o l igomers. For this 
purpo e. monomeric a-s)'n ( 1 00 11M )  wa aggregated in  the presence of Gn Rb 1 
(Gn Rb I :  a-syn molar ratio 4 : 1 ) . After 5 da s of incubation. the san1ples were 
centrifug d and the supernatant was injected in  a superdex 200 SE  column.  The 
e lution volume for monomeric a-syn was determined by molecular weight 
tandards. and was e luted in  a peak corresponding to column volume of 1 4- 1 6  mL 
whi le o l igomeric a-syn e luted i n  a peak corresponding to  a column vol ume of  
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F igure 5 . 5 .  Gn Rb I b inds to a-syn o l igomers (Gn Rb i :  a-syn molar ratio of 4 : 1 ) . 
A .  Gel fi l tration profile of the 5-day aggregated a-syn in  the presence of Gn Rb I 
at a (Gn Rb I :  a-syn)  molar ratio 4 : 1 (a-syn concentration = 1 00 11M )  using a 
superdex 200 SE  column. P I  and P2 samples contain the isolated fractions 
corresponding to the o l igomeric peak and P3 the isolated fractions corresponding 
to the monomeric peak. The elution was monitored at the absorbance wavelength 
of 2 1 5  nm . i rnmunoblot analysis of the samples P I  P2 and P3 separated by 
electrophoresis i n  a 1 5% SDS-PAGE gel .  B. E lectron microscopy images of 
negatively stained samples P I ,  P2 and P3 of a-syn in the presence of Gn Rb I 
( molar ratio of Gn Rb i :  a-syn 4 : 1 )  purified by S EC . Scale bar, 500 run .  C. uv 
absorbance spectra of Gn Rb 1 alone. The UV absorbance was recorded between 
200-600 nm employing a 1 0  mm quartz cuvette. D. UV absorbance spectra P I ,  P2 
and P3 . The UV absorbance was recorded between 200-600 nm employing a 1 0  
mm quartz cuvette. 
The fractions corresponding to the o l igomeric and monomeric a-syn peaks 
were pooled together giving rise to P I ,  P2 and P3 samples (F ig. 5 . 5  A) ,  which 
were concentrated using a speed vac. The a-syn species in  the samples were 
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characterized b) we tern blott ing and EM ( Fig .  5 . 5  . B ) . I n  agreement with the 
imunoblott ing resul ts ( Fig.  5 . 5  ) .  eJectron micro copy of  the samples indicated 
the pre ence of di fferent pecie of o l igomer in P I  and P2 ( Fig.  5 . 5  B) .  I n  order 
to detect the incorporated Gn Rb 1 in the P l .  P2 and P3 amples. we exploi ted the 
property of Gn Rb 1 to produce UV absorbance spectra with three notable  peaks 
( Fig.  5 . 5  ) .  
To furth r evaluate whether Gn Rb I interacts with u-s  n monomers. we 
monitored a t i tration of Gn Rb I i nto a solution of monomeric u-s n using two-
dimensional MR spectroscopy. which pro ides signal s covering the entire amino 
acid equence of u-s n ( Fig.  5 .6) .  At stoichiometries of up to 6 :  I Gn Rb I :  u-syn, 
\'v e ob en'ed no ignificant chemical shi ft  or resonance i ntensity changes ( Fig .  5 . 7  
A-D). confi nning that Gn Rb I ,  does not interact significant ly with monomeric u -
syn .  T"l�lnX'fl""lfWl II ' II� 'f'(\.U'II I>4 ' latoo:W ill \ n  � YI1  !I\tl.ru Gn Rhl 
90 8 5  80 7 5  70 65 6 0  
1 1 0  1 1 0  
·1' 
81", . 0  ,, \I G  .. Rtol 
:- 120 '20 
.25 '25 
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Figure 5 .6. Analysis of Gn Rb I binding to monomeric u-syn by MR 
spectroscopy, Proton-Nitrogen correlation ( H SQC) spectra of monomeric u-syn i n  
the presence of i ncreasing ratios of  Gn Rb I :  u-syn demonstrating that there are no  
sign ificant changes i n  the positions of  the N M R  resonances. indicat ing the lack of 
an i nteraction between Gn Rb I and monomeric u-syn. Protein concentration:  200 
J-lM .  
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F igure 5 . 7 . Peak intensity ratio plot of 200 �M 1 5N-labeled wt a-syn F L+ Gn Rb I 
(Gn Rbl : a-syn 1 : 1 , 2 : 1 .  4 : 1 and 6 : 1 ) .  From the HSQC spectra and the intensity 
plot. there m ight be no interaction between a-syn monomer and Gn Rb I .  A .  al l ;  B .  
1 : 1 10 : 1 and 0 : 1 /0 : 1 :  C .  2 : 1 /0 : 1 and 0 : 1 /0 : 1 ;  D.  4 : 1 /0 : 1 and 0 : 1 10 : 1 ;  E .  6 : 1 /0 : 1 and 
0 : 1 10 : 1 .  
5.4 D iscuss ion 
PD i s  a progressive neurodegenerative d isorder, the  incidence of which i s  
expected to  rise sharp ly  worldwide by 2030, with PD cases doubl ing by that t ime 
(Dorsey et al . ,  2007). Ex ist ing treatments for PD cannot cure the d isease and can 
onl offer moderate symptom rel ief, which is  moreover accompanied by adverse 
side effects. Hence, there is a definite and imperative need for the development of 
new and more efficient treatments. A l though PD pathology is considered to be 
induced by various etiological factors ( reviewed by ( Di Monte, 2003 ) ,  there i s  
ample evidence indicating that a-syn m isfolding and aggregation play a central 
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role in the pathogene is of PD and related di orders ( Baba, et a\ . ,  1 998:  
pi l lant in i ,  Cro\\1her, lake , Hasega\\ a, & Goedel1, 1 998: pi l lant ini ,  e t  aL 
1 997 . As a result, there i an ong ing end em or to ident ify or design molecules 
that can uppre s or even reverse a- yn aggregat ion ( reviewed by ( Findeis, 2000). 
In eng and i ts biological ly active components, the gin enosides, have been 
sho\\ n to ha\ e a benefic ia l  effect on neurological condi tions such as PD due to 
their neuropr tective propert ie ( Cho, 20 1 2 ; H .  l. Kim,  et a I . ,  20 1 3 ), but their  
potential a anti-amyloidogenic agents have never been assessed. This gap in  
knowledge prompted us to investigate the effect of the most frequent ly used 
gin enosides, namely Rb I ,  Rg l and Rg3 , on the f01l11ation of the early aggregates 
( o luble o l igomers)  and late aggregates ( fibri ls) of a-syn. For this purpose we 
employed an array of biophysical ,  biochemical and cel l -culhlred based 
teclu1 ique . 
Among the ginsenosides screened, ginsenoside Rb 1 was shown to be the 
only potent inh ibi tor of a-syn fibri l l ation that adequately  blocked a-syn-induced 
toxicity; it disaggregated prefonned a-syn fibri l s  and inhibi ted the seeded 
aggregation of a-syn. More pec ifical ly,  our results show for the fi rst t ime that Gn 
Rb 1 can d isrupt the fibri l lation of a-syn in  t itro ( Fig.  5 . 1 A, B)  al lowing only the 
fOnTIat ion of smal l ,  sheared, rod- l ike spec ies that are easi l y  d igested by PK (F ig. 
S . !  C)  and fai l  to e longate even after an extended aggregation period ( Fig.  5 . 1 D) .  
The accumulation of a-syn monomers was first detected by i mmunoblott ing and 
densi tometric analysis of the monomeric bands ( F ig.  S .2  A) and was further 
confinned by SEC ( Fig.  5 . 5  A) .  Furthem10re, Gn Rb 1 could satisfactori l y  curb the 
neurotoxic effect that was provoked by the aged a-syn, demonstrat ing a marked 
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incr a e in cel l survival and exhibit ing a neuroprotective effect on neuroblastoma 
cel l s  ( Fig. 5 . 3  A and D) .  Gn Rb i also disaggregated preformed a-syn fibri l s  
( Fig.  5 .4  and B)  and inh ibited the seeded aggregat ion of a-syn 1 11 a 
concentrat ion-dependent manner ( Fig. 5 .4 C and D), 
These re ult are i n  accordance with pre ious reports that described On Rb I as a 
neurotrophic and ant i- inflammatory agent. On Rb I has been pre iously shown to 
exert cel l protecti e effect against the toxic i ty induced by A i342 (Qian, Han, Hu . 
& hi ,  2009) and A(325-35 (X .  Xie  et aI . ,  20 1 0) .  I n  animal models, On Rb I was 
demonstrated to have anti - in fl ammatory activ i ty ( Wang et a1 . ,  20 1 1 )  and to reduce 
o luble Ai340 in a do e-dependent fashion ( Shi et a i . ,  20 1 0) .  Interestingly, Gn Rb 1 
\ a hown to attenuate the A(32s-3s- induced hyperphosphorylation of tau protein  in 
vilro ( Y. H .  Xie et a I . ,  2007) and A(325-35- induced memory impaimlent axonal 
atrophy and s naptic loss in vivo (Tohda, Matsumoto, Zou, Meselhy, & Komatsu, 
2004). 
In terms of structure, Gn Rb l is a tliterpene saponm, containing a four-ring 
steroidal structure that bears an a l iphat ic s ide chain and two disaccharide moieties 
attached to C-3 and C-20 of the tri terpene structure ( Scheme 5 . 1 ) . S ince one of the 
d isaccharides of Rb I is  attached to the 3 -position of the danunarane-type 
t ri terp ine, Gn Rb 1 is  a protopanaxadiol- type of gindenoside, l i ke Gn (20S)-Rg3 . 
By  comparing the structure of Gn Rb 1 with that of Gn (20S)-Rg3 that partial ly 
i nhibited fibri l lation but fai led to inh ibit  a-syn o l igomerisation and toxic i ty 
(Scheme 5 . 1 ), it becomes apparent that the d ifference between the two 
ginsenosides l ies i n  the presence of two addit ional sugar rings in Gn Rb 1 at C-20 
of the tri terpene. As a consequence, Gn Rb 1 possesses overal l  four sugar rings 
that are c lustered i n  the form of disaccharides i n  each side of the dammarane-type 
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tri terpene. thus confernng a more symmetrical tmcture to Gn Rb 1 a compared 
to Gn (20 )-Rg3 . v, hich ha nly a di accharide group attached to C-3 of the 
tri terpcne. I though tructural symmetry is not a prerequi ite for the inhibi t ion of 
am) loid aggregat ion, there are man natura l ly  occurring compounds who e 
tructural ymmetry renders them potent anti -aggregat ing agent in vitro 
(Caruana. et aL 20 1 1 :  Porat, et a l . .  2006) .  
Furthermore. i t  i wel l  und rstood that the specific action of each 
gin eno ide may depend on the type of sugar components, their number and their 
po ition on the aglycone (Z. Q .  Liu et al . .  2003 ;  ag, e t  a 1 . ,  20 1 2 ; Popovich & 
Kitt , 2002; Qi ,  Wang, & Yuan, 20 1 0; Sun, Yang, & Ye, 2006) .  I t  is therefore 
l i k  I) that the number of sugar moieties may also play an impoliant role in the 
ant i-am) Ioidogenic properties of the ginsenosides. Gn Rb 1 that was shown to be 
the most potent inhibitor possesses four sugar rings, whi le Gn (20S)-Rg3, which 
part ia l !  i nh ibi ted a-syn fibril lation but fai led to exbibi t  any i nh ibi tor effect in  
the  re  t of the  assays, and possesses two sugar moieties. Aliliough both Gn (20S)­
Rg3 and Gn Rg l (whicb fai led to inhibi t  fibri l l ation and st imulated the 
o l igomerisation of a-syn) contain two sugar rings, there is a major d ifference 
ben.veen the n.vo ginsenosides. Gn (20)-Rg3 belongs to the protopanaxadiol group 
of gindenosides, whereas Gn Rg l belongs to the protopanaxatriol group, which is 
characterized by the presence of an O H  or a sugar group at C-6 of the triterpene. 
Gn Rg i bears a sugar moiety at C-6 ( Scheme 5 . 1 ) . I t  has been reported before that 
the sugar l inkage at C-6 i s  associated with a decreased ginsenoside anticancer 
act iv i ty compared to the l inkages at C-3 or C-20 (R .  1. Chen, Chung, L i ,  Lin,  & 
Tzen. 2009). A lso, the sugar l inkage at C-6 has been shown to confer an 
antioxidant qual i ty to the ginsenosides (Z.  Q. Liu et aI . ,  2003 ) .  There is hence the 
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p sibi l ity that the -6 l inkage al 0 renders the gin enoside poor anti ­
amyloidog nic agents. Ba ed on our findings using both 1R and EC combined 
\\ ith U spectroscop) , Gn Rb 1 inhibi ts (1- yn fi bri l lation not by interact ing with 
the monomeric (1-S) n and pre\ enting it from fibri l l ation, but rather by stabi l izing 
the tructure of oluble o l igomeric (1-S n without any �-sheet content ( Fig.  5.2 A 
and 5 . 5  A). \\ hich appears to be non-toxic ( Fig.  5 . 3  A and D) .  mce some 
interactions between (1- yn and binding partners are not revealed in chemical shi ft 
changes, we al 0 analyzed for changes to resonance intensi ties, which can 
ometimes reveal interactions that are otherwise missed . In this case, neither 
chemical sh i ft nor inten ities changed. evertheless, i t  remain possible that a 
\ ery weak interaction occurs that is missed by both measures, as indeed was the 
ca e in the analysi of Hsp70 binding by Dedmon et a1 .  (Dedmon, Christodoulou, 
Wi l son, & Dobson, 2005 ). The M R  data suggests that i f  any interaction i s  
present \vith monomeric a-syn, i t  is  a very weak and transient one. When 
combined with the SIze exclusion data, we conclude that the *predominant* 
interaction of Rb 1 is  with ol igomeric a-syn rather than with the monomeric 
protein .  These findings are 1 11 accordance with previous studies indicating that 
ome polyphenol ic  compounds, such as baicalein, curcumin and epigal locatechin 
gal late i nduce the formation of sol uble, non-toxic ol igomers of a-syn or A� 
( Porat et aL 2006).  
Amyloid fibri l s  formed by aged a-syn are r ich in  � -sheet content and binding of 
these aggregates to the cel l  membrane results in  membrane permeabi l ization and a 
resultant al terat ion in  calcium homeostasis, which can cause cytotoxicity (E l ­
Agnaf, Jakes, Curran, M iddleton, e t  a1 . ,  1 998;  Pieri, Madiona, Bousset, & Melki ,  
20 1 2 ; Reynolds et  a1. , 20 1 1 ) . I ndeed, the fluorescence pattern of a-syn aggregates 
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that we ob erved in cultured BE(2 )-M- 1 7  cel l s  expo ed to aggregated a-syn alone 
is sugge ti\ e of the local ization of the e agh'T gate to the pia rna membrane, 
\\. hi le  the cel l lost their characteristic neuronal hape as they appeared rounded 
and unhealthy. Treatment of the cel l s  with a-syn aged in the presence of Gn Rb L 
\,."hich did not resu lt in u- yn fibri l lati n, appeared health without the 
accumulation of a- yn at the cel l membranes, whereas exposure to a-syn aged in 
the presence of Rg I or Rg3 , which \ ere poor inhibitors of a-syn fibri l l ation, led 
to the format ion of membrane-bOlmd aggregates, and the cells appeared unhealthy 
and r lll1ded. This observat ion is in  accordance with the results obtained from the 
M TT a say, wherein cel l s  treated \vi th aged a-syn alone or in the presence of Rg l 
or Rg displayed cytotox ic i ty. \vhich was not observed when the cel l s  were 
expo ed to a-syn aged in the presence of Rb 1 .  S ince Rb 1 was found to i nh ibi t  a­
syn fibri l l ation and stab i l ize soluble, non-toxic o l igomers without a �-sheet 
content ( Fig .  5 . 1 ), we hypothesize that the neuroprotecti e role of Rb I stems from 
its abi l ity to inhibit the formation of mature amyloid fibri l s  conta in ing �-sheet 
structures and thereby prevent plasma membrane di rupt ion in neuroblastoma 
cel l s .  Ho\ ever, we cannot exclude the possibi l ity that the anti -oxidant propert ies 
( Y .  H .  X ie, et a I . ,  2007) and the anti - inflammatory act ivity ( Wang, et a I . ,  20 1 1 )  of 
Gn Rb I may also contribute to its neuroprotective effect. I nterestingly, Gn R b I  
has previously been shown t o  be a much more potent ant i -oxidant than Rg l ,  whi le 
Rg3 was shown to promote the free radical - induced heamolysis in  human red 
b lood cel l s  (Z.  Q .  Liu,  et a I . ,  2003) .  
In  concl usion, from the three tested ginsenosides, Rb I was shown for the first 
t ime to inhibi t  a-syn fibri l lation and toxic i ty in vitro and to be able to di saggregate 
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pre[onned fibri l s  and block the a- ) n  seeded polymerization possibly by bind ing 
and stabi l i zing non-tox ic a- ) n o l igomer \vi thout �- heet ontent . The next tep 
is  to as c s i t  effect n PO animal models .  Gn Rb I could thus repre ent the 
tart ing point [or design ing new molecules that in tum could be used as new drugs 
for the treatment of PO and related disorder . 
6 C ha pte r 6 :  alvianolic acid b and Di h yd ro m y ricetin, 
i n hi bit t he fo r mation and to xicity of ea rly and late 
a l p ha-syn u clein agg regates. 
6. 1 I n t rod u c t i o n  
Drug unent ly  available for the treatment of PD provide symptomatic 
treatment but do not alter the cour e of the d isease ( He, et a J . ,  20 1 3 ) . Ho\ ever, the 
effecti \ ene s of these drugs d iminishes after several ears of treatment . Together 
with the increasing incidence of PD due to an aging population, these facts indicate 
the compel l ing need for more effective drugs and treatment for PD. Modem 
therapeut ic option that target di sease modi fication are on the rise. Hov ever, the 
mult ip le mechanisms involved in the pathogenesis of PD create considerable  
d ifficulty in producing effect ive treatments. Hence, the inhibi t ion of a-syn 
aggregation may represent a viable strategy for therapeutic intervention in PD and 
rel ated d isorders. I t  is  therefore essential to ident i fy compounds that can serve as 
potent inh ib i tors and intenupt the early stages of aggregation. 
Chinese medic inal compounds (CMCs) extracted from med icinal herbs and 
plant have been used for the treatment of a wide range of diseases for over a 
m i l lennium . I ndeed, trad i t ional Chi nese medicine has employed various CMCs as 
remedies for d isorders, inc luding dementia ( He, et a l . .  20 1 3 ) and neurodegenerative 
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disorder ( Kum et a I . ,  20 1 1 ), cardiovascular di eases ( Ce) lan-I ik .  F l iethman. Wold, 
& Ren. 2008)  and e\ en cancer ( reviewed b) ( . Li et a! . .  20 1 3 ) . s a consequence. 
trad it ional 'hinese med icine i consid red a good resource for the treatment of 
several di ease , inc luding PD. In fact. a lot of eff0I1 ha been invested into 
unrave l ing the molecular basi of everal CMC employed in tradit ional Chinese 
medicine .  Baicalein, the main component of the traditional Chinese herbal medicine 
Sell/ellaria haicaien is, ha been reported to inhibi t  the fibri l lation of \ i ld-type (Zhu, 
et a 1 . .  2004) and E46K a- n ( J iang et a J . .  20 ] 0) and to di saggregate prefOImed 
fibri l il1 vitro (Zhu. et a ! . ,  2004) .  Baicalein was also sho"m to a l leviate the toxic i ty 
induced by E46K a- yn in a PD ce I J  model ( J iang, et a1 . ,  20 1 0) .  Additional ly, 
curcumin, the main component of the trad it ional Chinese herbal medicine turmeric ,  
i solated from the roots of Curcuma longa. has been shown to inhibi t  the aggregation 
and tox ic i ty of �-an1J loid peptide ( F . Yang, et a1 . ,  2005 ) .  
The a im of this study was to assess the effects of a small l ibrary of CMCs on 
the o l igomerization, fi bri l lation and toxic i ty of a.-syn to ident i fY  potential inh ibitors 
of a- yn aggregation. E leven CMCs, which were extracted from Chinese herbal 
medicines ( CHMs) i nc lud ing ginseng, gardenia, gink go bi loba, Japanese raisin tree, 
Japanese arrowroot, peony, l i corice, and danshen , were systematical l y  tested using 
b iophysical , biochemical and cel l -culture techniques. 
e found that among the 1 1  CMCs, salvianol ic  ac id B (CMC l )  significant ly 
inhibi ted a-syn o l igomerization and fibril fOlmation and protected against a-syn­
induced toxic i ty,  whi le  d ihydromyricet in ( CMC7), was shown to inhibi t  a-syn 
o l igomerization and fibri l l at ion, but exhibited only mi ld  neuroprotective activity. 
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6.2 E x peri m e n ta l  p roced u re 
6.2 . 1  E x pre i o n  a n d  p u rificat ion o f  reco m b i n a n t  h u m a n  0.- y n  
A s  described i n  the exp rimentaJ procedure 3 .2 . ] 
6.2.2 ((- . n p u rificat ion and characteriza t ion 
s de ribed in the experimental procedure 3 .2 .2 
6.2 .3 Aggregat ion  of (l- y n  ill vitro. 
As de cribed in the experimental procedure 3 .2 . 3  
6.2A T h iotlav in-T (Th-T )  assay 
(1- yn fibri l format ion was monitored by Th-T binding assay. Th-T is a 
fluore cent dye that interacts with fibri l s  containing a �-sheet structure . A total of 1 0  
III of each sample \ as d i luted in 40 II I of Th-T in PBS .  Fluorescence was then 
measured in a 3 84-we l l ,  untreated black micro-wel l plate (Nunc, Denmark) u ing a 
microplate read r ( V ictor X3 2030 Perkin E lmer) with the exci tation and emission 
wavelengths set at 450 and 486 nm, respectively.  To al low for background 
fluorescence, the fluorescence intensity of a blank PBS solution was subtracted from 
all readings. 
6.2 .5 Tran m ission e lec t ro n  m i c roscopy ( T E M )  
A s  described in  the experimental procedure 3 .2 .8  
6.2 .6  I m m u noblot t ing  
s de cribed in  the experimental procedure 4 .2 .6  
6.2 .7  Congo red  b i n d ing  assay 
As described in the experimental procedure 4 .2 . 1 0  
6.2.8 T i  u e  c u l t u re of B E ( 2 )-M - 1 7  h u m a n  n e u roblastoma cel ls  
As described the experimental procedure 3 .2 . 1 0  
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6.2.9 M ea u rement  of cel l  v iab i l ity 
de cribed in the e perimental procedure 3 .2 . 1 3  
6.2 . 1 0  'eed ing  poly m e rizat ion a a 
As d s ribed in the experimental pr cedure 5 .2 . 1 3  
6.2. 1 1 0.- y n  d i  aggregat ion as ay 
s describ d in the e, perimental procedme 5 .2 . 1 2  
6.2 . 1 2  S ize Exclus ion C h ro m a tograp hy (SEC) for separa t i n g  a-sy n ol igom e rs 
a n d  m o n o m e rs 
s described in the experimental procedme 5 .2 . 1 4  
6.2. 1 3  UV sca n n ing.  
s described in the e perimental procedme 5.2 .  J 5 
6.3 Res u l ts 
6.3. 1 T h e  effect of  sa lv ianol ic  ac id B and d ihydromy riceti n  o n  a-syn 
fib ri lla t ion  
a- yn sol ut ion a t  a concentration of 25  1 1M was incubated at  3 7°C with 
continuous shaking for 5 days, leading to fibri l formation, which was monitored by 
Th-T fl uorescence at regular t ime intervals. a-Syn was incubated with each of the 
eleven CMCs ( see Table.  6 . 1 and Scheme 6. 1 )  at molar ratios of 4 : 1 , 2 : 1  and 1 : 1  
( molar ratio  CMC:  a-syn) with a constant a-syn concentrat ion of25  11M .  
147 
HO n H�  
'10') H l OCH, 
Loo 0 H6� 
OH 
cheme 6 . 1 :  Chemical tructure for the tested compounds. Sal ianol ic ac id B, 
Ammonium Glycynhizinate, Puerarin, inomenine, Paenoflorin, Gamma-
chi andrin, Dihydr myricetin, MagnoloL Honok io l ,  Geniposide, B i lobal ide. 
Table 6 . 1 .  The smal l  compounds from Chinese herbal medic ines and their effect on 
fibri l formation. o l igomerization and toxici ty 
I D  ame 





CMC4 S inomenine 
CMC5 Paenoflorin 
CMC6 Gamma-Schisandrin 
CMC7 Dih ydrom yricet in 
CMC8 Magnolol  
CMC9 Honokiol 
CMC I O  Geniposide 
CMC I I B i lobal ide 
I nh i bi t ion 
of fibri l 
b . I omlat IOn 
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of ol igomer 
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of fibri l 
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Inhl billon of (H.> n fibril fomlatloll \\as tested by Th·T assay as descnbed In the materials and methods Inhlbil lon of u-syll 
3 
ol igomer lomlauon v. as tested b) Immullobiottlllg as deSCribed in the matenals and methods InlllblllOn of u-syll fibril to. iClty 
tO\\ ard M ·  I 7 - neuroblastoma cell was tested by MTT assay as descnbed III the matenals and methods (+ + +. very potent; + 
+. potent. +. moderate. -. 110 effect ). 
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T\\ o compounds, a lyianol ic acid B ( C 1 ) and dih) drom)Ticeti n  (C 1C7) .  
inhibi ted a- ) n  fibri l lation a indicated by reduced Th-T fluore cence ( Fig. 6. 1 ) . 
More spec i fical ly ,  at concentration of 1 00 and 50 �M, CMC I exhibited a complete 
inhibi tor) effect, which \ as prominent on the third day of incubation. After 5 day of 
incubati n, CMC 1 at 1 00 �M complete ly abol i shed the fibri l lation of a- yn. whi le  at 
50 �M:  it i nhibited fibri l lation b almo t 80%. At a lower concentration ( i .e . . 25 
�M). CMC ] also i nduced the inhibi tion of a-syn fibril lation, the percentage of \ hich 
wa reduced by approximately  35% after 5 day of incubation ( Fig .  6. 1 ) . These 
re ults indicate that CMC 1 i nh ibi ted the formation of fibri l s  in a concentration-
dependent manner. CMC7 wa observed as a good inhibitor of fibri l lation, al though 
it i nhib i tory effect \-vas not comparable  wi th of CMC 1 . Indeed, after 5 days of 
incubation. CMC 1 0  inhibited a-syn fibri l l ation by 80 and 40% at 1 00 and 50 �M, 





m C'KI (1·s�n (4 1 )  
o C\1C I a·"n (1 1 )  
I:J C\KI ,,.,,n ( I  I I  
ID aged a ·5� n 
m (\KIO a-"n (4 1 ) 
t::I (MelO a-'�n (1 1 )  
I!lJ ('KIO "-S�ll ( I I)  






m (\.(O a·'�n (4 I )  
c:::J C\1('7 "','n 1 2 1)  
I!lJ (\1C7 (1-"n ( I I)  
Em aged a-s�" 
m (Mel I (1·"n (4 I) 
c;J (Me l l  a-,,,, (2 1)  
IIID CMC I I  o-"n (I  I )  
BI!I a.ged 0-5\ n 
F igure 6. 1 .  Th-T assay for CMCs. CMCs i nhib i t  a-syn fibri l lat ion in  a concentration­
dependent fashion. Samples of a-syn (25 �M) were incubated for 5 days at 3 7°C 
with continuous shaking in the presence of various concentrations of CMCs ( 1 00. 50 
and 25 �M) Salvianol ic  acid  B (CMC l), Dihydromyricetin  (CMC7) ,  Geniposide 
(CMC I O) and B i lobal ide (CMC 1 1 ) . F ibli l formation was then measured by Th-T 
binding assay. The assays were perfom1ed in tr ipl icate, and the means ± standard 
deviations are shown. 
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I n  contra 1. the compounds ammonium glycyrrhiz.inate (CMC2). puerann 
( M 3 ). inomenine ( MC4). paeoniflorin (CMC5). gamma- chi andrin (CMC6). 
magnolol ( MC8). honokiol ( MC9).and bi lobalide (CMC 1 1 ) had no significant 
effect on 0.- yn fibril lation becau e Th-T measurements indicated that the a-syn fibri l 
formation wa comparable to that for the control a-syn solution aged alone. ( see 
Table 6. 1 ) . Geniposide (CMC 1 0) had a l ight t imulat ing effect on fibri l l ation with 
increased Th-T mea urement ( Fig.  6. 1 ) . 
The abi l i ty of MC ] and CMC7 to block a-s n fibri l fOlTI1ation was further 
explored u ing the Congo red ( C R) binding assay. CR is a dye with h igh affinity for 
amy loid fibri l s  (Groenni ng. 20 1 0) .  Upon binding to cx-syn fibri ls, the absorption 
maximum of CR shifts from 490 to 508 nm, and thi s  shift is quite pronounced for 0.­
syn amples incubated in the absence of CMCs (F ig . 6.2). However, this 
characteristic shift was not observed for cx-s n samples aged in the presence of 
CMC I or CMC7. indicating that these compounds inh i bited the formation of 
amyloid fibri l s  (F ig. 6 .2) ,  comparing with CMC I 0 and CMC l l which did not i nh ibi t  
the fibri l  formation (F ig .  6 .2 ) .  I ndeed, the  absorption maximum of CR bound to  the 
cx-syn amples containing CMC I and CMC7 (at a l l  tested concentrations) only 
shifted a few nm and did not exceed the wavelength of 495 lID1 (Fig.  6.2) .  
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F igure 6_2_ Congo red binding assay assay for CMCs. Congo red binding for CMCs. 
a-Syn solution sam ples (5 ).lM )  either aged alone or with d ifferent molar ratios of 
CMCs \vere mixed with a final concentration of 5 ).lM Congo red. The UV 
absorbance spectrum was recorded from 400 to 600 run i n  a spectrophotometer 
Then the a-syn fom1ed aggregates were tested to see if they were resi stant to 
PK digestion. samples of a-syn aggregated alone or in the presence of CMC l ,  
CMC7, CMC I O  and CMC l l at molar ratio of 1 : 1  were treated with 2 .5  Ilg/ml PK;  
the digested samples were then run on  1 5% SDS-PAGE and the gel was s i lver 
stained. The a-syn aged in the presence of CMC I  and CMC7 was easi ly digested by 
PK and behaved exactly as monomeric a-syn ( Fig .  6 . 3 ) ,  whi le the samples of aged a-
syn alone or in  the presence of CMC l O  and CMC l l were resi stant to digestion (F ig .  
6 .3)  possibly due to the presence of �-sheets in  these samples ( Fig .  6. 1 and 6 .2) . 
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Figure 6 . 3 .  Proteinase K digest ion assay. S i l  er staining for 1 5% SDS gel of a-syn 
monomer . a- )'n aged alone or in the presence of CMC l ,  CMC7, CMC I 0  and 
CMC 1 ]  at molar ratio 1 :  1 after 2 . 5  ).lg/ml PK digestion. 
These findings \vere further confirmed by electron microscopy. TEM images 
of a-syn aged in the presence of CMC 1 and CMC 1 0  showed that a-syn formed thin, 
short rod- l ike fibri ls. with a fragmented appearance ( Fig.  6 .4) .  which was unl ike the 
dense meshes of long fibri l s  formed by a-syn aged alone (F ig. 6.4) .  For the rest of 
the compounds. TEM i mages confirmed that there were few or no changes in  fibri l 
morphology compared with the controL which i s  consistent with the Th-T 
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Figure 6-4 .  E lectron microscopy images for CMCs. Electron microscopy 
images of negatively stained samples of a-syn (25  11M )  aged alone or in the 
presence of CMCs (CMC:  a-syn molar ratios of 4 : 1 , 2 : 1 ,  and 1 : 1 )  for 5 days 
with continuous shaki ng at 37°C. Scale bar, 500 nm .  
6.3.2 The effect of salvia nol ic  acid B a n d  d ihyd romy ricetin o n  a-syn 
o l igomerization 
The effect of the compounds on a-syn o l igomerization was also assessed by 
immunoblot analysis .  The same fresh and aged solutions of a-syn alone or with 
CMCs were analyzed, and the majority of freshly prepared a-syn m igrated as a band 
at - 1 6  KDa, corresponding to a-syn monomers ( Figs. 6.5 A-D) .  CMC I and CMC I 0, 
which were shown to i nhib i t  a-syn fibri l lation, were also observed as potent 
inh ib i tors of a-syn o l igomerization. In fact s imi lar to their effect on a-syn 
fibri l lat ion, CMC I and CMC7 i nh ibited a-syn ol igomerization in a dose-dependent 
fashion ( Fi gs .  6 .5  A and B). 
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ore peci fical ly .  CMC I inhibited the formation of larger aggregate ( M W  
>250 kDa) and high M W  ol igomers band corre ponding to monomeric and dimeric 
a- yn were the mo t prominent pecies. and a band corre ponding to trimeric a-syn 
was faint ( Fig.  6.5 A) .  With decrea ing CMC I concentration, the dimeric. trimeric 
and o l igomeric bands v" ere increa ingly stronger, indicating that CMC 1 inhibi ted 00-
yn o l igomerization in a do e-dependent fa h ion ( Fig. 6.5 A). It should be noted that 
even at the lov,;e t concentration. CMC 1 sti l l  induced the inhibit ion of larger 
aggregate . CMC7 al 0 suppre sed the formation of o l igomeric forms in a 
concentration-dependent manner; the h ighest concentration was the most potent of 
the three concentrations tested ( Fig.  6 .5 B ) .  At the highest concentration of CMC7. 
Oo-syn produced faint d imeric and trimeric bands ( Fig.  6 .5  B) .  However. these bands 
were progressively stronger with decreasing CMC7 concentration, consistent with 
do e-dependent inhibit ion ( Fig .  6.5 B ) .  
The rest of the compounds te  ted had an  effect on  Oo-syn ol igomerizat ion 
analogous to their effect on fibri l lation. These compounds ei ther had no effect on u­
s. n o l igomerization or they st imulated i t .  For the sake of simpl ic i ty ,  we wi l l  only 
refer to two compounds : CMC 1 0, which represents the group of CMCs that induced 
o l igomerization ( Fig .  6 .5  C ), and CMC I L which represents the group of CMCs had 
no effect on ol igomerization ( Fig .  6 .5  D) .  Thus, I n  the presence of CMC 1 0, Oo-syn 
o l igomerization was enhanced compared to the controL as indicated by the detection 
of numerous strong bands corresponding to the o l igomeric species ( Fig.  6 .5 C), in  the 
presence of a l l  CMC l l concentrations. separation of a-syn in the gel generated 
bands comparable with that of the control ,  indicat ing that CMC 1 1  fai led to inhibit 00-
syn o l igomerization ( Fig .  6 .5  D) ,  which is s imi lar to its observed effect on 
fibri l l at ion. The amount of monomeric Oo-syn in the a-syn aged alone samples and in 
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the pre ence of M wa quantified against a fre h a-syn sample that contained 
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Figure. 6 . 5 .  I mmunoblot analysis of the effect of CMCs on a-syn o l igomerizat ion. a­
Syn alone or i n  the presence of CMCs at CMC: a-syn molar ratios of 1 :  L 2 :  1 and 
4 : 1 .  i ncubated for 5 days. Lane 1 ,  CMC:  a-syn 1 : 1 ,  lane 2, CMC : a-syn 2 : 1 . lane 3 .  
C M C :  a-syn 4 :  L A :  aged a-syn and M :  monomeric a-syn. A .  Salvianol ic  acid B 
(CMC l ). B .  D ihydromyricet in  (CMC7),  c .  Geniposide (CMC 1 0), D. B i lobal ide 
(CMC 1 1 ) . The amount of the monomeric a-syn was quant ified for a-syn samples 
incubated with or without the CMCs at d ifferent molar ratios using I mageJ software. 
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6.3.3 The effect of a iv iano t ic  acid B a n d  d i hydromyricet in on (l - yn- ind uced 
cy totoxic ity 
BE(2 )-M- 1 7  human neuroblastoma cel l s  were treated with aged a-syn 
olut ion at three different concentration , 0 .5 .  1 and 5 11M.  either alone or in the 
pre ence of MC . The CMCs tested included MC L CMC7. CMC I O  and CMC l l .  
The last two compound CMC 1 0  and CMC l l were included as negative controls 
becau e they fai led to inh ibit or even st imulate the formation of a-syn aggregation. 
The viabi l i ty of cel l treated with a-syn solution aged in the presence or 
ab ence of CMC \Va determined with an MTT assay. Prior to experiments. the 
effect of CMCs alone on cel l iab i l ity wa assessed. employing the same non-toxic 
CMCs concentrations that were later employed for experiments with aged a-syn 
solut ion ( Figs. 6 .6 left panel )  
Aged a-syn  inhibited the reduction in  MTT in  a dose-dependent fashion ( Fig.  
6.6) .  Because a reduction i n  MTT i s  d irect ly proportional to the number of surviving 
cel l s. i t  i s  apparent that fewer cel l s  survi ed at h igher concentrat ions of aged a-syn 
( Fig .  6 .6) .  However. aged a-syn solutions in the presence of CMC I and CMC7 were 
less toxic to cel ls ,  as indicated by the increase in MTT reduction ( Fig.  6 .6) .  which 
was directl y  proportional to the number of l iv ing cel ls .  I ndeed, S 11M of a-syn aged 
alone induced the reduction in viable cel l s  by almost 50% whereas in the presence of 
CMC L cel l surv ival  dramatical l y  improved, reach ing 95% for the molar ratios of 4: 1 
and 2 :  1 (F ig. 6 .6) .  I nterestingly, at these molar ratios, CMC I proved to be a good 
i nhib i tor for fibri l formation. as indicated by the reduction in the Th-T counts ( Fig .  
6. 1 ) . CMC7 also reduced the a-syn tox ic ity, but i t  was not as potent as CMC 1 ( Fig.  
6 .6) .  CMC7 exhibi ted slight protection for cel l s  at the h ighest concentration. which is 
represented by the molar ratio of 4 :  1 ,  thus improving cel l viabi l ity by approximately 
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] 0%. The e finding are in accordance with the Th-T fluore cence measurement 
( Fig.  6 . 1 )  and i mmunoblotting analy  e ( Fig.  6 .5 ) .  
A e pee ted . the rest of the t ted compounds, CMC 1 0 and CMC ] L did not 
hov, any protective effect for neuroblastoma cel l  against the toxici ty of aged a-syn 
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Figure 6 .6 .  The effect of the CMCs on the toxic ity induced by the aggregates of a­
syn. The viabi l i ty of BE(2 )-M- 1 7  human cel l s  was evaluated by MTT assay. The 
results are expressed as percentages of the average of the control ( i .e .  untreated 
cel ls ) .  The cel l s  were treated with either a-syn aged with or without the CMC L 
CMC7, CMC I O. and CMC l 1 for 48 hours prior to the addit ion of MTT. The graphs 
appearing on the left panel i l lustrate the toxic i ty of the compounds alone (a erage of 
3 wel l s  ± standard deviation). Statistical analysis was performed using a two-tai led 
unpaired t-test . * * * ,  p< 0 .00 1 :  * * ,  p< 0.0 1 ;  * ,  p< 0.05.  
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To confirm the to icit} effect ob erved in the MIT assay. BE( 2 )- 1 - 1 7  
neuroblastoma cel l s  were expo ed to 5 JlM a-syn aged in the presence or ab ence of 
the MC L CMC7. CMC I O. and CMC 1 1 at a molar ratio of 1 :4 (a-syn : CMC) and 
ubjected to immuno taining for a- yn. F luore cence microscopy revealed that 
whereas untreated cel l s  wer healthy and displayed diffuse cytoplasmic a-syn 
staining ( Fig .  6 .7  ) .  the cel l s  treated with aged a-syn lost their neuronal shape, 
appearing rounded and unhealthy, with aggregated fibri l s  being accumulate at the 
cel l membranes ( Fig .  6 . 7  B ) .  Thi effect was dramatical ly  reversed when the cel l s  
\vere treated with a- yn  aged in the presence of CMC I and CMC7, with no  apparent 
aggr gates detected on the cel l membranes ( Fig.  6 .7  C and D respecti e ly) .  In  
contrast , the cel l  treated with the a-syn aged in  the presence of CMC 1 0 and 
CMC l l ,  \vh ich were shown abo e not to inhibit  a-s)'n aggregation, appeared 
rounded, unhealthy and bearing extracel lular. membrane-bound aggregates ( Fig.  6 .7  
E and F) .  
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Figure 6. 7. I mmunocytochemistry against a-syn of BE(2)-M- 1 7  cel ls .  A.The cel l s  
were ei ther non-treated or  treated for 48 hours with 5 11M of B .  aged a-syn alone. or 
v" ith ginsenoside C. CMC l .  D. CMC7. E. CMC 1 0. F. CMC l l .  At a molar ratio of 
aged a- yn : compound 1 :-+. Scale bar 30 11m .  
6.3' "  The effect of  sa lvianol ic  a c i d  B and d ihyd romyricetin on p refo rmed 
a-syn a myloid fibri ls  
Becau e CMC I and CMC7 were shown to be effective inhibitors of a-syn 
fibri l lation. we wondered whether they could also reverse fibri l l at ion. Hence. 25 11M 
of prefOlmed a-syn fibri l s  was incubated at 3 7°C in the presence of the above 
mentioned CMCs at CMC:  a-syn molar ratios of 6 : 1 , 4 : 1 and 2 : 1 for a period of 48 
hours. By measuring the Th-T fluorescence counts ( Figs .  6 .8  A and B) .  we estimated 
the fibril content at the d ifferent points. At 0, the Th-T COWltS were approximately  
20,000 for a-syn incubated alone or  with CMC l ,  whi le  in the presence of CMC7.  the 
Th-T count was less at that t ime point (F ig. 6 .8  A and B) .  The a-syn fibri l s  that were 
i ncubated alone continued to aggregate further. as indicated by the increase in Th-T 
counts ( Fig .  6 .8  A and B ) . However, whi le  a-syn fibri l s  incubated in the presence of 
CMC7 d isaggregated over t ime, given the decrease in Th-T counts ( Fig.  6.8 B ), on 
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the other hand, M I fai led to di saggregate the preformed a-syn fibri l ( Fig. 6.8 A) .  
Thu MC7 di aggregated preformed a- yn fibri l in a dose-dependent fa ruon. 
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F igure 6 .8 .  Effect of CMC } and CMC7 on performed a-syn fibri ls. A and B .  
amples o f  aggregated a-syn were i ncubated for 4 8  hours at 37°C i n  the absence or 
presence of various concentrations of CMC } and CMC7 (CMC: a-syn at 6 : 1 , 4 : 1 ,  
and 2 : } ) . The fibri l content was then measured by a Th-T binding assay. The assays 
were performed in tripl icate (average of trip l icate measurements ± standard 
deviat ions) . C. E lectron m icroscopy images of negatively stained samples of aged u­
syn incubated with alone or in  the presence of CMC I and CMC7 CMC: a-syn at 
6 : 1 )  for a or 48 hours with continuous shaking at 3 7°C. Scale bar, 500 lun . 
6.3.5 The effect of  salvianol ic acid B a n d  d ihyd romy ricetin on the seed ing  of a-
syn monomers 
I t  has been previously shown that the process of amyloid fibri l  fOlmation 
fol lows a nucleation-dependent polymerization model ( Jarrett & Lansbury, 1 992). 
According to this mode l ,  soluble species generate v ia nucleation o l igomeric species 
(nucleation or lag t ime phase), which in tum polymerize ( polymerization or growth 
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pha ) to g nerate fibri l . thu reaching a fmal plateau knov,n a the equil ibrium 
pha e ( Harper. Wong. L ieber. & Lansbury. 1 999) .  mal l  aggregates or eed have 
been hov,;n to accelerate the nucleation phase of amyloid formation in vitro and in 
vim via a proce knov.n as eeding ( Harper & Lansbury, 1 997; Jarrett & Lansbur . 
1 993 : Luk. et a ! . .  20 1 2 : VolpiceU i -Daley. et a1 . .  20 1 1 ) . Gi  en that CMC I and CMC7 
i nhib i ted a- yn fibri l lation and that onJy CMC7 di saggregated prefonned a-syn 
fibri l . we ought to ident ify the effect of those compounds on the seeding of a-s n 
aggregation. More spec ifical ly .  mature a-syn fibri l s  were fragmented by sonication 
to obtain hort fibri ls .  which were employed as ' seeds' ( Fig .  6.9 C). These short 
fibri l lar eeds were then added to monomeric a-syn, which was a l lowed to aggregate 
a described above. As expected, the addit ion of the short fibri l lar seeds accelerated 
the fibri l l at ion proces of a-syn monomers, as indicated by an increase in Th-T 
count . Indeed, with seeding. the extent of a-s n fibri l lation after 6 hours of 
incubat ion \\'as comparable with the extent of fibri l l ation of protein incubated for 24 
hours without seeding ( Figs. 6.9 D, B and Fig.  6. 1 ). 
To assess the effect of CMC 1 and CMC7 on the seeding of a-syn aggregation, 
the compounds were added at concentrations of 1 0  or 50 11M to 1 00 11M monomeric 
a-syn containing seeds at a final concentration of 2 11M,  and the mixture was then 
incubated with continuous mixi ng at 3 7°C for 6 hours. The tested CMCs at a 
concentration of 50 11M i nhib i ted the seeding process by approximately  90%, as 
ind icated by the low Th-T counts ( Fig .  6.9 A and B) .  In  contrast, at a lower 
concentration ( l 0  11M ), only CMC7 showed an i nhib i tory effect on the seeding of a­
syn monomers. but to a lesser extent in the case of CMC I (Fig .  6 .9 A) .  These 
fmdings ( for 50 11M and 6 hours incubation) were confirmed by TEM ( Fig.  6.9 C) .  
161  






000 - - - C le I  1 0!lbl 
7000 C. tel  SOil. I 
6000 ..:r ,. . ' 5000 r' I �1 
�OOO r '" , 
3000 , , 
2000 .x _ - ?  l.... .... . :,; .. -::" r --1000 a.:.:'.,.� -1 -- -
0 




.. ,/ I "000 I 
I 
6000 I .'!i " :::> 5000 c u 






......... 0, jn+seeds 
- - - CMC7 1 0J.lM 








1- - -I 
. ..... � .
. �'�·r - - :r - - -
}--;';:':-';' 
-
- _:1 . - - - 1_ . I 
o 3 � 6 
Tune (bours) 
Figure 6.9.  Effect of CMC I and CMC7 on the seeding of a-syn monomers with 
fibri ls .  and B. amples of a-s n monomers ( 1 00 lJ-M )  were seeded with 2 lJ-M 
onicated a- yn fibri ls .  which were incubated in the presence or absence of CMC I 
and CMC7 at d ifferent concentrat ions ( 1 0  and 50 lJ-M) for 6 hours with continuous 
haking at 3 7°C. The extent of fibri l lation was estimated by Th-T binding assay. The 
a says v;ere performed in tripl icate (average of trip l icate measurements ± standard 
deviat ions) .  C. E lectron microscopy images of negat ively stained samples of seeds 
alone and a-syn i ncubated with seeds alone or in the presence of CMCs (50 lJ-M )  for 
6 hours with continuous shaking at 3 7°C. Scale bar, 500 nm . 
6.3.6 Salvianotic acid B a n d  dihydromyricetin i n h ibit ion of  a-syn fibri l lation is 
mediated via b inding to the in termediate s pecies a n d  fo rming sta ble 
o l igomers 
Monomeric a-syn ( 1 00 ).lM )  was aggregated in  the presence of CMC I and 
CMC7 and after 5 days of incubation the samples were centri fuged and the 
supernatant was i njected in a superdex 200 SE column. The elution volume for 
monomeric a-syn was determined by a molecular weight standard ( Fig .  4 .7  A) .  and 
was eluted in  a peak corresponding to a column volume of 1 4- 1 6  mL ( Fig.  4.7 B ), 
whi le o l igomeric a-syn e luted i n  a peak corresponding to colurnn volume of 
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C 
approximately 7-8 and 1 2- 1 4  ml  for P I  and P2 respec6vely ( Fig .  6. 1 0  A and 6. 1 1  A ) .  
The fraction corre ponding to  the ol igomeric and monomeric a-syn peaks were 
eparately pooled together giving rise to P I ,  P2 and P3 samples ( Fig .  6 . 1 0  A and 6. 1 1 
A 
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binding act iv ity to a-syn o l igomers (CMC 1 :  a-syn 4 :  1 ) . A. Gel fi ltration profile of 
1 00 J-lM a-syn sample incubated with CMC I at 4 : 1 molar ratio (CMC l : a-syn) for 5 
days as described before using superdex 200 SE column. P I  and P2 represent the 
o l igomeric species whi le  P3 represents the monomeric species, the e lution was 
monitored at absorbance wavelengths of A2 1 5  TEM images represent the resulted 
peaks in the top of A . B. I mm unoblot analysis of the pooled fractions represent P, P2 
AND P3 resulted from the presence of CMC 1 at molar ratios of CMC l : a-syn 4 : 1 
incubated for 5 days with continuous shaking at 3 7°C were separated by 
e lectrophoresis in a 1 5% SDS-PAGE gel . C.  P I ,  P2 and P3 samples of a-syn resulted 
from the SE chromatography were placed in  a 1 0mm quartz cuvette and the UV 
absorbance spectra were recorded from 200 nm to 600 nm . D.  The UV absorbance 
spectra of CMC 1 alone. 
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The (1- y n  pecies in  the ample were characterized by western blotti ng and 
EM ( Fig .  6 . 1 0  and 6 . 1 1 and B) .  ccording to the \J estern blotting results. the 
o l igomer generated during the incubation of a-syn with both CMC 1 and CMC7 are 
stable  under denaturing conditions ( Fig.  6 . 1 0 B and 6. 1 1  B ) .  E lectron microscopy of 
the same ample indicates the presence of d i fferent species of o l igomers in P I  and 
P2 ( Fig.  6. 1 0  A and 6 . 1 1  A). in  agreement with the imunoblotting resul ts ( Fig .  6. 1 0  B 
and 6. 1 1  B) .  
A 
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F igure 6. 1 1 .  CMC7 bind ing activity to a-syn o l igomers (CMC7:  a-syn 4 : 1 ). A. Gel 
fi l tration profile of 1 00 J.lM a-syn sample incubated with CM C7 at 4: 1 molar rat io 
(CMC7:  a-syn) for 5 days as described before using superdex 200 SE column, P I .  
P 2  represent the o l igomeric species and P3 represent the monomeric species, the 
elution was monitored at absorbance wavelengths of A2 I S .  TEM images represent the 
resul ted peaks in the top of A. B. I mn1 unoblot analysis of the pooled fract ions 
represent P I .  P2 and P3 resul ted from the presence of CMC7 at molar ratios of 
CMC7:  a-syn 4 : 1 incubated for 5 days with continuous shaking at 3 7°C were 
separated by electrophoresis in a 1 5% SDS-PAGE gel .  C. P I ,  P2 and P3 samples of 
a-syn resulted from the SE chromatography were placed in  a 1 0mm quartz cuvette 
and the UV absorbance spectra were recorded from 200 nm to 600 run . D. The UV 
absorbance spectra of CMC7 alone. 
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I n  order to detect the incorporated CMC 1 and CMC7 in  the P I .  P2 and P3 
sample , we exploited the property of both compounds to produce absorbance 
sp ctra with three notable  peak (F ig .  6 . 1 0  D and 6 . 1 1 D) .  In the sample containing 
CMC 1 :  a- yn at 4: I molar rat io. we detected CMC I only in  the ol igomeric P2 
ample ( Fig. 6 . 1 0  C) Vvhile in the sample containing CMC7: a-syn at 4 : 1 we 
detected CMC7 in both P2 and P3 which represent the ol igomeric and monomeric 
pecies respectively.  
To further e aluate whether CMC 1 and CMC7 interact with a-syn 
monomers, v. e monitored a t i tration of both compounds into a solution of monomeric 
a- yn u i ng two-dimensional MR spectroscopy. which provides signal s covering 
the entire ami no acid equence of a-syn ( Fig .  6. 1 2  and Fig.  6. 1 3  respectively) .  At 
stoichiometries of up to 6 : 1 CMC l :  a-syn, and 1 0 : 1  CMC7 :  a-syn, we obser ed no 
sign ificant chemical shifts or resonance i ntensi ty changes ( Fig .  6. 1 2  A and Fig. 6. 1 3  
A respectively), and the peak i ntensity ratio  plots of (wt a-syn + CMC 1 or CMC7) 
( Fig .  6. 1 2  B and Fig.  6 . 1 3  B respectively) indicate that there i s  no s ign of interaction 
between a-syn and CMC 1 or CMC7. confiml ing that CMC I and CMC7. does not 
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Figure 6. 1 2 . Analysis of  CMC I binding to  monomeric a-syn by  N M R  spectroscopy. 
A. Proton- i trogen correlation ( HSQC ) spectra of monomeric a-syn in  the presence 
of i ncreasing ratios of Salvianohc acid  B CMC 1 : a-syn. B. Peak i ntensity ratio plot 
of 200 )lM 1 - - labeled wt a-syn F L+ CMC I (CMC l : a-syn 1 : 1 , 2 : 1 , 4 : 1 and 6 : 1 ) . 
From the H SQC spectra and the intensity plot, there might be i nteraction between a­
s n monomer and CMC 1 .  A .  1 :  1 10 :  1 and 0 :  1 10 :  1 ;  B .  2 :  1 10 :  1 and 0 :  1 10 :  1 ;  C .  4 :  1 10 :  1 
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Figure 6 . 1 3 . Analysis of CMC7 binding to monomeric a-syn by M R  spectroscopy. 
A. Proton-Nitrogen correlat ion ( HSQC) spectra of monomeric a-syn in the presence 
of increasing ratios of D ihydromeryricet in  CMC7.  B. Peak i ntensity ratio plot of 200 
flM 1 5N-labeled wt a-syn F L+ CMC7 (CMC7:  a-syn 1 : 1 , 2 : 1 , 4 : 1 , 6 : 1 and 1 0 : 1 ) . 
From the H SQC spectra and the i ntensity plot, there is no interaction between a-syn 
monomer and CMC7.  a. 1 : 1 /0 : 1 and 0 : 1 10 : 1 ;  b. 2 : 1 10 : 1 and 0 : 1 /0 : 1 ; c .  4 : 1 /0 : 1 and 
0 : 1 10 : 1 :  d. 6 : 1 /0 : 1 and 0 : 1 10 : 1 ;  e .  1 0 : ] /0 : 1 and 0 : 1 10 : 1 
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6.4 D i  c u  I o n  
I n  thi tud) , a total of elev n C IC were a se sed for their effect on the 
f rmat ion of early aggregates ( soluble o l igomers )  and late aggregate ( fibri ls) .  
mong the compound creened, alvianol i  acid B and dihydromyricet in ( MC7) 
\\ ere h V\ n to be the most potent inhibi tors of a- n o l igomerization and 
fibri l lation. These compound were also able to protect neuroblast rna cel l s  from the 
tox i effe t of aged a- yn. 
alvianol ic acid B (CMC ] )  is  one of the mo t abundant compounds extracted 
from Radix Salvia milliorrhi::a ( Danshen ). For centuries, trad it ional Chinese 
medic ine has exploited the medicinal propert ies of danshen, employ ing it as a 
remedy against cardiova cular disorders. The med ici nal propert ies of salvianol ic acid 
B rel y  on its ant i -oxidative abi l i ty, which is attributed to i t  by its polyphenol i c  
structure. D ih  dromyricet in  (CMC7)  is  a flavonoid that can be extracted from the 
Japane e rais in t ree (Hovenia dulcis) and is employed as a hangover cure. 
Our resul ts show for the first t ime that salvianol ic  acid B and dihydromyriceti n  
di  rupt the o l igomer and fibri l fomlation of  a-syn in vitro. Salvianol ic  acid B and 
d ihydromyricetin blocked a-syn o l igomerization and fibri l l at ion in  a concentration­
dependent manner. a lvianol ic acid  B also protected neuroblastoma cel l s  against a­
syn toxici ty in vitro, demonstrating a marked increase in  cell survival ,  whi le  
dihydromyricet in  exhibited weak neuroprotection at  the highest concentrat ion. 
E lectron microscopy of a-syn aged solut ions with salvianol ic  acid B and 
d ihydromyricetin showed that the protein  fom1s smal l  non-toxic, sheared, rod- l i ke 
fibri l s  that fai l  to elongate. 
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These result are in accordance v, ith pre\ iou reports that describ d sah ianol ic 
acid B as an ant i - fibri l logenic and neuroprotective compound. I ndeed. sal \' ianol ic 
acid B has been previously reported to inhibit the fibri l formation of certain 
am) loidogenic compound W-arn loid (A�), human islet runyloid pol peptide 
(h ]  PP) ]  and to  protect cel l s  from their to  i c  effects. In fact, salvianol ic  acid B not 
nly block the tibri l lation of A� (Tang & Zhang. 200 1 but also di saggregates 
preformed � fibri l s  ( Durairajan et aI., 2008) .  Furthermore, salvianolic ac id B was 
bO\ n to have neurotrophic properties, protect ing cel l s  from the toxic effects of �42 
( Ourairajan, et a l . .  2008) and A�25-35 ( Lin  et aI . ,  2006; Tang & Zhang. 200 1 ) . Recent 
report ind icate that th neurotrophic properties of salvianol ic ac id B also extend to 
animals (D .  H. Kim. et a l . ,  20 1 L Y. W. Lee et aI . ,  20 1 3 ) .  A recent tudy also 
demonstrated that salvianol ic  acid B i nhibits the fibri l lation of hIAPP, disaggregates 
preformed h I  PP fibri l  and protects pancreat ic INS- J cel ls against the tox ic effects 
of h IAPP (Cheng et aI . ,  20 1 3 ). 
MarlY phenol ic compounds, includ ing baicalein (Caruana, et a I . ,  20 1 1 ;  Zhu, et 
aL 2004) ,  epigal locatechin gal late ( EGCG) (D .  E. Ehmhoefer, et a I . ,  2008), 
rosmarinic acid  (Caruana, et aI . ,  20 1 1 ;  Rao, Dua, & Ulmer, 2008), tannic ac id 
(Caruana, et a l . ,  20 1 L Ono & Yamada, 2006) and myricetin (Caruana, et a l . .  20 1 1 ;  
Ono & Yamada, 2006), have been previously shown to inh ibit  the ol igomerization 
and fibri l l at ion of a-syn, which is in  accordance with our findings. Furthermore, 
several l i nes of evidence i ndicate that polyphenol ic  compounds inhibit  the elongation 
phase of amyloid aggregation ( Ono et a I . ,  2003;  Zhu, et a i . ,  2004), which may 
explain why salv ianol ic  acid B and d ihydromyricetin inhibi ted a-syn fibril lation 
( Fig.  6. 1 and Fig. 6 .2)  and generated small aggregates with a sheared appearance and 
not resi stant to PK d igestion ( Fig. 6.3 and Fig. 6 .4) .  Salvianol ic  acid B (CMC 1 )  and 
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dihy drom) ricetin ( 7 )  are phenol ic  compound containing four and t\vo phenyl 
rings in their tructure . re pect i \ ely .  The mechan ism by wh ich phenol ic compounds 
inhibi t  a-s) n aggregation i bel ieved to be med iated b interactions between the 
phenol ic  compounds and the aromatic residues of the an1yloids, directing the former 
towards the am) loidogenic core and thus interfering with the n-stack ing of the rings 
of the aromatic re idue that promote amyloid aggregation ( Porat, et ai . , 2006). I n  
addit ion, the hydro. yl moietie attached to the phenyl rings of  the phenol ic 
compound are considered to play an essential role in the inhibition of the � -sheet 
structure by compet itive hydrogen bond ing ( Porat, et aL, 2006) . .  Interestingly, 
CMC7 wa able to di  aggregate the preformed fibri ls ( Fig.  6 .8  B), whereas CMC 1 
fai led to do 0 ( Fig.  6 .8  A) .  Moreover, both CMC 1 and CMC7 were shown to block 
the eeding of a-s n monomers with preformed fibri ls, and CMC7 was capable of 
inhibit ion at both tested concentrat ions ( Fig. 6 .9 B ) ,  while CMC 1 had this effect only 
at 50 11M ( Fig.  6.9 A) .  In this study, we showed also that CMC I has the abi l ity to 
bind to o l igomers ( Fig.  6. 1 0  C) whi le CMC7 was found to b ind to both monomers 
and o l igomers ( Fig.  6 . 1 1  C) ,  which could be a start ing point to i nvestigate the 
mechani m behind the act iv i ty of these two compounds, to inhibit  the fibri l  
formation of a-syn. 
Regarding the neuroprotect ive effect that salv iano l ic acid B exerted on 
neuroblastoma cel ls, we assumed that i t  i s  due to the anti -aggregating act iv i ty that 
both compounds demonstrated. but we cannot exclude the possibi l ity that the ant i ­
oxidant properties of salv iano l ic ac id B ( L in, et aL ,  2006) also contribute to  this 
effect. Membrane pem1eab i l ization and al teration in  calcium homeostasis, which can 
cause cytotoxic i ty, resu lted from the binding of the rich �-sheet amyloid fibri l s  
formed by aged a-syn ( E I-Agnaf, Jakes, Cunan, M iddleton, e t  a l . ,  1 998;  Pieri , et a l . ,  
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20 1 2 ; Rey nolds, et al . .  20 1 1 ) . The fluorescence pattern of a- yn aggregates that \\ e 
ob en'ed in cultured 8£(2)- 1 - 1 7  cel l s  treated with aggregated a- yn alone i 
indicative of the local ilation of these aggregates to the pia ma membrane, whi l e  the 
cel l s  10 t th ir characteri tic neuronal hape as they appeared rounded and unhealthy 
( Fig.  6 .7  B )  Whi le  treatment 01' the cel l s  with a-syn aged in the presence of CMC I 
and C 1C7, \\h ich did not result in a-syn fibri l lation, appeared healthy without the 
accumulation of a- yn at the ce l l  membranes ( Fig.  6 .7  C and D ), whereas exposure to 
a-syn aged in the presence of CMC 1 0  or CMC 1 1 , which were poor inhibi tors of a-
yn fibri l lation, led to the fom1at ion of membrane-bound aggregates \ here the cel l s  
appeared unhealthy and rounded ( Fig. 6 .7  £ and F ) .  This  observat ion is in  
accordance with the results obtained from the MTT assay, wherein ce l l s  treated with 
aged a- yn alone or in the presence of CMC I 0 or CMC 1 1  displayed cytotoxici ty, 
\\ h i  h was not ob erved when the cel l s  \\'ere exposed to a-syn aged in the presence 
of CM I or CMC7.  ince both CMC 1 and CMC7 were found to  inhibi t  a-syn 
fibri l lation and tabi l ize so luble, non-toxic o l igomers wi thout a (3-sheet content ( Fig.  
6 . 1 ), we hypothesize that the neuroprotective role  of CMC 1 and CMC7 stems from 
its abi l i ty to i nh ib i t  the formation of mature amyloid fibri l s  contain ing (3-sheet 
structures and thereby prevent plasma membrane disrupt ion in neuroblastoma cel ls .  
Our findings using both NMR and SEC combined with UV spectroscopy, 
suggested that sal ianol ic  ac id B inhibi ts a-syn fibri l lation not by i nteract ing with the 
monomeric a-syn and preventing i t  from fibri l l at ion, but rather by stab i l izing the 
structure of soluble ol igomeric a-syn without any (3-sheet content ( Fig.  6 . 1 0  A, and 
F ig. 6. 1 2) ,  \\'hich appears to be non-toxic ( Fig. 6.6 A and Fig.  6 .7  C) .  Whi le 
dihydromyricetin binds to both o l igomers and monomers as shown in  the FPLC 
analysis ( Fig.  6 . 1 1  D ) ,  whereas the NMR analysis didn t show the binding of this 
17 1  
compound \\ ith monomeric a- yn ( Fig. 6. 1 3 ). inc some interaction between a-syn 
and binding partners are not re ealed in chemical h i ft changes. we also analyzed for 
change to re onance inten it ie , \" hicb can ometimes reveal interaction that are 
otherv. ise overlooked . In  thi case, neither chemical shifts nor intensit ies changed. 
everthelc s. it remains po ib le that a ver weak interaction occur that is  missed 
b) both mea ures, as indeed \Vas the case in the anal si of Hsp70 binding by 
Dedm n et a1 .  ( Dedmon. et a1 . ,  2005) .  The MR data suggests that if any interaction 
is present with m nomeric a-syn, i t  is a very weak and transient one. When 
combined \\ ith the size exclusion data, we conclude that the predominant interaction 
of dihydromyricet in is  with o l igomeric a-syn rather than v ith the monomeric protein .  
The e find ings are in  accordance \ i th previous studies indicating that some 
pol y  phenol ic compounds, such as baicalein,  curcumin and epigal locatechin gal late 
induce the formation of soluble,  non-tox ic o l igomers of a-syn or A� ( Parat. et a1 . ,  
2006) .  
In  conc lusion, two compounds from a smal l  l ibrary of e leven CMCs isolated 
from widely used C HMs, al ianol ic  acid B and dihydromyricet in ,  were shown for 
the fir t t ime to inhibi t  a-syn aggregation and toxicity in vitro. The next step is to 
elucidate the mechanism by which these compounds inhibit  a-syn aggregat ion and 
toxic i ty and to as ess their effect on PD animal models .  The compounds we 
ident ified in this study could represent the start ing point for designing new molecules 
that may be used as drugs far the treatment of PD and related disorders. 
172 
7 C ha pte r 7 :  Concl u Ion 
7. 1 Co n c I u  I O n 
everaJ studies upport ing the h pothesis that the aggregat ion of native 
protein is  direct l J  eeded by exogenou aggregates. 0 era l l ,  these stud ies support 
the notion that am) loid to ic i ty i mediated by a nucleation-dependent 
pol) merization process. In agreement with those studies, our in vitro data also 
howed that the a- I n  amyloid tox ic ity i s  mediated by the ongoing nucleation­
dependent polymerization ' seed ing ' .  I n  contrast with wt-a-syn, p-S 1 29 a-syn 
found to inhibit the seeded aggregation of wt-a-syn, and fai led to aggregate and 
form amyloid fibri ls .  The e finding prompted us to screen compounds that can 
inhibit the fibri l  fOlmation and the seed ing of a-syn aggregat ion. From the 
compounds screened, onl gal l ic acid, g insenoside Rb 1 ,  salvialon ic  acid B and 
d ihydromyricet ine found to inhibit  the seeding aggregat ion of a-syn and also 
d isplayed an i nh ibi tor effect on a-syn fibri l formation by stab i l izing non-toxic 
soluble ol igomers \ i th no p-sheet content, while only dihydromyricet ine was 
found to bind with both monomeric and ol igomeric forms of a-syn. Those 
compounds may represent the start ing point for designing new molecules that 
could be used for the t reatment of PD and related disorders. 
7.2 F u t u re work 
There i s  an  immediate need to  further i nvestigate the correlation between 
the aggregation and toxicity of a-syn and the phosphor [ation at S 1 29, especial ly 
in  the l ight of recent findings support ing the idea that a-syn mediated toxic i ty is  
caused by the nucleat ion-dependent polymerization process. 
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Ba ed on our in vitro creenmg, together \\ ith previous finding , tho e 
potent compound need to be tested in vivo to invest igate their abi l i t) to inhibit 
the seeded aggregat ion or (1,- yn and their effect on the motor beha ior and 
pathology of PD an imal model . 
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